Pediatrics

Contents
General Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Pediatric History and Physical Examination . . . . . . . . . . . . . . . . . . . . . . . . 7
Progress Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Discharge Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Prescription Writing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Procedure Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Developmental Milestones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Immunizations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Haemophilus Immunization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Varicella Immunization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Influenza Immunization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Pediatric Symptomatic Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Antipyretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antitussives, Decongestants, Expectorants, and Antihistamines . . . . . .
Analgesia and Sedation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antiemetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17
17
17
22
24
Cardiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pediatric Advanced Life Support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congestive Heart Failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypertensive Emergencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27
27
31
32
34
Pulmonology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allergic Rhinitis and Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Anaphylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pleural Effusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
35
35
38
40
41
Infectious Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Suspected Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meningitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Specific Therapy for Meningitis and Encephalitis . . . . . . . . . . . . . . . . . .
Infective Endocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Endocarditis Prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Community Acquired Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Immunosuppressed, Neutropenic Pneumonia . . . . . . . . . . . . . . . . . .
Specific Therapy for Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pertussis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Viral Laryngotracheitis (Croup) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43
43
44
45
47
48
49
50
51
52
55
56
56
Varicella Zoster Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ventriculoperitoneal Shunt Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pneumocystis Carinii Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Oropharyngeal Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Invasive or Disseminated Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . .
Cryptococcus Neoformans Meningitis . . . . . . . . . . . . . . . . . . . . . . . . .
Herpes Simplex Infections in Immunocompromised Host . . . . . . . . . .
Herpes Simplex Encephalitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Herpes Varicella Zoster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cytomegalovirus Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Toxoplasmosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Disseminated Histoplasmosis or Coccidiomycosis . . . . . . . . . . . . . . .
Mycobacterium Avium Complex . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Septic Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Appendicitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lower Urinary Tract Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pyelonephritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Osteomyelitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Otitis Media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Otitis Externa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tonsillopharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Streptococcal Pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retropharyngeal Abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Epiglottitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Helicobacter Pylori . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Active Pulmonary Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cellulitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Periorbital Cellulitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Impetigo, Scalded Skin Syndrome, and Staphylococcal Scarlet Fever . .
Tetanus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pelvic Inflammatory Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pediculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Scabies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dermatophytoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bite Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lyme Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
57
58
58
59
61
61
61
61
61
62
62
62
62
62
62
63
64
65
66
67
68
69
69
69
70
70
71
72
74
74
75
76
76
78
78
79
80
82
Gastroenterology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gastroenteritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Specific Therapy for Gastroenteritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hepatitis A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hepatitis B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ulcerative Colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Parenteral Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
83
83
84
86
86
87
88
Gastroesophageal Reflux Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antidotes to Common Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Narcotic or Propoxyphene Overdose . . . . . . . . . . . . . . . . . . . . . . . . . .
Methanol or Ethylene Glycol Overdose . . . . . . . . . . . . . . . . . . . . . . . .
Carbon Monoxide Inhalation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cyanide Ingestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Phenothiazine Reaction (Extrapyramidal Reaction) . . . . . . . . . . . . . .
Digoxin Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benzodiazepine Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Alcohol Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Organophosphate Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Anticholinergic Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Heparin Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warfarin Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acetaminophen Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lead Toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Theophylline Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Iron Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
93
93
93
93
93
93
93
94
94
94
94
94
94
94
95
95
96
97
97
Neurology and Endocrinology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
Seizure and Status Epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
Adjunctive Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
Spasticity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
New Onset Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Diabetic Ketoacidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
Hematologic and Inflammatory Disorders . . . . . . . . . . . . . . . . . . . . . . . 107
Sickle Cell Crisis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
Kawasaki's Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Fluids and Electrolytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Dehydration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hyperkalemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypokalemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypernatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hyponatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypophosphatemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypomagnesemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
111
111
113
114
115
115
116
118
Newborn Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Neonatal Resuscitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Suspected Neonatal Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Respiratory Distress Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Necrotizing Enterocolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Apnea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bronchopulmonary Dysplasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hyperbilirubinemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital Syphilis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital Herpes Simplex Infection . . . . . . . . . . . . . . . . . . . . . . . . . . .
Patent Ductus Arteriosus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hepatitis Prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Neonatal HIV Prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
123
123
124
124
125
126
126
126
127
127
Commonly Used Formulas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
Pediatric History and Physical Examination 7
General Pediatrics
Pediatric History and Physical Examination
History
Identifying Data: Patient's name; age, sex. List the patients significant medical
problems. Name and relationship to child of informant (patient, mother).
Chief Compliant: Reason given by patient/informant for seeking medical care
and the duration of the symptom(s).
History of Present Illness (HPI): Describe the course of the patient's illness,
including when it began, character of the symptom(s); aggravating or alleviating
factors; pertinent positives and negatives. Past diagnostic testing.
Past Medical History (PMH): Past diseases, surgeries, hospitalizations; medical
problems; history of asthma.
Birth History: Gestational age at birth, preterm, obstetrical problems.
Developmental History: Motor skills, language development, self-care skills.
Medications: Include prescription and OTC drugs, vitamins, herbal products,
natural remedies, nutritional supplements.
Feedings: Diet, volume of formula per day.
Immunizations: Up-to-date?
Drug Allergies: Penicillin, codeine?
Food Allergies:
Family History: Medical problems in family, including the patient's disorder.
Asthma, cancer, tuberculosis, allergies.
Social History: Family situation, alcohol, smoking, drugs. Level of education.
Review of Systems (ROS):
General: Weight loss, fever, chills, fatigue, night sweats.
Skin: Rashes, skin discolorations.
Head: Headaches, dizziness, seizures.
Eyes: Visual changes.
Ears: Tinnitus, vertigo, hearing loss.
Nose: Nose bleeds, discharge.
Mouth and Throat: Dental disease, hoarseness, throat pain.
Respiratory: Cough, shortness of breath, sputum (color and consistency).
Cardiovascular: Dyspnea on exertion, edema, valvular disease.
Gastrointestinal: Abdominal pain, vomiting, diarrhea, constipation.
Genitourinary: Dysuria, frequency, hematuria.
Gynecological: Last menstrual period (frequency, duration), age of menarche;
dysmenorrhea, contraception, vaginal bleeding, breast masses.
Endocrine: Polyuria, polydipsia.
8 Pediatric History and Physical Examination

Musculoskeletal: Joint pain or swelling, arthritis, myalgias.
Skin and Lymphatics: Easy bruising, lymphadenopathy.
Neuropsychiatric: Weakness, seizures.
Pain: quality (sharp/stabbing, aching, pressure), location, duration
Physical Examination
General appearance: Note whether the patient looks ill, well, or malnourished.
Physical Measurements: weight, height, head circumference (plot on growth
charts).
Vital Signs: Temperature, heart rate, respiratory rate, blood pressure.
Skin: Rashes, scars, moles, skin turgor, capillary refill (in seconds).
Lymph Nodes: Cervical, axillary, inguinal nodes: size, tenderness.
Head: Bruising, masses, fontanels.
Eyes: Pupils: equal, round, and reactive to light and accommodation (PERRLA);
extra ocular movements intact (EOMI). Funduscopy (papilledema, hemorrhages,
exudates).
Ears: Acuity, tympanic membranes (dull, shiny, intact, infected, bulging).
Mouth and Throat: Mucus membrane color and moisture; oral lesions, dentition,
pharynx, tonsils.
Neck: Thyromegaly, lymphadenopathy, masses.
Chest: Equal expansion, rhonchi, crackles, rubs, breath sounds.
Heart: Regular rate and rhythm (RRR), first and second heart sounds (S1, S2);
gallops (S3, S4), murmurs (grade 1-6), pulses (graded 0-2+).
Breast: Discharge, masses; axillary masses.
Abdomen: Bowel sounds, bruits, tenderness, masses; hepatomegaly,
splenomegaly; guarding, rebound, percussion note (tympanic), suprapubic
tenderness.
Genitourinary: Inguinal masses, hernias, scrotum, testicles.
Pelvic Examination: Vaginal mucosa, cervical discharge, uterine size, masses,
adnexal masses, ovaries.
Extremities: Joint swelling, range of motion, edema (grade 1-4+); cyanosis,
clubbing, edema (CCE); pulses.
Rectal Examination: Sphincter tone, masses, fissures; test for occult blood
Neurological: Mental status and affect; gait, strength (graded 0-5), sensation,
deep tendon reflexes (biceps, triceps, patellar, ankle; graded 0-4+).
Labs: Electrolytes (sodium, potassium, bicarbonate, chloride, BUN, creatinine),
CBC (hemoglobin, hematocrit, WBC count, platelets, differential); x-rays, ECG,
urine analysis (UA), liver function tests (LFTs).
Assessment (Impression): Assign a number to each problem and discuss
separately. Discuss differential diagnosis and give reasons that support the
working diagnosis; give reasons for excluding other diagnoses.
Plan: Describe therapeutic plan for each numbered problem, including testing,
laboratory studies, medications.
Progress Notes 9
Progress Notes
Daily progress notes should summarize developments in a patient's hospital
course, problems that remain active, plans to treat those problems, and
arrangements for discharge. Progress notes should address every element of the
problem list.
Example Progress Note

Date/time:
Identify Discipline and Level of Education: e.g. Pediatric resident PL-3
Subjective: Any problems and symptoms of the patient should be charted.
Appetite, pain, or fussiness may be included.
Objective:
General appearance.
Vitals, including highest temperature (Tmax) over past 24 hours.
Feedings, fluid inputs and outputs (I/O), including oral and parenteral
intake and urine and stool volume output.
Physical exam, including chest and abdomen, with particular attention
to active problems. Emphasize changes from previous physical exams.
Labs: Include new test results and flag abnormal values.
Current Medications: List all medications and dosages.
Assessment and Plan: This section should be organized by problem. A
separate assessment and plan should be written for each problem.
Discharge Note
The discharge note should be written in the patients chart prior to discharge.
Discharge Note
Date/time:
Diagnoses:
Treatment: Briefly describe treatment provided during hospitalization,
including surgical procedures and antibiotic therapy.
Studies Performed: Electrocardiograms, CT scans.
Discharge Medications:
Follow-up Arrangements:
10 Prescription Writing
Prescription Writing
Patients name:
Date:
Drug name, dosage form, dose, route, frequency (include concentration for oral
liquids or mg strength for oral solids): Amoxicillin 125mg/5mL 5 mL PO tid
Quantity to dispense: mL for oral liquids, # of oral solids
Refills: If appropriate
Signature
Procedure Note
A procedure note should be written in the chart after a procedure is performed
(e.g. lumbar puncture).
Procedure Note
Date and time:
Procedure:
Indications:
Patient Consent: Document that the indications, risks and alternatives to
the procedure were explained to the parents and patient. Note that the
parents and the patient were given the opportunity to ask questions and
that the parents consented to the procedure in writing.
Lab tests: Relevant labs, such as the CBC
Anesthesia: Local with 2% lidocaine
Description of Procedure: Briefly describe the procedure, including
sterile prep, anesthesia method, patient position, devices used, anatomic
location of procedure, and outcome.
Complications and Estimated Blood Loss (EBL):
Disposition: Describe how the patient tolerated the procedure.
Specimens: Describe any specimens obtained and labs tests which were
ordered.
Developmental Milestones 11
Developmental Milestones
Age
Milestones
1 month
Raises head slightly when prone; alerts to sound; regards

face, moves extremities equally.
2-3
months
Smiles, holds head up, coos, reaches for familiar objects,

recognizes parent.
4-5
months
Rolls front to back and back to front; sits well when

propped; laughs, orients to voice; enjoys looking around;
grasps rattle, bears some weight on legs.
6 months
Sits unsupported; passes cube hand to hand; babbles;

uses raking grasp; feeds self crackers.
8-9
months
Crawls, cruises; pulls to stand; pincer grasp; plays pat-acake; feeds self with bottle; sits without support; explores
environment.
12 months
Walking, talking a few words; understands "no"; says

"mama/dada" discriminantly; throws objects; imitates
actions, marks with crayon, drinks from a cup.
15-18
months
Comes when called; scribbles; walks backward; uses 4-20

words; builds tower of 2 blocks.
24-30
months
Removes shoes; follows 2 step command; jumps with both

feet; holds pencil, knows first and last name; knows
pronouns. Parallel play; points to body parts, runs, spoon
feeds self, copies parents.
3 years
Dresses and undresses; walks up and down steps; draws

a circle; uses 3-4 word sentences; takes turns; shares.
Group play.
4 years
Hops, skips, catches ball; memorizes songs; plays

cooperatively; knows colors; copies a circle; uses plurals.
5 years
Jumps over objects; prints first name; knows address and

mother's name; follows game rules; draws three part man;
hops on one foot.
12 Immunizations
Immunizations
Immunization Schedule for Infants and Children
Age
Immunizations
Comments
Birth - 2 mo
HBV
If mother is HbsAg positive or unknown

status, the first dose of HBV should be
given within 12 hours of birth along
with hepatitis B immune globulin 0.5
mL.
1-4 mo
HBV
The second HBV dose should be given

at least one month after the first dose.
For infants of HbsAg positive or
unknown status mothers, the second
dose should be given at 1-2 months of
age.
2 mo
DTaP, Hib, IPV, PCV
DTP and Hib are available combined

as Tetramune. The pneumococcal
vaccine recommendation is new for
2001.
4 mo
DTaP, Hib, IPV, PCV
6 mo
DTaP, (Hib), PCV
Dose 3 of Hib is not indicated if the

product for doses 1 and 2 was
PedvaxHIB.
6-18 mo
HBV, IPV
The third HBV dose should be

administered at least 4 months after
the first dose and at least 2 months
after the second dose. For infants of
HbsAg positive or unknown status
mothers, the third dose should be
given at 6 months of age.
12-15 mo
12-18 mo
Hib, PCV, MMR

VAR
Tuberculin testing may be done at the

same visit if indicated. Varicella
vaccine is recommended in children
who do not have a reliable history of
having had the clinical disease.
15-18 mo
DTaP
The 4th dose of DTaP should be given

6-12 mo after the third dose of DTaP
and may be given as early as 12 mo,
provided that the interval between
doses 3 and 4 is at least 6 mo.
Immunizations 13
Age
Immunizations
Comments
4-6 yr
DTaP, IPV, MMR
DTaP and IPV should be given at or

before school entry. DTaP should not
be given after the 7th birthday
11-12 yr
MMR
Omit if MMR dose was given at age 46 years.
14-16 yr
Td
Repeat every 10 yrs throughout life
HBV = Hepatitis B virus vaccine; DTaP = diphtheria and tetanus toxoids and
acellular pertussis vaccine; Hib = Haemophilus influenzae type b conjugate vaccine;
IPV = inactivated polio vaccine; MMR = live measles, mumps, and rubella viruses
vaccine; PCV = pneumococcal conjugate vaccine (Prevnar); Td = adult tetanus
toxoid (full dose) and diphtheria toxoid (reduced dose), for children >7 yr and adults;
VAR = varicella virus vaccine
Recommended Schedule for Children Younger than 7 Years Not

Immunized in the First Year of Life
Age
Immunizations
Comments
First visit
DTaP, (Hib), HBV,

MMR, IPV, (PCV),
VAR
If indicated, tuberculin testing may

be done at the same visit.
If child is $5 years, Hib is not
indicated. PCV recommended for all
children < 2 yrs or 24-59 months of
age and at high risk for invasive
pneumococcal disease (e.g. sickle
cell anemia, HIV,
immunocompromised). Varicella
vaccine if child has not had
varicella disease.
DTaP, HBV
Second dose of Hib is indicated

only if first dose was received when
<15 months. Second dose of PCV
6-8 weeks after first dose (if criteria
met above).
Interval after
1st visit
1 month
2 months
$8 months
DTaP, Hib, IPV,

(PCV)
DTaP, HBV, IPV
14 Immunizations
4-6 years (at or

before school
entry)
DTaP, IPV, MMR
DTaP is not necessary if the fourth

dose was given after the fourth
birthday. IPV is not necessary if the
third dose was given after the fourth
birthday.
11-12 yr
MMR
MMR should be given at entry to

middle school or junior high school
if it wasnt given at age 4-6 years.
10 yr later
Td
Repeat every 10 yrs
Recommended Schedule for Children >7 Years Who Were Not

Immunized Previously
Age
Immunizations
Comments
First visit
HBV, IPV, MMR, Td,

VAR
Varicella vaccine if child has not

had varicella disease.
8-14 months
HBV, IPV, Td, VAR,

MMR
HBV, Td, IPV
If child is $13 years old, a second

varicella vaccine dose is needed
4-8 weeks after the first dose.
11-12 yrs old
MMR
Omit if MMR dose was given at

age 4-6 years.
10 yr later
Td
Repeat every 10 years
Interval after
First visit
2 months
Haemophilus Immunization
H influenzae type b Vaccination in Children Immunized Beginning at
2 to 6 Months of Age
Vaccine Product
Total Number
Regimens
of Doses
PedvaxHIB (PRP
OMP)
2 doses two months apart plus booster at

12-15 months which must be at least two
months after previous dose. Any vaccine
may be used for the booster.
Varicella Immunization 15
HibTITER
(HbOC), ActHIB
(PRP-T),
OmniHIB (PRP-T)
3 doses two months apart plus booster at

12-15 months which must be at least two
months after previous dose. Any vaccine
may be used for the booster.
H influenzae type b Vaccination When the Initial Vaccination was

Delayed Until 7 Months of Age or Older
Age at Initiation
Vaccine Product
Total Doses
Regimens
7-11 mo
any vaccine
(PedvaxHIB or
HibTITER or
ActHIB or
2 doses at 2-month
intervals plus
booster at 12-18
months (at least 2
months after
previous dose)
OmniHIB)
12-14 mo
any vaccine
2 doses 2 months
apart
15-59 mo
any vaccine
Single dose of any

product
$5 years
Any vaccine
Only recommended
for children with
chronic illness known
to be associated with
an increased risk for
H flu disease.
Varicella Immunization
Indications for Varicella Immunization:
A. Age 12 to 18 months: One dose of varicella vaccine is recommended for
universal immunization for all healthy children who lack a reliable history of
varicella.
B. Age 19 months to the 13th birthday: Vaccination of susceptible children is
recommended and may be given any time during childhood but before the
13th birthday because of the potential increased severity of natural varicella
after this age. Susceptible is defined by either lack of proof of either
varicella vaccination or a reliable history of varicella. One dose is
recommended.
C. Healthy adolescents and young adults: Healthy adolescents past their 13th
16 Influenza Immunization
birthday who have not been immunized previously and have no history of
varicella infection should be immunized against varicella by administration
of two doses of vaccine 4 to 8 weeks apart. Longer intervals between
doses do not necessitate a third dose, but may leave the individual
unprotected during the intervening months.
D. All susceptible children aged 1 year to 18 years old who are in direct
contact with people at high risk for varicella related complications (eg,
immunocompromised individuals) and who have not had a documented
case of varicella.
Influenza Immunization
Indications for Influenza Vaccination
A. Targeted high-risk children and adolescents (eg, chronic pulmonary
disease including asthma, sickle cell anemia, HIV infection).
B. Other high-risk children and adolescents (eg, diabetes mellitus, chronic
renal disease, chronic metabolic disease).
C. Close contacts of high risk patients.
D. Foreign travel if exposure is likely.
Vaccine Administration. Administer in the Fall, usually October 1 - November
15, before the start of the influenza season.
Influenza Immunization Administration

Age
Vaccine Type
Dosage (mL)
Number of
Doses
6-35 months
Split virus only
0.25
1-2*
3-8 yrs
Split virus only
0.5
1-2*
9-12 yrs
Split virus only
0.5
> 12 yrs
Whole or split
virus
0.5
*Two doses administered at least one month apart are recommended for
children who are receiving influenza vaccine for the first time.
Antipyretics 17
Pediatric Symptomatic Care

Antipyretics
Analgesics/Antipyretics:
-Acetaminophen (Tylenol) 10-20 mg/kg/dose PO/PR q4-6h, max 5 doses/day or
80 mg/kg/day or 4 gm/day (whichever is smaller) OR
-Acetaminophen dose by age (if weight appropriate for age):
AGE:
mg/dose PO/PR q4-6h prn:
0-3 mo
40 mg/dose
4-11 mo
80 mg/dose
1-2 yr
120 mg/dose
2-3 yr
160 mg/dose
4-5 yr
240 mg/dose
6-8 yr
320 mg/dose
9-10 yr
400 mg/dose
11-12 yr
480 mg/dose
>12 yr
325-650 mg/dose
-Preparations: caplets: 160, 500 mg; caplet, ER: 650 mg; drops: 80 mg/0.8 mL;
elixir: 80 mg/2.5 mL, 80 mg/5 mL, 120 mg/5 mL, 160 mg/5 mL, 325 mg/5 mL,
500 mg/15 mL; suppositories: 80, 120, 325, 650 mg; tabs: 325, 500 mg; tabs,
chewable: 80, 120, 160 mg.
-Ibuprofen (Motrin, Advil, Nuprin, Medipren, Children's Motrin)
Analgesic: 4-10 mg/kg/dose PO q6-8h prn
Antipyretic: 5-10 mg/kg/dose PO q6-8h.
-Preparations: cap: 200 mg; caplet: 100 mg; oral drops: 40 mg/mL; susp: 100
mg/5 mL; tabs: 100, 200, 300, 400, 600, 800 mg; tabs, chewable: 50, 100 mg.
May cause GI distress, bleeding.
Antitussives, Decongestants, Expectorants, and

Antihistamines
Antihistamines:
-Brompheniramine (Dimetane) [elixir: 2 mg/5 mL; tab: 4, 8, 12 mg; tab, SR: 8,
12 mg]
< 6 yr: 0.5 mg/kg/day PO q6h prn (max 8 mg/day)
6-11 yr: 2-4 mg PO q6-8h
$12 yr: 4-8 mg PO q4-6h or 8 mg SR PO q8-12h or 12 mg SR PO q12h
(max 24 mg/day).
18 Antitussives, Decongestants, Expectorants, and Antihistamines

-Chlorpheniramine (Chlor-Trimeton) [cap, SR: 8, 12 mg; syrup 2mg/5mL; tabs:
4, 8, 12 mg; tab, chew: 2 mg; tab, SR: 8, 12 mg]
2-5 yr: 1 mg PO q4-6h prn
6-11 yr: 2 mg PO q4-6h prn
$ 12 yr: 4 mg PO q4-6h prn or 8-12 mg SR PO q8-12h
Antitussives (Pure) - Dextromethorphan:
-Benylin DM Cough Syrup [syrup: 10 mg/5mL]
-Benylin Pediatric [syrup: 37.5mg/5mL]
-Robitussin Pediatric [syrup: 7.5 mg/5mL]
-Vicks Formula 44 Pediatric Formula [syrup: 3 mg/5mL]
2-5 yr: 2.5-5 mg PO q4h prn or 7.5 mg PO q6-8h prn
6-11 yr 5-10 mg PO q4h prn or 15 mg PO q6-8h prn
$12 yr: 10-20 mg PO q4h prn or 30 mg PO q6-8h prn.
Expectorants:
-Guaifenesin (Robitussin) [syrup: 100 mg/5 mL]
<2 yr: 12 mg/kg/day PO q4-6h prn
2-5 yr: 50-100 mg PO q4h prn (max 600 mg/day)
6-11 yr: 100-200 mg PO q4h prn (max 1.2 gm/day)
$12 yr: 100-400 mg PO q4h prn (max 2.4 gm/day)
May irritate gastric mucosa; take with large quantities of fluids.
Decongestants:
-Pseudoephedrine (Sudafed, Novafed): [cap: 60 mg; cap, SR: 120, 240 mg;
drops: 7.5 mg/0.8 mL; syrup: 15 mg/5 mL, 30 mg/5 mL; tabs: 30, 60 mg].
<2 yr: 4 mg/kg/day PO q6h.
2-5 yr: 15 mg po q6h
6-11 yr: 30 mg po q6h
>12 yr: 30-60 mg/dose PO q6h or sustained release 120 mg PO q12h or
sustained release 240 mg PO q24h.
-Phenylephrine (Neo-synephrine) [nasal drops: 1/4, , 1%; nasal spray: 1/4,
, 1%].
Children: Use 1/4 % spray or drops, 1-2 drops/spray in each nostril q3-4h.
Adults: Use 1/4-1/2% drops/spray, 1-2 drops/sprays in each nostril q3-4h
Discontinue use after 3 days to avoid rebound congestion.
Combination Products:
-Actifed [per cap or tab or 10 mL syrup: Triprolidine 2.5 mg, Pseudoephedrine
60 mg].
4 mth-2 yr: 1.25 mL PO q6-8h
2-4 yr: 2.5 mL PO q6-8h
4-6 yr: 3.75 mL PO q6-8h
6-11y: 5 mL or tab PO q6-8h
$12 yr: 10 mL or 1 cap/tab PO q6-8h OR
4 mg pseudoephedrine/kg/day PO tid-qid
-Actifed with Codeine cough syrup [syrup/5 mL: Codeine 10 mg, Triprolidine
1.25 mg, Pseudoephedrine 30 mg].
Antihistamines, Decongestants, and Antitussives 19

4 mth-2 yr: 1.25 mL PO q6-8h
2-4 yr: 2.5 mL PO q6-8h
4-6 yr: 3.75 mL PO q6-8h
6-11y: 5 mL PO q6-8h
$12 yr: 10 mL PO q6-8h OR
4 mg pseudoephedrine/kg/day PO tid-qid.
-Dimetane Decongestant [cap/cplt or 10 mL: Brompheniramine 4 mg,

Phenylephrine 5 mg].
6-11 yr: 5 mL or cap/caplet PO q4-6h prn
$ 12 yr: 10 mL or 1 cap/caplet PO q4-6h prn
-Dimetane DX [syrup per 5 mL: Brompheniramine 2 mg, Dextromethorphan
10 mg, Pseudoephedrine 30 mg].
2-5 yrs: 2.5 mL PO q4-6h prn
6-11 yrs: 5 mL PO q4-6h prn
$ 12 yrs: 10 mL PO q4-6h prn
-PediaCare Cough-Cold Chewable Tablets: [tab, chew: Pseudoephedrine 15
mg, Chlorpheniramine 1 mg, Dextromethorphan 5 mg].
3-5 yr: 1 tab PO q4-6h prn (max 4 tabs/day)
6-11 yr: 2 tabs PO q4-6h (max 8 tabs/day)
$12 yr: 4 tabs PO q4-6h (max 16 tabs/day)
-PediaCare Cough-Cold Liquid [liquid per 5 mL: Pseudoephedrine 15 mg,
Chlorpheniramine 1 mg, Dextromethorphan 5 mg].
3-5 yr: 5 mL PO q6-8h prn
$12 yr: 20 mL PO q6-8h prn
-PediaCare Night Rest Cough-Cold Liquid [liquid per 5 mL: Pseudoephedrine
15 mg, Chlorpheniramine 1 mg, Dextromethorphan 7.5 mg].
-Phenergan VC [syrup per 5 mL: Phenylephrine 5 mg, Promethazine 6.25 mg].
2-5 yr: 1.25 mL PO q4-6h prn
6-11 yr: 2.5 mL PO q4-6h prn
-Phenergan VC with Codeine [per 5 mL: Promethazine 6.25 mg, Codeine 10
mg, Phenylephrine 5 mg].
2-5 yr: 1.25 mL PO q4-6h prn
6-11 yr: 2.5 mL PO q4-6h prn
Adults: 5-10 mL q4-6h prn (max 120 mg codeine per day)
-Phenergan with Codeine [syrup per 5 mL: Promethazine 6.25 mg, Codeine
10 mg].
2-5 yr: 1.25 mL PO q4-6h prn
6-11 yr: 2.5 mL PO q4-6h prn
20 Antitussives, Decongestants, Expectorants, and Antihistamines

Adults: 5-10 mL q4-6h prn (max 120 mg codeine per day)
-Phenergan with Dextromethorphan [syrup per 5 mL: Promethazine 6.25 mg,

Dextromethorphan 15 mg].
2-5 yr: 1.25 mL PO q4-6h prn
6-11 yr: 2.5 mL PO q4-6h prn
-Robitussin AC [syrup per 5 mL: Guaifenesin 100 mg, Codeine 10 mg].
6 mos-2 yr: 1.25-2.5 mL PO q4h prn
2-5 yrs: 2.5 mL PO q4h prn
6-11 yrs: 5 mL PO q4h prn
$12 yrs: 10 mL PO q4-6h prn.
-Robitussin-DAC [syrup per 5 mL: Codeine 10mg, Guaifenesin 100 mg,
Pseudoephedrine 30 mg].
2-5 yrs: 1-1.5 mg/kg/day of codeine PO q4-6h prn (max 30 mg/day)
6-11 yrs: 5 mL PO q4-6h prn
$12 yrs: 10 mL PO q4-6h prn
-Robitussin DM [syrup per 5 mL: Guaifenesin 100 mg, Dextromethorphan 10
mg].
2-5 yr: 2.5 mL PO q4h prn, max 10 mL/day
6-11 yr: 5 mL PO q4h prn, max 20 mL/day
$12 yr: 10 mL PO q4h prn, max 40 mL/day
-Robitussin Pediatric Cough and Cold [syrup per 5 mL: Dextromethorphan
7.5mg, Pseudoephedrine 15 mg].
$12 yr: 15 mL po q4-6h prn
Maximum four doses daily.
-Rondec drops [drops per 1 mL: Carbinoxamine maleate 2 mg, Pseudoephed
rine 25 mg].
4-5 mg pseudoephedrine/kg/day PO q6h prn OR
1-3 m: 1/4 dropperful (1/4 mL) PO q6h prn
3-6 m: dropperful ( mL) PO q6h prn
6-9 m: 3/4 dropperful (0.75 mL) PO q6h prn
9-18 m: 1 dropperful (1 mL) PO q6h prn.
-Rondec syrup [syrup per 5 mL: Pseudoephedrine 60 mg, Carbinoxamine
maleate 4 mg].
4-5 mg pseudoephedrine/kg/day PO q6h prn.
-Rondec DM drops [drops per mL: Carbinoxamine maleate 2 mg,
Pseudoephedrine 25 mg, Dextromethorphan 4 mg].
4-5 mg pseudoephedrine/kg/day PO q6h prn OR
1-3 m: 1/4 dropperful (1/4 mL) PO q6h prn
3-6 m: dropperful ( mL) PO q6h prn
6-9 m: 3/4 dropperful (0.75 mL) PO q6h prn
Antihistamines, Decongestants, and Antitussives 21

9-18 m: 1 dropperful (1 mL) PO q6h prn.
-Rondec DM syrup [syrup per 5 mL: Carbinoxamine maleate 4 mg,
Pseudoephedrine 60 mg, Dextromethorphan 15 mg].
4-5 mg pseudoephedrine/kg/day PO q6h prn.
-Ryna Liquid [liquid per 5 mL: Chlorpheniramine 2 mg; Pseudoephedrine 30
mg].
6-11 yrs: 5 mL PO q6h prn
$12 yr: 10 mL PO q6h prn
-Ryna-C [liquid per 5 mL: Chlorpheniramine 2mg, Codeine 10 mg,
4-5 mg/kg/day of pseudoephedrine component PO q6h prn
-Ryna-CS [liquid per 5 mL: Codeine 10 mg, Guaifenesin 100 mg,
4-5 mg pseudoephedrine/kg/day PO q6h prn
-Rynatan Pediatric [susp per 5 mL: Chlorpheniramine 2 mg, Phenylephrine 5
mg, Pyrilamine 12.5 mg].
2-5 yr: 2.5-5 mL PO bid prn
6-11 yr: 5-10 mL PO bid prn
$12 yr: 10-15 mL PO bid prn
-Tylenol Cold Multi-Symptom Plus Cough Liquid, Childrens [liquid per 5 mL:
Acetaminophen 160 mg, Chlorpheniramine 1 mg, Pseudoephedrine 15
mg].
2-5 yr: 5 mL PO q4h prn
$12 yr: 20 mL po q4h prn
-Tylenol Cold Plus Cough Chewable Tablet, Childrens [tab, chew:
Acetaminophen 80 mg, Chlorpheniramine 0.5 mg, Dextromethorphan 2.5
mg, Pseudoephedrine 7.5 mg].
2-5 yr: 2 tabs PO q4h prn
6-11 yr: 4 tabs PO q4h prn
$12 yr: 4 tabs PO q4h prn
-Vicks Childrens NyQuil Night-time Cough/Cold [liquid per 5 mL:
Chlorpheniramine 0.67 mg; Dextromethorphan 5 mg, Pseudoephedrine
10 mg].
-Vicks Pediatric Formula 44D [liquid per 5 mL: Dextromethorphan 5 mg,
2-5 yr: 3.75 mL PO q6h prn
6-11 yr: 7.5 mL po q6h prn
-Vicks Pediatric Formula 44E [syrup per 5 mL: Dextromethorphan 3.3 mg,
22 Analgesia and Sedation

Guaifenesin 33.3 mg].
$12 yr: 15 mL po q4h prn
-Vicks Pediatric Formula 44M Multi-Symptom Cough and Cold Liquid [liquid
per 5 mL: Chlorpheniramine 0.67 mg, Dextromethorphan 5 mg,
2-5 yr: 7.5 mL PO q6h prn
Analgesia and Sedation

Analgesics/Anesthetic Agents:
-Acetaminophen (Tylenol) 10-15 mg/kg PO/PR q4-6h prn (see page 17 for
detailed list of available products)
-Acetaminophen/Codeine [per 5 mL: Acetaminophen 120 mg, Codeine 12 mg;
tabs: Tylenol #2: 15 mg codeine/300 mg acetaminophen; #3: 30 mg
codeine/300 mg acetaminophen; #4: 60 mg codeine/300 mg
acetaminophen]
0.5-1.0 mg codeine/kg/dose PO q4h prn.
-Acetaminophen/Hydrocodone [elixir per 5 mL: hydrocodone 2.5 mg, aceta
minophen 167 mg]
Tab:
Lortab 2.5/500: Hydrocodone 2.5 mg, acetaminophen 500 mg
Lortab 5/500 and Vicodin: Hydrocodone 5 mg, acetaminophen 500 mg
Lortab 7.5/500: Hydrocodone 7.5 mg, acetaminophen 500 mg
Vicodin ES: Hydrocodone 7.5 mg, acetaminophen 750 mg
Lortab 10/500: Hydrocodone 10 mg, acetaminophen 500 mg
Lortab 10/650: Hydrocodone 10 mg, acetaminophen 650 mg
Children: 0.6 mg hydrocodone/kg/day PO q6-8h prn
<2 yr: do not exceed 1.25 mg/dose
2-12 yr: do not exceed 5 mg/dose
>12 yr: do not exceed 10 mg/dose
-ELAMax [lidocaine 4% cream (liposomal): 5, 30 gm]
Apply 10-60 minutes prior to procedure. Occlusive dressing is optional.
Available OTC.
-EMLA cream (eutectic mixture of local anesthetics) [ cream: 2.5% lidocaine
and 2.5% prilocaine: 5, 30 gm; transdermal disc]. Apply and cover with
occlusive dressing at least 1 hour (max 4 hours) prior to procedure.
-Fentanyl 1-2 mcg/kg IV q1-2h prn or 1-3 mcg/kg/hr continuous IV infusion.
-Hydromorphone (Dilaudid) 0.015 mg/kg IV/IM/SC q3-4h or
Antiemetics 23
0.0075 mg/kg/hr continuous IV infusion titrated as necessary for pain
relief or 0.03-0.08 mg/kg PO q6h prn.
-Ketamine 4 mg/kg IM or 0.5-1 mg/kg IV. Onset for IV administration is 30
seconds, duration is 5-15 minutes.
-Lidocaine, buffered: Add sodium bicarbonate 1 mEq/mL 1 part to 9 parts
lidocaine 1% for local infiltration (eg, 2 mL lidocaine 1% and 0.22 mL
sodium bicarbonate 1 mEq/mL) to raise the pH of the lidocaine to neutral
and decrease the sting of subcutaneous lidocaine.
-Meperidine (Demerol) 1 mg/kg IV/IM q2-3h prn pain.
-Morphine 0.05-0.1 mg/kg IV q2-4h prn or 0.02-0.06 mg/kg/hr continuous IV
infusion or 0.1-0.15 mg/kg IM/SC q3-4h or 0.2-0.5 mg/kg PO q4-6h.
Sedation:
Fentanyl and Midazolam Sedation:
-Fentanyl 1 mcg/kg IV slowly, may repeat to total of 3 mcg/kg AND
-Midazolam (Versed) 0.05-0.1 mg/kg slow IV [inj: 1 mg/mL, 5 mg/mL].
Have reversal agents available: naloxone 0.1 mg/kg (usual max 2 mg) IM/IV
for fentanyl reversal and flumazenil 0.01 mg/kg (usual max 5 mg) IM/IV for
midazolam reversal.
Benzodiazepines:
-Diazepam (Valium) 0.2-0.5 mg/kg/dose PO/PR or 0.05-0.2 mg/kg/dose IM/IV,
max 10 mg.
-Lorazepam (Ativan) 0.05-0.1 mg/kg/dose IM/IV/PO, max 4 mg.
-Midazolam (Versed) 0.08-0.2 mg/kg/dose IM/IV over 10-20 min, max 5 mg;
or 0.2-0.4 mg/kg/dose PO x 1, max 15 mg, 30-45 min prior to procedure;
or 0.2 mg/kg intranasal (using 5 mg/mL injectable solution, insert into
nares with needleless tuberculin syringe.)
Phenothiazines:
-Promethazine (Phenergan) 0.5-1 mg/kg/dose IM or slow IV over 20 min, max
50 mg/dose.
-Chlorpromazine (Thorazine) 0.5-1 mg/kg/dose IM or slow IV over 20min, max
50 mg/dose.
Antihistamines:
-Diphenhydramine (Benadryl) 1 mg/kg/dose IV/IM/PO, max 50 mg.
-Hydroxyzine (Vistaril) 0.5-1 mg/kg/dose IM/PO, max 50 mg.
Barbiturates:
-Methohexital (Brevital)
IM: 5-10 mg/kg
IV: 1-2 mg/kg
PR: 25 mg/kg (max 500 mg/dose)
-Thiopental (Pentothal): Sedation, rectal: 5-10 mg/kg; seizures, IV: 2-3 mg/kg
Other Sedatives:
-Chloral hydrate 25-100 mg/kg/dose PO/PR (max 1.5 gm/dose), allow 30 min
for absorption.
24 Antiemetics
Nonsteroidal Anti-inflammatory Drugs:
-Ibuprofen (Motrin, Advil, Nuprin, Medipren, Children's Motrin)
Anti-inflammatory: 30-50 mg/kg/day PO q6h, max 2400 mg/day.
[cap: 200 mg; caplet: 100 mg; oral drops: 40 mg/mL; susp: 100 mg/5 mL;
tabs: 100, 200, 300, 400, 600, 800 mg; tabs, chewable: 50, 100 mg].
-Ketorolac (Toradol)
Single dose: 0.4-1 mg/kg IV/IM (max 30 mg/dose IV, 60 mg/dose IM)
Multiple doses: 0.4-0.5 mg/kg IV/IM q6h prn (max 30 mg/dose)
[inj: 15 mg/mL, 30 mg/mL].
Do not use for more than three days because of risk of GI bleed.
-Naproxen (Naprosyn)
Analgesia: 5-7 mg/kg/dose PO q8-12h
Inflammatory disease: 10-15 mg/kg/day PO q12h, max 1000 mg/day
[susp: 125 mg/5mL; tab: 250, 375, 500 mg; tab, DR: 375, 500 mg
-Naproxen sodium (Aleve, Anaprox, Naprelan)
Analgesia: 5-7 mg/kg/dose PO q8-12h
Inflammatory disease: 10-15 mg/kg/day PO q12h, max 1000 mg/day
[tab: 220, 275, 550 mg; tab, ER: 375, 500, 750 mg]. Naproxen sodium
220 mg = 200 mg base.
Antiemetics
-Chlorpromazine (Thorazine)
0.25-1 mg/kg/dose slow IV over 20 min/IM/PO q4-8h prn, max 50 mg/dose
[inj: 25 mg/mL,; oral concentrate 30 mg/mL; supp: 25,100 mg; syrup: 10
mg/5 mL; tabs: 10, 25, 50, 100, 200 mg].
-Diphenhydramine (Benadryl)
1 mg/kg/dose IM/IV/PO q6h prn, max 50 mg/dose
[caps: 25, 50 mg; inj: 10 mg/mL, 50 mg/mL; liquid: 12.5 mg/5 mL; tabs: 25,
50 mg].
-Dimenhydrinate (Dramamine)
$12 yrs: 5 mg/kg/day IM/IV/PO q6h prn, max 300 mg/day
Not recommended in <12y due to high incidence of extrapyramidal side
effects.
[cap: 50 mg; inj: 50 mg/mL; liquid 12.5 mg/4 mL; tab: 50 mg; tab, chew:
50mg].
-Prochlorperazine (Compazine)
$12 yrs: 0.1-0.15 mg/kg/dose IM, max 10 mg/dose or 5-10 mg PO q6-8h,
max 40 mg/day OR 5-25 mg PR q12h, max 50 mg/day
Not recommended in <12y due to high incidence of extrapyramidal side
effects
[caps, SR: 10, 15, 30 mg; inj: 5 mg/mL; supp: 2.5, 5, 25 mg; syrup: 5 mg/5
Analgesia and Sedation 25

mL; tabs: 5, 10, 25 mg].
-Promethazine (Phenergan)
0.25-1 mg/kg/dose PO/IM/IV over 20 min or PR q4-6h prn, max 50 mg/dose
[inj: 25,50 mg/mL; supp: 12.5, 25, 50 mg; syrup 6.25 mg/5 mL, 25 mg/5 mL;
tabs: 12.5, 25, 50 mg].
-Trimethobenzamide (Tigan)
15 mg/kg/day IM/PO/PR q6-8h, max 100 mg/dose if <13.6 kg or 200
mg/dose if 13.6-41kg.
[caps: 100, 250 mg; inj: 100 mg/mL; supp: 100, 200 mg].
Post-Operative Nausea and Vomiting:
-Ondansetron (Zofran) 0.1 mg/kg IV x 1, max 4 mg.
-Droperidol (Inapsine) 0.01-0.05 mg/kg IV/IM q4-6h prn, max 5 mg [inj: 2.5
mg/mL].
Chemotherapy-Induced Nausea:
-Ondansetron (Zofran)
0.15 mg/kg/dose IV 30 minutes before chemotherapy and repeated 4 hr and
8 hr later (total of 3 doses) OR
0.3 mg/kg/dose IV x 1 30 minutes before chemotherapy OR
0.45 mg/kg/day as a continuous IV infusion OR
Oral:
<0.3 m2: 1 mg PO three times daily
0.3-0.6 m2: 2 mg PO three times daily
0.6-1 m2: 3 mg PO three times daily
>1 m2: 4 mg PO three times daily OR
4-11 yr: 4 mg PO three times daily
>11 yr: 8 mg PO three times daily
[inj: 2 mg/mL; oral soln: 4mg/5 mL; tab: 4, 8, 24 mg; tab, orally
disintegrating: 4, 8 mg]
-Dexamethasone
10 mg/m2/dose (max 20 mg) IV x 1, then 5 mg/m2/dose (max 10 mg) IV q6h
prn
[inj: 4 mg/mL, 10 mg/mL]
-Granisetron (Kytril)
10-20 mcg/kg IV given just prior to chemotherapy (single dose) [inj: 1
mg/mL]
Adults (oral) 1 mg PO bid or 2 mg PO qd [tab: 1 mg]
-Metoclopramide (Reglan)
0.5-1 mg/kg/dose IV q6h prn.
Pretreatment with diphenhydramine 1 mg/kg IV is recommended to
decrease the risk of extrapyramidal reactions.
[inj: 5 mg/mL]
26 Antiemetics
-Dronabinol (Marinol)
5 mg/m2/dose PO 1-3 hrs prior to chemotherapy, then q4h prn afterwards.
May titrate up in 2.5 mg/m2/dose increments to max of 15 mg/m2/dose.
[cap: 2.5, 5, 10 mg]
Pediatric Advanced Life Support 27
Cardiology
Pediatric Advanced Life Support
I. Cardiopulmonary assessment
A. Airway (A) assessment. The airway should be assessed and cleared.
B. Breathing (B) assessment determines the respiratory rate, respiratory
effort, breath sounds (air entry) and skin color. A respiratory rate of less
than 10 or greater than 60 is a sign of impending respiratory failure.
C. Circulation (C) assessment should quantify the heart rate and pulse. In
infants, chest compressions should be initiated if the heart rate is less than
80 beats/minute (bpm). In children, chest compressions should be initiated
if the heart rate is less than 60 bpm.
II. Respiratory failure
A. An open airway should be established. Bag-valve-mask ventilation should
be initiated if the respiratory rate is less than 10. Intubation is performed if
prolonged ventilation is required. Matching the endotracheal tube to the
size of the nares or fifth finger provides an estimate of tube size.
Intubation
Age
ETT
Laryngoscope
Blade
NG Tube Size
Premature
Newborn >2 kg
Infant
12 mo
36 mo
6 yr
10 yr
Adolescent
Adult
2.0-2.5
3.0-3.5
3.5-4.0
4.0-4.5
4.5-5.0
5.0-5.5
6.0-6.5
.0-7.5
7.5-8.0
0
1
1
1.5
2
2
2
3
3
8
10
10
12
12-14
14-16
16-18
18-20
20
Uncuffed ET tube in children <8 yrs.

Straight laryngoscope blade if <6-10 yrs; curved blade if older.
B. Vascular access should be obtained. Gastric decompression with a
nasogastric or oral gastric tube is necessary in endotracheally intubated
children and in children receiving bag-valve-mask ventilation.
28 Pediatric Advanced Life Support

III. Shock
A. If the child is in shock, oxygen administration and monitoring are followed
by initiation of vascular access. Crystalloid (normal saline or lactated
Ringer's) solutions are used for rapid fluid boluses of 20 mL/kg over less
than 20 minutes until the shock is resolved.
B. Shock secondary to traumatic blood loss may require blood replacement
if perfusion parameters have not normalized after a total of 40 to 60
mL/kg of crystalloid has been administered.
C. Children in septic shock and cardiogenic shock should initially receive
crystalloid solution (boluses of 20 mL/kg). Epinephrine should be
considered if septic or cardiogenic shock persists after intravenous
volume has been repleted (repletion requires 40 to 60 mL/kg of
crystalloid).
IV. Cardiopulmonary failure
A. Oxygen is delivered at a concentration of 100%.
B. Intubation and foreign body removal are completed. If signs of shock
persist, crystalloid replacement is initiated with boluses of 20 mL/kg over
less than 20 minutes. Inotropic agents are added if indicated.
Inotropic Agents Used in Resuscitation of Children

Agent
Intravenous dosage
Indications
Epinephrine
0.1 to 1.0 g/kg/minute

(continuous infusion)
Symptomatic bradycardia, shock

(cardiogenic, septic, anaphy
lactic), hypotension
Dopamine
2 to 5 g/kg/minute
10 to 20 g/kg/minute
Low dose: improve renal and

splanchnic blood flow
2 to 20 g/kg/minute
Normotensive cardiogenic shock
Dobutamine
High dose: useful in the treatment

of hypotension and shock in the
presence of adequate intravas
cular volume
V. Dysrhythmias
A. Bradycardia
1. Bradycardia is the most common dysrhythmia in children. Initial
management is ventilation and oxygenation. Chest compressions
should be initiated if the heart rate is <60 bpm in a child or <80 bpm
Pediatric Advanced Life Support 29

in an infant.
2. If these measures do not restore the heart rate, epinephrine is
administered. Intravenous or intraosseous epinephrine is given in a
dose of 0.1 mL/kg of the 1:10,000 concentration (0.01 mg/kg).
Endotracheal tube epinephrine is given as a dose of 0.1 mL/kg of the
1:1,000 concentration (0.1 mg/kg) diluted to a final volume of 3-5 mL
in normal saline. This dose may be repeated every three to five
minutes.
3. Atropine may be tried if multiple doses of epinephrine are
unsuccessful. Atropine is given in a dose of 0.2 mL/kg IV/IO/ET of the
1:10,000 concentration (0.02 mg/kg). The minimum dose is 0.1 mg;
the maximum single dose is 0.5 mg for a child and 1 mg for an
adolescent. Endotracheal tube administration of atropine should be
further diluted to a final volume of 3-5 mL in normal saline.
4. Pacing may be attempted if drug therapy has failed.
B. Asystole
1. Epinephrine is the drug of choice for asystole. The initial dose of
intravenous or intraosseous epinephrine is given in a dose of 0.1
mL/kg of the 1:10,000 concentration of epinephrine (0.01 mg/kg).
Endotracheal tube administration of epinephrine is given as a dose of
0.1 mL/kg of the 1:1,000 concentration of epinephrine (0.1 mg/kg),
further diluted to a final volume of 3-5 mL in normal saline.
2. Subsequent doses of epinephrine are administered every three to five
minutes at 0.1 mL/kg IV/IO/ET of the 1:1,000 concentration (0.1
mg/kg).
C. Supraventricular tachycardia
1. Supraventricular tachycardia presents with a heart rate >220
beats/minute in infants and >180 beats/minute in children.
Supraventricular tachycardia is the most common dysrhythmia in the
first year of life.
2. Stable children with no signs of respiratory compromise or
shock and a normal blood pressure
a. Initiate 100% oxygen and cardiac monitoring, and obtain pediatric
cardiology consultation.
b. Administer adenosine 0.1 mg/kg (max 6 mg) by rapid intravenous
push. The dose of adenosine may be doubled to 0.2 mg/kg (max
12 mg) and repeated if supraventricular tachycardia is not
converted.
c. Verapamil (Calan) may be used; however, it is contraindicated
under one year; in congestive heart failure or myocardial
depression; in children receiving beta- adrenergic blockers; and
in the presence of a possible bypass tract (ie, Wolff-ParkinsonWhite syndrome). Dose is 0.1-0.3 mg/kg/dose (max 5 mg) IV;
may repeat dose in 30 minutes prn (max 10 mg).
30 Pediatric Advanced Life Support

3. Supraventricular tachycardia in unstable child with signs of
shock: Administer synchronized cardioversion at 0.5 joules (J)/kg. If
supraventricular tachycardia persists, cardioversion is repeated at
double the dose: 1.0 J/kg.
D. Ventricular tachycardia with palpable pulse
1. A palpable pulse with heart rate $120 bpm with a wide QRS (>0.08
seconds) is present. Initiate cardiac monitoring, administer oxygen
and ventilate.
2. If vascular access is available, administer a lidocaine bolus of 1
mg/kg; if successful, begin lidocaine infusion at 20-50 g/kg/minute.
3. If ventricular tachycardia persists, perform synchronized cardioversion
using 0.5 J/kg.
4. If ventricular tachycardia persists, repeat synchronized cardioversion
using 1.0 J/kg.
5. If ventricular tachycardia persists, administer a lidocaine bolus of 1.0
mg/kg, and begin lidocaine infusion at 20-50 g/kg/min.
6. Repeat synchronized cardioversion as indicated.
E. Ventricular fibrillation and pulseless ventricular tachycardia
1. Apply cardiac monitor, administer oxygen, and ventilate.
2. Perform defibrillation using 2 J/kg. Do not delay defibrillation.
3. If ventricular fibrillation persists, perform defibrillation using 4 J/kg.
5. If ventricular fibrillation persists, perform intubation, continue CPR,
and obtain vascular access. Administer epinephrine, 0.1 mL/kg of
1:10,000 IV or IO (0.01 mg/kg); or 0.1 mL/kg of 1:1000 ET (0.1
mg/kg).
7. If ventricular fibrillation persists, administer lidocaine 1 mg/kg IV or IO,
or 2 mg/kg ET.
9. If ventricular fibrillation persists, continue epinephrine, 0.1 mg/kg
IV/IO/ET, 0.1 mL/kg of 1:1,000; administer every 3 to 5 minutes.
10. If ventricular fibrillation persists, alternate defibrillation (4 J/kg) with
lidocaine and epinephrine. Consider bretylium 5 mg/kg IV first dose,
10 mg/kg IV second dose.
F. Pulseless electrical activity is uncommon in children. It usually occurs
secondary to hypoxemia, hypovolemia, hypothermia, hypoglycemia,
hyperkalemia, cardiac tamponade, tension pneumothorax, severe
acidosis or drug overdose. Successful resuscitation depends on
treatment of the underlying etiology.
1. The initial dose of IV or IO epinephrine is given in a dose of 0.1 mL/kg
of the 1:10,000 concentration (0.01 mg/kg). Endotracheal epinephrine
is given as a dose of 0.1 mL/kg of the 1:1,000 concentration (0.1
mg/kg) diluted to a final volume of 3-5 mL in normal saline.
Congestive Heart Failure 31

2. Subsequent doses are administered every three to five minutes as 0.1
mL/kg of the 1:1,000 concentration IV/IO/ET (0.1 mg/kg).
VI. Serum glucose concentration should be determined in all children
undergoing resuscitation. Glucose replacement is provided with 25%
dextrose in water, 2 to 4 mL/kg (0.5 to 1 g/kg) IV over 20 to 30 minutes for
hypoglycemia. In neonates, 10% dextrose in water, 5 to 10 mL/kg (0.5 to 1
g/kg), is recommended.
Congestive Heart Failure

1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Congestive Heart Failure
Condition:
Vital signs: Call MD if:
Activity:
Nursing: Daily weights, inputs and outputs
Diet: Low salt diet
IV Fluids:
Special Medications:
-Oxygen 2-4 L/min by NC.
-Furosemide (Lasix) 1 mg/kg/dose IV/IM/PO q6-12h prn, max 80 mg PO, 40
mg IV; may increase to 2 mg/kg/dose IV/IM/PO
[inj: 10 mg/mL; oral liquid: 10 mg/mL, 40 mg/5 mL; tabs: 20, 40, 80 mg] OR
-Bumetanide (Bumex) 0.015-0.1 mg/kg PO/IV/IM q12-24h, max 10 mg/day [
inj: 0.25 mg/mL; tabs: 0.5, 1, 2 mg].
Digoxin:
-Obtain a baseline ECG, serum electrolytes (potassium), and serum creatinine
before administration.
Initial digitalization is given over 24 hours in three divided doses: total
digitalizing dose (TDD) at time 0 hours, 1/4 TDD at 8-12 hours, and 1/4
TDD 8-12 hours later.
Maintenance therapy is then started.
Total Digitalizing Dose
PO
IV
Premature infant
20-30 mcg/kg
10-30 mcg/kg
Full term newborn (0-2 weeks) 30 mcg/kg

20-25 mcg/kg
2 wks-2 yr
40-50 mcg/kg
30-40 mcg/kg
2-10 yr
30-40 mcg/kg
25-30 mcg/kg
>10 yr
0.75-1.5 mg
10 mcg/kg (max 1
mg)
32 Atrial Fibrillation
Maintenance digoxin dose
PO
IV
Preterm neonate
4-10 mcg/kg/day
4-9 mcg/kg/day
Term neonate (0-2 wks)
6-10 mcg/kg/day
6-8 mcg/kg/day
2 weeks - 2 yr
10-12 mcg/kg/day
8-10 mcg/kg/day
2-10 yr
8-10 mcg/kg/day
6-8 mcg/kg/day
>10 yr
5 mcg/kg/day
2-3 mcg/kg/day
Adult
0.125-0.5 mg/day
0.1-0.4 mg/day
Divide bid if <10 yrs or qd if $10 yrs.
[caps: 50, 100, 200 mcg; elixir: 50 mcg/mL; inj: 100 mcg/mL, 250 mcg/mL;
tabs: 0.125, 0.25, 0.5 mg].
Other Agents:
-Dopamine (Intropin) 2-20 mcg/kg/min continuous IV infusion, titrate cardiac
output and BP.
-Dobutamine (Dobutrex) 2-20 mcg/kg/min continuous IV infusion, max of 40
mcg/kg/min.
-Nitroglycerin 0.5 mcg/kg/min continuous IV infusion, may increase by 1
mcg/kg q20min; usual max 5 mcg/kg/min.
-Captopril (Capoten)
Neonates: 0.05-0.1 mg/kg/dose PO q6-8h
Infants: 0.15-0.3 mg/kg/dose PO q8h.
Children: 0.5 mg/kg/dose PO q6-12h. Titrate as needed up to max of 6
mg/kg/day
[tabs: 12.5, 25, 50,100 mg]. Tablets can be crushed and made into
extemporaneous suspension.
-KCl 1-4 mEq/kg/day PO q6-24h.
10. Extras and X-rays: CXR PA and LAT, ECG, echocardiogram.
11. Labs: ABG, SMA 7, Mg, Ca, CBC, iron studies, digoxin level, UA.
Atrial Fibrillation
1.
2.
3.
4.
5.
6.
7.
8.
Admit to:
Diagnosis: Atrial fibrillation
Condition:
Activity:
Nursing:
Diet:
IV Fluids:
Atrial Fibrillation 33
9. Special Medications:
Cardioversion (if unstable or refractory to drug treatment):
1. If unstable, synchronized cardioversion using 0.5 J/kg immediately. In
stable patient with atrial fibrillation, consider starting quinidine or
procainamide 24-48h prior to cardioversion.
-Quinidine gluconate 2-10 mg/kg/dose IV q3-6h
-Procainamide: loading dose: 3-6 mg/kg IV over 5 min (max 100 mg), may
repeat every 5-10 minutes to max of 15 mg/kg (max 500 mg).
Maintenance: 20-80 mcg/kg/min continuous IV infusion (max 2 gm/24 hrs)
2. Midazolam (Versed) 0.1 mg/kg (max 5 mg) IV over 2 min, repeat prn until
amnesic.
3. Synchronized cardioversion using 0.5 J/kg. Increase stepwise by 0.5 J/kg if
initial dosage fails to convert the patient. Consider esophageal overdrive
pacing.
Digoxin Rate Control:
Initial digitalization is given over 24 hours in three divided doses: total
digitalizing dose (TDD) at time 0 hours, 1/4 TDD at 8-12 hours, and 1/4
TDD 8-12 hours later. Maintenance therapy is then started.
Total Digitalizing Dose
IV
PO
Premature infant
20-30 mcg/kg
10-30 mcg/kg
Full term newborn (0-2 weeks)
30 mcg/kg
20-25 mcg/kg
2 wks-2 yr
40-50 mcg/kg
30-40 mcg/kg
2-10 yr
30-40 mcg/kg
25-30 mcg/kg
>10 yr
0.75-1.5 mg
10 mcg/kg (max 1
mg)
Maintenance Digoxin Dose
PO
IV
Preterm neonate
4-10 mcg/kg/day
4-9 mcg/kg/day
Term neonate (0-2 wks)
6-10 mcg/kg/day
6-8 mcg/kg/day
2 weeks - 2 yr
10-12 mcg/kg/day 8-10 mcg/kg/day
2-10 yr
8-10 mcg/kg/day
6-8 mcg/kg/day
>10 yr
5 mcg/kg/day
2-3 mcg/kg/day
Divide bid if <10 yrs or qd if $10 yrs.
[caps: 50, 100, 200 mcg; elixir: 50 mcg/mL; inj: 100 mcg/mL, 250 mcg/mL;
tabs: 0.125, 0.25, 0.5 mg].
Other Rate Control Agents:
-Propranolol 0.01-0.1 mg/kg slow IV push over 10 minutes, repeat q6-8h prn
(max 1 mg/dose) or 0.5-4 mg/kg/day PO q6-8h (max 60 mg/day)
[inj: 1 mg/mL; oral solutions: 4 mg/mL, 8 mg/mL; oral concentrate: 80
mg/mL; tabs: 10, 20, 40, 60, 80, 90 mg].
34 Hypertensive Emergencies
Pharmacologic Conversion (after rate control):
-Procainamide (Pronestyl): Loading dose of 2-6 mg/kg/dose IV over 5 min,
then 20-80 mcg/kg/min IV infusion (max 100 mg/dose or 2 gm/24h). Oral
maintenance: 15-50 mg/kg/day PO q3-6h (max 4 gm/day).
[caps: 250, 375, 500 mg; inj: 100 mg/mL, 500 mg/mL; tabs: 250, 375, 500
mg; tabs, SR: 250, 500, 750, 1000 mg].
10. Extras and X-rays: Portable CXR, ECG, echocardiogram.
11. Labs: CBC, SMA 7, Mg, Ca, UA, ABG. Serum drug levels.
Hypertensive Emergencies
1.
2.
3.
4.
Admit to:
Diagnosis: Hypertensive Emergency
Condition:
Vital signs: Call MD if systolic BP >150 mmHg, diastolic bp >90 mmHg, MAP
> 120 mmHg.
5. Activity:
6. Nursing: BP q1h, ECG, daily weights, inputs and outputs.
7. Diet:
8. IV Fluids:
-Nitroprusside (Nipride) 0.5-10 mcg/kg/min continuous IV infusion. Titrate to
desired blood pressure. Cyanide and thiocyanate toxicity may develop with
prolonged use or in renal impairment.
-Labetalol (Trandate) 0.2 mg/kg (max 20 mg) IV over 2 min or 0.4-1 mg/kg/hr
continuous infusion.
-Enalaprilat (Vasotec IV) 5-10 mcg/kg/dose IV q8-24h prn.
-Nifedipine (Adalat, Procardia): 0.25-0.5 mg/kg/dose PO (max 10 mg/dose)
q4h prn [trade name capsules: 10 mg/0.34 mL, 20 mg/0.45 mL; may
puncture capsule with tuberculin syringe and draw up partial oral dosages].
10.Extras and X-rays: CXR, ECG, renal Doppler and ultrasound. Hypertensive
intravenous pyelography.
11. Labs: CBC, SMA 7, BUN, creatinine, UA with micro. Urine specific gravity,
thyroid panel, 24h urine for metanephrines; ANA, complement, ASO titer;
toxicology screen.
Asthma 35
Pulmonology
Asthma
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Exacerbation of asthma
Condition:
Activity:
Nursing: Pulse oximeter, measure peak flow rate in older patients.
Diet:
IV Fluids: D5 1/4 NS or D5 NS at maintenance rate.
-Oxygen humidified prn, 1-6 L/min by NC or 25-80% by mask, keep sat >92%.
Aerosolized and Nebulized Beta 2 Agonists:
-Albuterol (Ventolin) (using 0.5% = 5 mg/mL soln) nebulized 0.2-0.5 mL in
2 mL NS q1-4h and prn; may also be given by continuous aerosol.
[soln for inhalation: 0.83 mg/3 mL unit dose; 5 mg/mL 20 mL multidose
bulk bottle]
-Albuterol (Ventolin, Proventil) 2 puffs q1-6h prn with spacer and mask.
[capsule for inhalation (Rotacaps) using Rotahaler inhalation device: 200
mcg; MDI: 90 mcg/puff, 200 puffs/17 gm]
-Levalbuterol (Xopenex)
2-11 yrs: 0.16-1.25 mg nebulized
$12 yrs: 0.63-1.25mg nebulized q6-8h
[soln for inhalation: 0.63 mg/3 mL, 1.25 mg/3 mL]. Levalbuterol 0.63 mg is
comparable to albuterol 2.5 mg.
-Salmeterol (Serevent) > 4 yrs: 2 puffs bid. Not indicated for acute treatment.
[Serevent Diskus: 50 mcg/puff; MDI: 21 mcg/puff, 60 puffs/6.5gm or 120
puffs/13 gm]
-Formoterol (Foradil): $5 yrs: 12 mcg capsule aerosolized using dry powder
inhaler bid. [capsule for aerosolization: 12 mcg]
-Metaproterenol (Alupent, Metaprel)
> 12 yrs: 2-3 puffs q3-4h prn, max 12 puffs/24 hrs. [MDI: 0.65 mg/puff]
-Racemic epinephrine (2.25% sln) 0.05 mL/kg/dose (max 0.5 mL) in 2-3 mL
saline nebulized q1-6h.
Intravenous Beta-2 Agonist:
-Terbutaline (Brethaire, Brethine, Bricanyl)
Loading dose: 2-10 mcg/kg IV
Maintenance continuous IV infusion: 0.08-6 mcg/kg/min
Monitor heart rate and blood pressure closely.
36 Asthma
[inj: 1 mg/mL]
Corticosteroid (systemic) Pulse Therapy:
-Prednisolone 1-2 mg/kg/day PO q12-24h x 3-5 days
[syrup: 5 mg/5 mL; Orapred 20.2 mg/5mL; Prelone 15 mg/5 mL] OR
-Prednisone 1-2 mg/kg/day PO q12-24h x 3-5 days
[oral solution: 1 mg/mL, 5 mg/mL; tabs: 1, 2, 5, 10, 20, 50 mg] OR
-Methylprednisolone (Solu-Medrol) 2 mg/kg/dose IV/IM q6h x 4 doses, then 1
mg/kg/dose IV/IM q6h x 3-5 days.
Aminophylline and theophylline:
-Therapeutic range 10-20 mcg/mL. Concomitant drugs (e.g. erythromycin or
carbamazepine) may increase serum theophylline levels by decreasing
drug metabolism.
-Aminophylline loading dose 5-6 mg/kg total body weight IV over 20-30 min
[1 mg/kg of aminophylline will raise serum level by 2 mcg/mL].
-Aminophylline maintenance as continuous IV infusion (based on ideal body
weight)
1-6 mth: 0.5 mg/kg/hr
6-12 mth: 0.6-0.75 mg/kg/hr
1-10 yr: 1.0 mg/kg/hr
10-16 yr: 0.75-0.9 mg/kg/hr
>16 yr: 0.7 mg/kg/hr OR
-Theophylline PO maintenance
80% of total daily maintenance IV aminophylline dose in 2-4 doses/day OR
1-6 mth: 9.6 mg/kg/day.
6-12 mth: 11.5-14.4 mg/kg/day.
1-10 yr: 19.2 mg/kg/day.
10-16 yr: 14.4-17.3 mg/kg/day.
>16 yr: 10 mg/kg/day.
-Give theophylline as sustained release theophylline preparation: q8-12h or
liquid immediate release: q6h.
-Slo-Phyllin Gyrocaps, may open caps and sprinkle on food [60, 125, 250 mg
caps] q8-12h
-Slobid Gyrocaps, may open caps and sprinkle on food [50, 75, 100, 125, 200,
300 mg caps] q8-12h
-Theophylline oral liquid: 80 mg/15 mL, 10 mg/mL] q6-8h.
-Theo-Dur [100, 200, 300, 450 mg tabs; scored, may cut in half, but do not
crush] q8-12h.
-Theophylline Products
Cap: 100, 200 mg
Cap, SR: 50, 60, 65, 75, 100, 125, 130, 200, 250, 260, 300 mg
Liquid: 80 mg/15 mL, 10 mg/mL
Tab: 100, 125, 200, 250, 300 mg
Tab, SR: 50, 75, 100, 125, 130, 200, 250, 260, 300, 400, 450, 500 mg
Asthma 37
Corticosteroid metered dose inhalers or nebulized solution:
-Beclomethasone (Beclovent, Vanceril) MDI 1-4 puffs bid-qid with spacer and
mask, followed by gargling with water. [42 mcg/puff].
-Beclomethasone (Vanceril Double Strength) MDI 2 puffs bid [84 mcg/puff]
-Budesonide (Pulmicort Turbohaler) MDI 1-2 puffs bid [200 mcg/puff]
-Budesonide (Pulmicort) 0.25-0.5 mg nebulized bid [0.25 mg/2mL, 0.5
mg/2mL]
-Flunisolide (Aerobid) MDI 2-4 puffs bid [250 mcg/puff]
-Fluticasone (Flovent) MDI 1-2 puffs bid [44, 110, 220 mcg/actuation]
-Triamcinolone (Azmacort) MDI 1-4 puffs bid-qid [100 mcg/puff]
Cromolyn/nedocromil:
-Cromolyn sodium (Intal) MDI 2-4 puffs qid [800 mcg/puff] or nebulized 20 mg
bid-qid [10 mg/mL 2 mL unit dose ampules]
-Nedocromil (Tilade) MDI 2 puffs bid-qid [1.75 mg/puff]
Oral beta-2 agonists:
-Albuterol (Proventil)
2-6 years: 0.1-0.2 mg/kg/dose PO q6-8h
6-12 years: 2 mg PO tid-qid
>12 years: 2-4 mg PO tid-qid or 4-8 mg ER tab PO bid
[soln: 2 mg/5 mL; tab: 2, 4 mg; tab, ER: 4, 8 mg]
-Metaproterenol (Alupent, Metaprel)
< 2 yrs: 0.4 mg/kg/dose PO tid-qid
2-6 yrs: 1.3-2.6 mg PO q6-8h
6-9 yrs: 10 mg PO q6-8h
[syrup: 10 mg/5mL; tabs: 10, 20 mg]
Leukotriene receptor antagonists:
-Montelukast (Singulair)
2-5 yr: 4 mg PO qPM
6-14 yr: 5 mg PO qPM
> 14 yr: 10 mg PO qPM
[tab: 10 mg; tab, chew : 4, 5 mg]
-Zafirlukast (Accolate)
7-11 yr: 10 mg PO bid
$12 yr: 20 mg PO bid
[tabs: 10, 20 mg]
-Zileuton (Zyflo)
$12 yr: 600 mg PO qid (with meals and at bedtime)
[tab: 600 mg]
10. Extras and X-rays: CXR, pulmonary function test, peak flow rates.
11. Labs: CBC, CBG/ABG. Urine antigen screen, UA, theophylline level.
38 Allergic Rhinitis and Conjunctivitis
Allergic Rhinitis and Conjunctivitis

Antihistamines:
-Astemizole (Hismanal):
6-12 yr: 5 mg/day PO qd
>12 yr: 10 mg PO qd
[tab: 10 mg].
-Loratadine (Claritin)
>3 yrs and < 30 kg: 5 mg PO qd
>30 kg: 10 mg PO qd.
[syrup: 1mg/mL; tab: 10 mg; tab, rapidly disintegrating: 10 mg]
-Cetirizine (Zyrtec)
12 y: 5-10 mg qd
6-11 y: 5-10 mg qd
[tabs: 5, 10 mg Syrup: 5 mg/5 mL]
-Fexofenadine (Allegra), 12 y: 60 mg bid [60 mg]
-Actifed [per cap or tab or 10 mL syrup: triprolidine 2.5 mg, pseudoephedrine
60 mg]
4 mg pseudoephedrine/kg/day PO tid-qid OR
4 m-2 yr: 1.25 mL PO q6-8h
2-4 yr: 2.5 mL PO q6-8h
4-6 yr: 3.75 mL PO q6-8h
6-11y: 5 mL or tab PO q6-8h
>12 yr: 10 mL or 1 cap/tab PO q6-8h.
-Chlorpheniramine maleate (Chlor-Trimeton):
0.35 mg/kg/day PO q4-6h OR
2-5 yr: 1 mg PO q4-6h (max 4 mg/day)
6-11y: 2 mg PO q4-6h (max 12 mg/day)
$12y: 4 mg PO q4-6h or 8-12 mg SR q8-12h (max 24 mg/day).
[cap, SR: 8,12 mg; soln: 2 mg/5 mL; tab: 4, 8, 12 mg; tab, chew: 2 mg; tab,
SR: 8, 12 mg]
-Diphenhydramine (Benadryl)
1 mg/kg/dose PO q6h prn, max 50 mg/dose
[elixir/liquid: 12.5 mg/5 mL; tab, cap: 25, 50 mg].
Intranasal Therapy:
-Azelastine (Astelin)
3-12 yr: 1 spray in each nostril bid
> 12 yr: 2 sprays in each nostril bid
[nasal soln: 1 mg/mL, 17 mL (137 mcg/spray)]
-Beclomethasone (Beconase, Vancenase)
6-11 yrs: 1 spray into each nostril tid
$12 yrs: 1 spray into each nostril bid-qid
[42 mcg/actuation]
Allergic Rhinitis and Conjunctivitis 39

-Beclomethasone aqueous (Beconase AQ)
6-11 yrs: 1-2 sprays into each nostril bid
$12 yrs: 1-2 sprays into each nostril bid
[42 mcg/actuation]
-Beclomethasone Double Strength (Vancenase AQ)
6-11 yrs: 1-2 puffs into each nostril qd
$12 yrs: 1-2 sprays into each nostril qd
[84 mcg/actuation]
-Budesonide (Rhinocort)
6-11 yrs: 2 sprays into each nostril bid or 4 sprays into each nostril qAM
$12 yrs: 2 sprays into each nostril bid or 4 sprays into each nostril qAM
[32 mcg/actuation]
-Budesonide aqueous(Rhinocort AQ)
6-11 yrs: 1-2 sprays into each nostril bid
$12 yrs: 1 sprays into each nostril qd, may increase up to 4 sprays into
each nostril qAM
[32 mcg/actuation]
-Cromolyn (Nasalcrom)
1 puff into each nostril q3-4h
[40 mg/mL 13 mL].
-Flunisolide (Nasalide, Nasarel)
6-11 yrs: 1 spray into each nostril tid or 2 sprays into each nostril bid
$12 yrs: 2 sprays into each nostril bid-tid
[25 mcg/actuation].
-Fluticasone (Flonase)
4-6 yrs: 1-2 sprays into each nostril qd
6-11 yrs: 1-2 sprays into each nostril qd
$ 12 yrs: 1 spray into each nostril bid or 2 sprays into each nostril qd
[50 mcg/actuation]
-Mometasone (Nasonex)
4-6 yrs: 1 spray into each nostril qd
6-11 yrs: 1 spray into each nostril qd
$12 yrs: 2 sprays into each nostril qd
[50 mcg/actuation]
-Triamcinolone (Nasacort)
6-11 yr: 2 sprays into each nostril qd
>12 yr: 2 sprays into each nostril qd.
[55 mcg/actuation]
-Triamcinolone aqueous (Nasacort AQ)
6-11 yr: 2 spray into each nostril qd
>12 yr: 2 sprays into each nostril qd.
[55 mcg/actuation]
Allergic Conjunctivitis Therapy:
-Azelastine (Optivar)
40 Anaphylaxis
$3 yr: instill 1 drop into affected eye(s) bid
[ophth soln: 0.05% 6 mL]
-Cromolyn ophthalmic (Crolom, Opticrom)
Instill 2 drops into each affected eye(s) q4-6h
[ophth soln: 4% 2.5, 10 mL].
Decongestants:
-Pseudoephedrine (Sudafed, Novafed)
<12 yr: 4 mg/kg/day PO q6h.
>12 yr and adults: 30-60 mg/dose PO q6-8h or sustained release 120 mg
PO q12h or sustained release 240 mg PO q24h
[cap/cplt, SR: 120, 240 mg; drops: 7.5 mg/0.8mL; syrup: 15 mg/5mL, 30
mg/5mL; tabs: 30, 60 mg]
Anaphylaxis
1.
2.
3.
4.
5.
6.
7.
8.
Admit to:
Diagnosis: Anaphylaxis
Condition:
Activity:
Nursing: Inputs and outputs, ECG monitoring, pulse oximeter.
Diet:
IV Fluids: 2 IV lines. Normal saline or LR 10-20 mL/kg rapidly over 1h, then
D5 NS at 1-1.5 times maintenance.
-O2 at 4 L/min by NC or mask.
-Epinephrine, 0.01 mg/kg [0.01 mL/kg of 1 mg/mL = 1:1000] (maximum 0.5
mL) subcutaneously, repeat every 15-20 minutes prn. Usual dose for
infants is 0.05-0.1mL, for children 0.1-0.3 mL, and for adolescents 0.3-0.5
mL. If anaphylaxis is caused by an insect sting or intramuscular injection,
inject an additional 0.1 mL of epinephrine at the site to slow antigen
absorption.
-Epinephrine racemic (if stridor is present), 2.25% nebulized, 0.25-0.5 mL in
2.5 mL NS over 15 min q30 min-4h.
-Albuterol (Ventolin) (0.5%, 5 mg/mL sln) nebulized 0.01-0.03 mL/kg (max 1
mL) in 2 mL NS q1-2h and prn; may be used in addition to epinephrine if
necessary.
Corticosteroids:
-For severe symptoms, give hydrocortisone 5 mg/kg IV q8h until stable, then
change to oral prednisone. If symptoms are mild, give prednisone: initially
2 mg/kg/day (max 40 mg) PO q12h, then taper the dose over 4-5 days.
Pleural Effusion 41
Antihistamines:
-Diphenhydramine (Benadryl) 1 mg/kg/dose IV/IM/IO/PO q6h, max 50
mg/dose; antihistamines are not a substitute for epinephrine OR
-Hydroxyzine (Vistaril) 0.5-1 mg/kg/dose IM/IV/PO q4-6h, max 50 mg/dose.
10. Extras and X-rays: Portable CXR.
11. Labs: CBC, SMA 7, ABG.
Pleural Effusion
1.
2.
3.
4.
5.
6.
7.
8.
Admit to:
Diagnosis: Pleural effusion
Condition:
Activity:
Diet:
IV Fluids:
Extras and X-rays: CXR PA and LAT, lateral decubitus, ultrasound, sputum
AFB. Pulmonary consult.
9. Labs: CBC with differential, SMA 7, protein, albumin, ESR, UA.
Pleural fluid:
Tube 1 - LDH, protein, amylase, triglycerides, glucose, specific gravity (10 mL
red top).
Tube 2 - Gram stain, culture and sensitivity, AFB, fungal culture and
sensitivity (20-60 mL).
Tube 3 - Cell count and differential (5-10 mL, EDTA purple top).
Tube 4 - Cytology (25-50 mL, heparinized).
Syringe - pH (2 mL, heparinized).
Evaluation of Thoracentesis Fluid

Transudate
Exudate
Specific gravity
<1.016
>1.016
Protein ratio pleural

fluid/serum
<0.5
>0.5
Protein (gm/100 mL)
<3.0
>3.0
LDH ratio pleural

fluid/serum
<0.6
>0.6
WBC
<1,000/mm3
>1,000/mm3
42 Pleural Effusion
Glucose
Transudate
Exudate
Equivalent to serum
Less than serum
Suspected Sepsis 43
Infectious Diseases
Suspected Sepsis
1. Admit to:
2. Diagnosis: Suspected sepsis
3. Condition:
4. Vital signs: Call MD if:
5. Activity:
6. Nursing: Inputs and outputs, daily weights, cooling measures prn temp >38C,
consent for lumbar puncture.
7. Diet:
8. IV Fluids: Correct hypovolemia if present; NS 10-20 mL/kg IV bolus, then IV
fluids at 1-1.5 times maintenance.
Term newborns <1 month old (Group B strep, E coli, Group D strep, gram
negatives, Listeria monocytogenes): Ampicillin and gentamicin or cefotaxime.
-Ampicillin IV/IM: <7d: 150 mg/kg/day q8h; >7d: 200 mg/kg/day q6h.
-Cefotaxime (Claforan) IV/IM: <7 days: 100 mg/kg/day q12h; >7 days: 150
mg/kg/day q8h.
-Gentamicin (Garamycin) IV/IM: 5 mg/kg/day q12h.
-Also see page 121.
Infant 1-2 months old (H. flu, strep pneumonia, N meningitidis, Group B
strep):
-Ampicillin 100 mg/kg/day IV/IM q6h AND EITHER
-Cefotaxime (Claforan) 100 mg/kg/day IV/IM q6h OR
-Ceftriaxone (Rocephin) 50-75 mg/kg/day IV/IM q12-24h OR
-Gentamicin (Garamycin) 7.5 mg/kg/day IV/IM q8h
Children 2 months to 18 years old (S pneumonia, H flu, N. meningitidis):
-Cefotaxime (Claforan) 100 mg/kg/day IV/IM q6h, max 12 gm/day OR
-Ceftriaxone (Rocephin) 50-75 mg/kg/day IV/IM q 12-24h, max 4 gm/day.
Immunocompromised Patients (Gram negative bacilli, Pseudomonas,
Staph, Strep viridans):
-Ticarcillin (Ticar) 200-300 mg/kg/day IV/IM q6h, max 24 gm/day
-Ticarcillin/clavulanate (Timentin) 200-300 mg/kg/day of ticarcillin IV/IM q6-8h,
max 24gm/day OR
-Piperacillin (Pipracil) 200-300 mg/kg/day IV/IM q6h, max 24 gm/day OR
-Piperacillin/tazobactam (Zosyn) 240 mg/kg/day of piperacillin IV/IM q6-8h,
max 12 gm/day OR
-Ceftazidime (Fortaz) 100-150 mg/kg/day IV/IM q8h, max 12 gm/day AND
-Tobramycin (Nebcin) or Gentamicin (Garamycin) (normal renal function):
44 Meningitis
<5 yr (except neonates): 7.5 mg/kg/day IV/IM q8h.
5-10 yr: 6.0 mg/kg/day IV/IM q8h.
>10 yr: 5.0 mg/kg/day IV/IM q8h AND (if gram positive infection strongly
suspected)
-Vancomycin (Vancocin) (central line infection) 40-60 mg/kg/day IV q6-8h, max

4 gm/day
10. Symptomatic Medications:
-Ibuprofen (Advil) 5-10 mg/kg/dose PO q6h-8h prn temp >38C OR
-Acetaminophen (Tylenol) 10-15 mg/kg PO/PR q4-6h prn temp >38C or pain.
11. Extras and X-rays: CXR.
12. Labs: CBC, SMA 7. Blood culture and sensitivity x 2. UA, urine culture and
sensitivity; antibiotic levels. Stool for Wright stain if diarrhea. Nasopharyngeal
washings for direct fluorescent antibody (RSV, chlamydia).
CSF Tube 1 - Gram stain, culture and sensitivity for bacteria, antigen screen
(1-2 mL).
CSF Tube 2 - Glucose, protein (1-2 mL).
CSF Tube 3 - Cell count and differential (1-2 mL).
Meningitis
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Meningitis.
Condition: Guarded.
Activity:
Nursing: Strict isolation precautions. Inputs and outputs, daily weights; cooling
measures prn temp >38C; consent for lumbar puncture. Monitor for signs of
increased intracranial pressure.
7. Diet:
8. IV Fluids: Isotonic fluids at maintenance rate.
Term Newborns <1 months old (Group B strep, E coli, gram negatives,
Listeria):
-Ampicillin, 0-7 d: 150 mg/kg/day IV/IM q8h; >7d: 200 mg/kg/day IV/IM q6h
AND
-Cefotaxime (Claforan): <7d: 100 mg/kg/day IV/IM q12h; >7 days: 150
mg/kg/day q8h IV/IM.
Infants 1-3 months old (H. flu, strep pneumonia, N. Meningitidis, group B
strep, E coli):
-Ceftriaxone (Rocephin) 100 mg/kg/day IV/IM q12-24h AND
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6h.
Meningitis and Encephalitis 45

-Dexamethasone 0.6 mg/kg/day IV q6h x 4 days. Initiate before or with the first
dose of parenteral antibiotic.
Children 3 months to 18 years old (S pneumonia, H flu, N. meningitidis):
-Cefotaxime (Claforan) 200 mg/kg/day IV/IM q6h, max 12 gm/day or
ceftriaxone (Rocephin) 100 mg/kg/day IV/IM q12-24h, max 4 gm/day AND
-Vancomycin (Vancocin) 60 mg/kg/day IV q6h, max 4gm/day.
-Dexamethasone 0.6 mg/kg/day IV q6h x 4 days. Initiate before or with the first
dose of parenteral antibiotic.
-Ibuprofen (Advil) 5-10 mg/kg/dose PO q6-8h prn OR
-Acetaminophen (Tylenol) 15 mg/kg PO/PR q4h prn temp >38C or pain.
11. Extras and X-rays: CXR, MRI.
12. Labs: CBC, SMA 7. Blood culture and sensitivity x 2. UA, urine culture and
sensitivity; urine specific gravity. Antibiotic levels. Urine and blood antigen
testing.
Lumbar Puncture:
CSF Tube 1 - Gram stain, culture and sensitivity, bacterial antigen screen (1-2
mL).
CSF Tube 2 - Glucose, protein (1-2 mL).
Specific Therapy for Meningitis and Encephalitis

Dexamethasone (0.6 mg/kg/day IV q6h x 4 days) given before the first dose of
antibiotics decreases hearing deficits and possibly other neurologic sequelae in
Haemophilus influenzae meningitis.
Streptococcus pneumoniae:
Until sensitivities are available, combination therapy with vancomycin and
cefotaxime/ceftriaxone is recommended. For children with severe hypersensitivity
to beta-lactams, the combination of vancomycin and rifampin is recommended.
-Penicillin G 250,000-400,000 U/kg/day IV/IM q4-6h, max 24 MU/day
-Cefotaxime (Claforan) 200-300 mg/kg/day IV/IM q6h, max 12 gm/day
-Ceftriaxone (Rocephin) 100 mg/kg/day IV/IM q12-24h, max 4 gm/day
-Vancomycin (Vancocin) 60 mg/kg/day IV q6h, max 4 gm/day
-Rifampin 20 mg/kg/day IV q12h, max 600 mg/day
-Meropenem (Merrem) 120 mg/kg/day IV q8h, max 6 gm/day
-Chloramphenicol (Chloromycetin) 75-100 mg/kg/day IV q6h, max 4 gm/day
Neisseria meningitidis:
Penicillin is the drug of choice. Cefotaxime and ceftriaxone are acceptable
alternatives.
-Penicillin G 250,000-400,000 U/kg/day IV/IM q4h x 7-10d, max 24 MU/d.
-Cefotaxime (Claforan) 200-300 mg/kg/day IV/IM q6h, max 12 gm/day
46 Meningitis and Encephalitis

-Ceftriaxone (Rocephin) 100 mg/kg/day IV/IM q12-24h, max 4 gm/day
Meningococcal exposure prophylaxis (see H flu prophylaxis below):
-Ceftriaxone (Rocephin) IM x 1 dose; #12y: 125 mg; >12y: 250 mg OR
-Rifampin, #1 mth: 5 mg/kg/dose PO bid x 2 days; >1 mth: 10 mg/kg/dose
(max 600 mg/dose) PO q12h x 2 days [caps: 150 mg, 300 mg;
extemporaneous suspension] OR
-Ciprofloxacin (Cipro) 500 mg PO x 1 for adults (>18 yr).
Haemophilus influenzae
Ampicillin should not be used alone as initial therapy until sensitivities are
available as 10-40% of isolates are ampicillin-resistant.
-Cefotaxime (Claforan) 200-300 mg/kg/day IV/IM q6h, max 12 gm/day OR
-Ceftriaxone (Rocephin) 100 mg/kg/day IV/IM q12-24h, max 4 gm/day OR
-Ampicillin (beta-lactamase negative) 200-400 mg/kg/day IV/IM q4-6h, max 12
gm/day.
H influenzae type B exposure prophylaxis and eradication of
nasopharyngeal carriage:
-Rifampin <1 month: 10 mg/kg/day PO q24h x 4 days; >1 month: 20
mg/kg/day PO qd x 4 doses (max 600 mg/dose). [caps: 150, 300 mg;
extemporaneous suspension].
Group A or non-enterococcal Group D Streptococcus:
-Penicillin G 250,000 U/kg/day IV/IM q4-6h, max 24 MU/d.
Listeria monocytogenes or Group B Streptococcus:
-Ampicillin 200 mg/kg/day IV/IM q6h, max 12 gm/day AND
-Gentamicin (Garamycin) or Tobramycin (Nebcin) (normal renal function):
>10 yr: 5.0 mg/kg/day IV/IM q8h
Staphylococcus aureus:
-Nafcillin (Nafcil) or Oxacillin (Bactocill, Prostaphlin)150-200 mg/kg/day IV/IM
q4-6h, max 12 gm/day OR
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6h, max 4 gm/day (may require
concomitant intrathecal therapy).
Herpes Simplex Encephalitis:
-Acyclovir (Zovirax) 1500 mg/m2/day or 30 mg/kg/day IV over 1h q8h x 14-21
days
Infective Endocarditis 47
Infective Endocarditis
1. Admit to:
2. Diagnosis: Infective endocarditis
3. Condition:
5. Activity:
6. Diet:
7. IV Fluids:
Subacute Bacterial Endocarditis Empiric Therapy:
-Penicillin G 250,000 U/kg/day IV/IM q4-6, max 24 MU/day AND
-Gentamicin (Garamycin) or Tobramycin (Nebcin) (normal renal function):
>10 yr: 5.0 mg/kg/day IV/IM q8h
Acute Bacterial Endocarditis Empiric Therapy (including IV drug user):

-Gentamicin (Garamycin) or Tobramycin (Nebcin), see above for dose AND
EITHER
-Nafcillin (Nafcil) or oxacillin (Bactocill, Prostaphlin) 150 mg/kg/day IV/IM q6h,
max 12 gm/day OR
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6-8h, max 4 gm/day
Streptococci viridans/bovis:
-Penicillin G 150,000 u/kg/day IV/IM q4-6h, max 24 MU/day OR
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6-8h, max 4 gm/day.
Staphylococcus aureus (methicillin sensitive):
max 12 gm/day AND
-Gentamicin (Garamycin) or Tobramycin (Nebcin), see above for dose.
Methicillin-resistant Staphylococcus aureus:
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6h, max 4 gm/day.
Staphylococcus epidermidis:
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6h max 4 gm/day AND
-Gentamicin (Garamycin) or Tobramycin (Nebcin), see above for dose.
9. Extras and X-rays: CXR PA and LAT, echocardiogram, ECG. Cardiology and
infectious disease consultation.
10. Labs: CBC, ESR. Bacterial culture and sensitivity x 3-4 over 24h, MBC.
Antibiotic levels. UA, urine culture and sensitivity.
48 Endocarditis Prophylaxis
Endocarditis Prophylaxis
Prophylactic Regimens for Dental, Oral, Respiratory Tract, or
Esophageal Procedures
Situation
Drug
Regimen
Maximum Dose
Standard general
prophylaxis
Amoxicillin
50 mg/kg PO as a
single dose 1 hr
before procedure
2000 mg
Unable to take
oral medication
Ampicillin
50 mg/kg IV/IM
within 30 minutes
before procedure
2000 mg
Allergic to
penicillin
Clindamycin
or
20 mg/kg PO as a
single dose 1
hour before
procedure
600 mg
Cephalexin
(Keflex) or
cefadroxil
(Duricef)
or
50 mg/kg PO as a
single dose 1
hour before
procedure
2000 mg
Azithromycin
(Zithromax) or
clarithromycin
(Biaxin)
15 mg/kg PO as a
single dose 1
hour before
procedure
500 mg
Clindamycin
20 mg/kg IV 30
minutes before
procedure
600 mg
25 mg/kg IV/IM
within 30 minutes
before procedure
1000 mg
Allergic to
penicillin and
unable to take
oral medications
or
Cefazolin (Ancef)
Prophylactic Regimens for Genitourinary/Gastrointestinal Procedures

Situation
Drug
Regimen
Maximum Dose
High-risk patients
Ampicillin
plus
50 mg/kg IV/IM
2000 mg
Gentamicin
1.5 mg/kg IV/IM

within 30 minutes
before starting
procedure
120 mg
25 mg/kg IV/IM
25 mg/kg PO
six hours later
1000 mg
1000 mg
followed by
Ampicillin or
Amoxicillin
Pneumonia 49
Situation
Drug
Regimen
Maximum Dose
High-risk patients
allergic to
penicillin
Vancomycin
plus
20 mg/kg IV over
1-2 hours
1000 mg
Gentamicin
1.5 mg/kg IV/IM to

be completed
within 30 minutes
before starting
procedure
120 mg
Moderate-risk
Patients
Amoxicillin
or
50 mg/kg PO one
hour before
procedure
2000 mg
Ampicillin
50 mg/kg IV/IM
within 30 minutes
of starting pro
cedure
2000 mg
Vancomycin
20 mg/kg IV over
1-2 hours,
completed within
30 minutes of
starting the
procedure
1000 mg
Moderate-risk
patients allergic to
penicillin
Pneumonia
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Pneumonia
Condition:
Activity:
Nursing: Pulse oximeter, inputs and outputs. Bronchial clearance techniques,
vibrating vest.
7. Diet:
8. IV Fluids:
-Humidified O2 by NC at 2-4 L/min or 25-100% by mask, adjust to keep
saturation >92%
Term Neonates <1 month:
-Ampicillin 100 mg/kg/day IV/IM q6h AND
-Cefotaxime (Claforan) <1 wk: 100 mg/kg/day IV/IM q12h; >1 wk: 150
mg/kg/day IV/IM q8h OR
-Gentamicin (Garamycin) 5 mg/kg/day IV/IM q12h.
Children 1 month-5 years old:
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h OR
50 Pneumonia
-Ampicillin 100 mg/kg/day IV/IM q6h AND
-Gentamicin (Garamycin) or Tobramycin (Nebcin):
7.5 mg/kg/day IV/IM q8h (normal renal function).
-If chlamydia is strongly suspected, add erythromycin 40 mg/kg/day IV q6h.
Oral Therapy:
-Cefuroxime axetil (Ceftin)
tab: child: 125-250 mg PO bid; adult: 250-500 mg PO bid
susp: 30 mg/kg/day PO q12h, max 1000 mg/day
[susp: 125 mg/5 mL; tabs: 125, 250,500 mg] OR
-Loracarbef (Lorabid)
30 mg/kg/day PO q12h, max 800 mg/day
[cap: 200, 400 mg; susp: 100 mg/5 mL, 200 mg/5mL]
-Cefpodoxime (Vantin)
[susp: 50 mg/5 mL, 100 mg/5 mL; tabs: 100, 200 mg]
-Cefprozil (Cefzil)
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg].
-Cefixime (Suprax)
8 mg/kg/day PO qd-bid, max 400 mg/day
[susp: 100 mg/5 mL; tabs: 200, 400 mg].
-Clarithromycin (Biaxin)
15-30 mg/kg/day PO bid, max 1000 mg/day
-Azithromycin (Zithromax)
Children $2 yrs: 12 mg/kg/day PO qd x 5 days, max 500 mg/day
$16 yrs: 500 mg PO on day 1, 250 mg PO qd on days 2-5
[cap: 250 mg; susp: 100 mg/5mL, 200 mg/5mL; tabs: 250, 600 mg]
-Amoxicillin/clavulanate (Augmentin)
30-40 mg/kg/day of amoxicillin PO q8h , max 500 mg/dose
[elixir 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg; tabs, chew: 125, 250
mg;]
-Amoxicillin/clavulanate (Augmentin BID)
30-40 mg/kg/day PO q12h, max 875 mg (amoxicillin)/dose
[susp 200 mg/5 mL, 400 mg/5 mL; tab: 875 mg; tabs, chew: 200, 400 mg]
Community Acquired Pneumonia 5-18 years old (viral, Mycoplasma
pneumoniae, chlamydia pneumoniae, pneumococcus, legionella):
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h, max 9 gm/day OR
-Erythromycin estolate (Ilosone) 30-50 mg/kg/day PO q8-12h, max 2 gm/day
[caps: 125, 250 mg; drops: 100 mg/mL; susp: 125 mg/5 mL, 250 mg/5 mL;
tab: 500 mg; tabs, chew: 125,250 mg]
-Erythromycin ethylsuccinate (EryPed, EES)
30-50 mg/kg/day PO q6-8h, max 2gm/day
[susp: 200 mg/5 mL, 400 mg/5 mL; tab: 400 mg; tab, chew: 200 mg]
Pneumonia 51
-Erythromycin base (E-mycin, Ery-Tab, Eryc)
[cap, DR: 250 mg; tabs: 250, 333, 500 mg]
-Erythromycin lactobionate
20-40 mg/kg/day IV q6h, max 4 gm/day
[inj: 500 mg, 1 gm]
15-30 mg/kg/day PO bid, max 1000 mg/day
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg]
Immunosuppressed, Neutropenic Pneumonia (S. pneumoniae, group A
strep, H flu, gram neg enterics, Klebsiella, Mycoplasma Pneumonia, Legion
ella, Chlamydia pneumoniae, S aureus):
-Tobramycin (Nebcin) (normal renal function):
>10 yr: 5.0 mg/kg/day IV/IM q8h OR
-Ceftazidime (Fortaz)150 mg/kg/day IV/IM q8h, max 12 gm/day AND
-Ticarcillin/clavulanate (Timentin) 200-300 mg/kg/day of ticarcillin IV q6-8h,
max 24 gm/day OR
max 12 gm/day OR
-Vancomycin (Vancocin) 40 mg/kg/day IV q6h, max 4 gm/day.
Cystic Fibrosis Exacerbation (Pseudomonas aeruginosa):
-Ticarcillin/clavulanate (Timentin) 200-300 mg/kg/day of ticarcillin IV q6-8h,
max 24 gm/day OR
-Piperacillin/tazobactam (Zosyn) 300 mg/kg/day of piperacillin IV q6-8h, max
12 gm/day OR
-Piperacillin (Pipracil) 200-300 mg/kg/day IV/IM q4-6h, max 24 gm/day AND
-Tobramycin (Nebcin):
-Ceftazidime (Fortaz) 150 mg/kg/day IV/IM q8h, max 12 gm/day OR

-Aztreonam (Azactam) 150-200 mg/kg/day IV/IM q6-8h, max 8 gm/day OR
-Imipenem/Cilastatin (Primaxin) 60-100 mg/kg/day imipenem component IV
-Meropenem (Merrem) 60-120 mg/kg/day IV q8h, max 6gm/day.
-Acetaminophen (Tylenol) 10-15 mg/kg PO/PR q4h prn temp >38C or pain.
11. Extras and X-rays: CXR PA and LAT, PPD.
12. Labs: CBC, ABG, blood culture and sensitivity x 2. Sputum gram stain,
culture and sensitivity, AFB. Antibiotic levels. Nasopharyngeal washings for
direct fluorescent antibody (RSV, adenovirus, parainfluenza, influenza virus,
chlamydia) and cultures for respiratory viruses. UA.
52 Pneumonia
Specific Therapy for Pneumonia

Pneumococcal pneumonia:
-Erythromycin estolate (Ilosone)
30-50 mg/kg/day PO q8-12h, max 2 gm/day
-Erythromycin base (E-Mycin, Ery-Tab, Eryc)
[tab: 250, 333, 500 mg]
-Erythromycin lactobionate
[inj: 500 mg, 1 g m] OR
-Vancomycin (Vancocin) 40 mg/kg/day IV q6h, max 4 gm/day OR
-Penicillin G 150,000 U/kg/day IV/IM q4-6h, max 24 MU/day.
Staphylococcus aureus:
-Oxacillin (Bactocill, Prostaphlin) or Nafcillin (Nafcil) 150-200 mg/kg/day IV/IM
-Vancomycin (Vancocin) 40 mg/kg/day IV q6h, max 4 gm/day
Haemophilus influenzae (<5 yr of age):
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h (beta-lactamase pos),
max 9 gm/day OR
-Ampicillin 100-200 mg/kg/day IV/IM q6h (beta-lactamase negative), max 12
gm/day
Pseudomonas aeruginosa:
-Tobramycin (Nebcin):
>10 yr: 5.0 mg/kg/day IV/IM q8h AND
-Piperacillin (Pipracil) or ticarcillin (Ticar) 200-300 mg/kg/day IV/IM q4-6h, max
24 gm/day OR
-Ceftazidime (Fortaz) 150 mg/kg/day IV/IM q8h, max 12 gm/day.
Mycoplasma pneumoniae:
-Clarithromycin (Biaxin) 15-30 mg/kg/day PO q12h, max 1 gm/day
Pneumonia 53
[cap, DR: 250 mg; tabs: 250, 333, 500 mg]
-Erythromycin lactobionate (Erythrocin)
[inj: 500 mg, 1 gm]
-Tetracycline (Achromycin)
>8 yrs only
25-50 mg/kg/day PO q6h, max 2 gm/day
[caps: 100, 250, 500 mg; susp: 125 mg/5 mL; tabs: 250, 500 mg]
Moraxella catarrhalis:
15 mg/kg/day PO q12h, max 1 gm/day
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg] OR
[cap, DR: 250 mg; tabs: 250, 333, 500 mg]
[inj: 500 mg, 1 gm] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra)
6-12 mg TMP/kg/day PO/IV q12h, max 320 mg TMP/day
[inj per mL: TMP 16 mg/SMX 80 mg; susp per 5 mL: TMP 40 mg/SMX 200
mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400 mg]
54 Pneumonia
Chlamydia pneumoniae (TWAR), psittaci, trachomatous:
[cap, DR: 250 mg; tabs: 250, 333, 500 mg]
[inj: 500 mg, 1 gm ] OR
children $2 yrs: 12 mg/kg/day PO qd x 5 days, max 500 mg/day
$16 yrs: 500 mg PO on day one, then 250 mg PO qd on days 2-5
Influenza Virus:
-Oseltamivir (Tamiflu)
$1 yr and <15 kg: 30 mg PO bid
15-23 kg: 45 mg PO bid
>23 - 40 kg: 60 mg PO bid
>40 kg: 75 mg PO bid
>18 yr: 75 mg PO bid
[cap: 75 mg; susp: 12 mg/mL]
Approved for treatment of uncomplicated influenza A or B when patient has
been symptomatic no longer than 48 hrs. OR
-Rimantadine (Flumadine)
<10 yr: 5 mg/kg/day PO qd, max 150 mg/day
[syrup: 50 mg/5 mL; tab: 100 mg].
Approved for treatment or prophylaxis of Influenza A. Not effective against
Influenza B. OR
-Amantadine (Symmetrel)
1-9 yr: 5 mg/kg/day PO qd-bid, max 150 mg/day
>9 yr: 5 mg/kg/day PO qd-bid, max 200 mg/day
[cap: 100 mg; syr: 50 mg/5 mL].
Influenza B.
Bronchiolitis 55
Bronchiolitis
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Bronchiolitis
Condition:
Activity:
Nursing: Pulse oximeter, peak flow rate. Respiratory isolation.
Diet:
IV Fluids:
-Oxygen, humidified 1-4 L/min by NC or 40-60% by mask, keep sat >92%.
Nebulized Beta 2 Agonists:
-Albuterol (Ventolin, Proventil) (5 mg/mL sln) nebulized 0.2-0.5 mL in 2 mL NS
(0.10-0.15 mg/kg) q1-4h prn.
Treatment of Respiratory Syncytial Virus (severe lung disease or underlying
cardiopulmonary disease):
-Ribavirin (Virazole) therapy should be considered in high risk children <2 yrs
with bronchopulmonary dysplasia or with history of premature birth less
than 35 weeks gestational age. Ribavirin is administered as a 6 gm vial,
aerosolized by SPAG nebulizer over 18-20h qd x 3-5 days or 2 gm over 2
hrs q8h x 3-5 days.
Prophylaxis Against Respiratory Syncytial Virus:
-Recommended use in high risk children <2 yrs with BPD who required
medical management within the past six months, or with history of
premature birth less than or equal to 28 weeks gestational age who are
less than one year of age at start of RSV season, or with history of
premature birth 29-32 weeks gestational age who are less than six months
of age at start of RSV season.
-Palivizumab (Synagis) 15 mg/kg IM once a month throughout RSV season
(usually October-March)
-RSV-IVIG (RespiGam) 750 mg/kg IV once a month throughout RSV season
(usually from October to March).
Influenza A:
-Oseltamivir (Tamiflu)
$1 yr and <15 kg: 30 mg PO bid
15-23 kg: 45 mg PO bid
>23 - 40 kg: 60 mg PO bid
>40 kg: 75 mg PO bid
[cap: 75 mg; susp: 12 mg/mL]
Approved for treatment of uncomplicated influenza A or B when patient has
been symptomatic no longer than 48 hrs. OR
56 Viral Laryngotracheitis (Croup)

-Rimantadine (Flumadine)
<10 yr: 5 mg/kg/day PO qd, max 150 mg/day
[syrup: 50 mg/5 mL; tab: 100 mg].
Influenza B. OR
-Amantadine (Symmetrel)
1-9 yr: 5 mg/kg/day PO qd-bid, max 150 mg/day
>9 yr: 5 mg/kg/day PO qd-bid, max 200 mg/day
[cap: 100 mg; syr: 50 mg/5 mL].
Influenza B.
Pertussis:
The estolate salt is preferred due to greater penetration.
-Erythromycin estolate 50 mg/kg/day PO q8-12h, max 2 gm/day
-Erythromycin lactobionate (Erythrocin) 20-40 mg/kg/day IV q6h, max 4
gm/day
[inj: 500 mg, 1 gm].
Oral Beta 2 Agonists and Acetaminophen:
-Albuterol liquid (Proventil, Ventolin)
2-6 years: 0.1-0.2 mg/kg/dose PO q6-8h
6-12 years: 2 mg PO tid-qid
>12 years: 2-4 mg PO tid-qid
[soln: 2 mg/5 mL; tabs: 2,4 mg; tabs, SR: 4, 8 mg]
-Acetaminophen (Tylenol) 10-15 mg/kg PO/PR q4-6h prn temp >38.
11. Labs: CBC, SMA 7, CBG/ABG, UA. Urine antigen screen. Nasopharyngeal
washings for direct fluorescent antibody (RSV, adenovirus, parainfluenza,
influenza virus, chlamydia), viral culture.
Viral Laryngotracheitis (Croup)

1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Croup
Condition:
Activity:
Nursing: Pulse oximeter, laryngoscope and endotracheal tube at bedside.
Respiratory isolation, inputs and outputs.
7. Diet:
Varicella Zoster Infections 57

8. IV Fluids:
-Oxygen, cool mist, 1-2 L/min by NC or 40-60% by mask, keep sat >92%.
-Racemic epinephrine (2.25% sln) 0.05 mL/kg/dose (max 0.5 mL) in 2-3 mL
saline nebulized q1-6h.
-Dexamethasone (Decadron) 0.25-0.5 mg/kg/dose IM/IV q6h prn, max dose
10 mg OR
-Prednisone 1-2 mg/kg/day PO q12-24h x 3-5 days [syr: 1mg/mL, 5 mg/mL;
tabs: 1, 2.5, 5, 10, 20, 50 mg]
-Prednisolone 1-2 mg/kg/day PO q12-24h x 3-5 days [5 mg/5 mL, Orapred
20.2mg/5mL, Prelone 15 mg/5 mL].
10. Extras and X-rays: CXR PA and LAT, posteroanterior x-ray of neck.
11. Labs: CBC, CBG/ABG, blood culture and sensitivity; UA, culture and
sensitivity. Urine antigen screen.
Varicella Zoster Infections

Immunocompetent Patient
A. Therapy with oral acyclovir is not recommended routinely for the
treatment of uncomplicated varicella in the otherwise healthy child <12
years of age.
B. Oral acyclovir may be given within 24 hours of the onset of rash.
Administration results in a modest decrease in the duration and
magnitude of fever and a decrease in the number and duration of skin
lesions.
C. Acyclovir (Zovirax) 80 mg/kg/day PO q6h for five days, max 3200 mg/day
[cap: 200 mg; susp: 200 mg/5 mL; tabs: 400, 800 mg]
Immunocompromised Patient
A. Intravenous acyclovir should be initiated early in the course of the illness.
Therapy within 24 hours of rash onset maximizes efficacy. Oral acyclovir
should not be used because of unreliable oral bioavailability.
Dose: 500 mg/m2/dose IV q8h x 7-10 days
B. Varicella zoster immune globulin (VZIG) may be given shortly after
exposure to prevent or modify the course of the disease. It is not effective
once disease is established.
Dose: 125 U per 10 kg body weight, round up to nearest vial size to max of
625 U [vial: 125 U/1.25ml]. Must be administered IM.
58 Ventriculoperitoneal Shunt Infection
Ventriculoperitoneal Shunt Infection

1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: VP Shunt Infection
Condition: Guarded.
Activity:
Nursing: Inputs and outputs, daily weights; cooling measures prn temp
>38C.
7. Diet:
-Vancomycin 40-60 mg/kg/day IV q6-8h, max 4 gm/day OR
-Nafcillin (Nafcil) or oxacillin (Bactocill, Prostaphlin) 150-200 mg/kg/day IV/IM
q6h, max 12 gm/day
-Ibuprofen 5-10 mg/kg/dose PO q6-8h prn OR
-Acetaminophen 15 mg/kg PO/PR q4h prn temp >38C or pain.
11. Extras and X-rays: Neurosurgery consultation. CT Scan, MRI.
12. Labs: CBC, SMA 7. Blood culture and sensitivity. CSF cell count, culture,
sensitivity, Gram stain, CSF glucose, protein.
Pneumocystis Carinii Pneumonia

1. Admit to:
2. Diagnosis:
3. Condition:
5. Activity:
6. Nursing: Daily weights.
7. Diet:
8. IV Fluids:
Pneumocystis Carinii Pneumonia (PCP) Treatment:
-Oxygen prn for hypoxia.

-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 15-20 mg TMP/kg/day
IV/PO q6h x 14-21 days [inj per mL: TMP 16 mg/SMX 80 mg; susp per 5
mL: TMP 40 mg/SMX 200 mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS:
TMP 80mg/SMX 400 mg] x 14-21 days
Oral therapy is reserved for patients with mild disease who do not have
malabsorption or diarrhea OR
-Pentamidine isethionate (Pentam) 4 mg/kg/day IV over 1-2h for 14-21days
AIDS 59
-Prednisone:
<13 yrs: 2mg/kg/day PO qd x 7-10 days, then taper over the next 10-14
days.
>13 yrs old with hypoxia: 40 mg PO bid x 5 days, then 40 mg PO qd x 5
days, then 20 mg PO qd x 11 days.
Pneumocystis Carinii Pneumonia Prophylaxis:
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 150 mg/m 2
trimethoprim/kg/day PO bid three days per week. [inj per mL: TMP 16
mg/SMX 80 mg; susp per 5 mL: TMP 40 mg/SMX 200 mg; tab DS: TMP
160 mg/SMX 800 mg; tab SS: TMP 80/SMX 400 mg] OR
-Dapsone (Avlosulfon) ($1 mo) 2 mg/kg/day PO q24h, max 100 mg/day or 4
mg/kg/dose PO q week, max 200 mg/dose [tabs: 25,100 mg] OR
-Aerosolized Pentamidine (NebuPent) (if $5 yrs): 300 mg nebulized monthly
-Atovaquone (Mepron)
1-3 months and >24 months: 45 mg/kg/day PO qd
4-24 months: 30 mg/kg/day PO qd
[liquid: 750 mg/5mL]
10. Extras and X-rays: CXR PA and LAT, PPD.

11. Labs: CBC, SMA 7, LDH. Blood culture and sensitivity x 2. Sputum Gram
stain, culture and sensitivity. Sputum stain for Pneumocystis, AFB. CD4 count,
HIV RNA PCR, UA.
AIDS
Antiretroviral Therapy:
-Zidovudine (Retrovir, AZT) - oral
<2 weeks: 8 mg/kg/day PO q6h
2-4 weeks: 12 mg/kg/day PO q6h
4 wks -12 yr: 90-180 mg/m2/dose q6h, max 200 mg/dose
>12 yr, monotherapy and asymptomatic: 100 mg q4h while awake (max
500 mg/day).
>12 yr, monotherapy and symptomatic: 100 mg q4h
> 12 yrs and combination therapy: 200 mg PO q8h
[cap: 100 mg; soln: 10 mg/mL; tab: 300 mg]
-Zidovudine - intravenous
<2 weeks: 6 mg/kg/day IV q6h
2-4 weeks: 9 mg/kg/day IV q6h
4 wks to 12 yr: 0.5-1.8 mg/kg/hr continuous IV infusion or 100-120
mg/m2/dose IV q6h
>12 yr: 1 mg/kg/dose q4h
[inj: 10 mg/mL]
-Lamivudine (Epivir, 3TC)
60 AIDS
3 mos-12 yr: 2-4 mg/kg/dose PO bid (max 150 mg/dose)
>12 yr: if < 50kg: 2 mg/kg/dose PO bid; if $50kg: 150 mg PO bid
[soln: 10 mg/mL; tab: 150 mg]
-Didanosine (Videx, ddI)
<90 days: 100 mg/m2/day PO q12h
90 days to 13 yrs: 100-300 mg/m2/day PO bid
$13 yrs:
<60 kg: 125mg q12h (tablets or powder packets) or 167mg PO q12h (oral
susp)
$60 kg: 200mg q12h (tablets or powder packets) or 250mg PO q12h

(oral susp)
Children >1 yr should take drug as two chewable tablets or as powder
packets or as suspension to ensure that adequate buffering is obtained;
must be taken on an empty stomach.
[Powd pkt, buffered: 100, 167, 250 mg; susp: 2, 4 gm bottles (final
concentration 10 mg/mL when admixed with antacid); tabs, chew/buffered:
25, 50, 100, 150, 200 mg]
-Zalcitabine (ddC, Hivid)
<13 yr: 0.005 - 0.01 mg/kg/dose PO q8h
$13 yr: 0.75 mg PO q8h.
[tabs: 0.375, 0.75 mg]
-Stavudine (d4T, Zerit)
7 mos-15 yrs: 1-2 mg/kg/day PO bid, max 80 mg/day
>15 yrs or if $40 kg: 40 mg PO bid.
[caps: 15, 20, 30, 40 mg; soln: 1 mg/mL]
-Saquinavir (Fortovase, SQV, Invirase)
1050 mg/m2/day PO q8h, max 3600 mg/day
Diarrhea, abdominal cramps, hyperglycemia. Take with a full meal for
better absorption.
[cap: 200 mg]
-Indinavir (IDV, Crixivan)
350-500 mg/m2/dose PO q8h.
Adolescents: 800mg PO q8h.
Adverse drug reactions include kidney stones, abdominal pain, and fatigue.
Take on an empty stomach with ample fluids.
[cap: 200, 400 mg]
-Ritonavir (RTV, Norvir)
Pediatric: Start at less than 100 mg bid and titrate up over five days to 500800 mg/m2/day PO bid
Adolescents: start at 300 mg PO bid, increase to full dose of 600 mg PO
bid over 5 days.
Paresthesias, anorexia, increased liver function tests. Take with food.
[cap: 100 mg; soln: 80 mg/mL]
AIDS 61
-Combivir (zidovudine and lamivudine)
Adolescents: 1 tab PO bid
[tab: zidovudine 300 mg, lamivudine 150 mg].
Oropharyngeal Candidiasis:
-Ketoconazole (Nizoral) 5-10 mg/kg/day PO qd-bid, max 800 mg/day [tab: 200
mg; extemporaneous suspension may be made] OR
-Nystatin susp. Premature infants: 1 mL; infants: 2 mL; children: 5 mL; > 12
yrs: 10mL. Swish and swallow qid OR
-Fluconazole (Diflucan) 6 mg/kg IV or PO loading dose, followed by 3
mg/kg/day PO or IV qd [inj: 2 mg/mL; susp: 10 mg/mL, 40 mg/mL; tabs: 50,
100, 150, 200 mg].
-Itraconazole (Sporanox) 3-5 mg/kg/day PO qd; adolescents may also use oral
suspension 10 mL swish/swallow qd-bid [cap: 100 mg; oral soln: 100 mg/10
mL)
Invasive or Disseminated Candidiasis:
-Amphotericin B (Fungizone): test dose of 0.1 mg/kg (max 1 mg), followed by
remainder of first days dose if tolerated. Initial dose: 0.25 mg/kg/day; increase by 0.25 mg/kg/day q1-2 days. Usual dose 0.5-1 mg/kg/day; usual
max dose 50 mg. Infuse over 2-4 hours.
Pretreatment (except test dose) - Acetaminophen, hydrocortisone, diphen
hydramine; give meperidine (Demerol) during infusion if chilling occurs.
-Amphotericin B liposomal (AmBisome) 3-5 mg/kg IV over 2 hrs qd.
-Amphotericin B lipid complex (Abelcet) 5 mg/kg IV over 2 hrs qd.
-Fluconazole (Diflucan) 6-12 mg/kg/day PO/IV qd [inj: 2 mg/mL; susp: 10
mg/mL, 40 mg/mL; tabs: 50, 100, 150, 200 mg]
-Flucytosine (Ancobon) 100-150 mg/kg/day PO q6h [caps: 250, 500 mg;
extemporaneous suspension]. Must use in combination with amphotericin
B as resistance develops quickly if used alone. Monitor serum levels and
adjust dose in renal impairment.
Cryptococcus Neoformans Meningitis:
-Amphotericin B (Fungizone) 1 mg/kg/day IV qd over 2-4h x 8-12 weeks (see
test dose and titration, page 61) OR
-Fluconazole (Diflucan) 6-12 mg/kg/day IV/PO qd [inj: 2 mg/mL; susp: 10
mg/mL, 40 mg/mL; tabs: 50, 100, 150, 200 mg].
-Flucytosine (Ancobon, 5-FC) 100-150 mg/kg/day PO q6h [caps: 250, 500 mg;
extemporaneous suspension].
-Patients infected with HIV who have completed initial therapy for
cryptococcosis should receive lifelong maintenance with low-dose
fluconazole.
Herpes Simplex Infections in Immunocompromised Host:
-Acyclovir (Zovirax) 15-30 mg/kg/day or 250-500 mg/m2/dose IV q8h for 7-14
days (infuse each dose over 1 hr) or 500 mg/m2/dose PO 4-5 times daily.
Herpes Simplex Encephalitis:
-Acyclovir (Zovirax) 30 mg/kg/day or 500 mg/m2/dose IV q8h (infuse each
62 Septic Arthritis
dose over 1 hr).
Herpes Varicella Zoster:
-Acyclovir (Zovirax) 30 mg/kg/day or 500 mg/m2/dose IV q8h for 10 days
(infuse each dose over 1 hr).
Cytomegalovirus Infections:
-Ganciclovir (Cytovene) children >3 months-adults: 10 mg/kg/day IV over 1-2h
q12h x 14-21 days, then maintenance 5 mg/kg/day IV qd for 5-7 days per
week.
Toxoplasmosis:
-Pyrimethamine (Daraprim) 2 mg/kg/day PO qd x 3 days, then 1 mg/kg/day
PO q24h, max 25 mg/day [tab: 25 mg] and folinic acid 5-10 mg PO q3 days
[tabs: 5, 15, 25 mg] AND
-Sulfadiazine 100-200 mg/kg/day PO qid x 3-4 weeks, max 6 gm/day [tab: 500
mg; extemporaneous suspension]. Take with ample fluids.
Disseminated Histoplasmosis or Coccidiomycosis:
-Amphotericin B (Fungizone) 1 mg/kg/day IV qd over 2-4h for $6 weeks (see
test dose and titration, page 61).
Mycobacterium Avium Complex (MAC):
-Azithromycin (Zithromax) 10-20 mg/kg/day PO qd, max 500 mg [cap: 250 mg;
susp: 100 mg/5 mL, 200 mg/5 mL; tabs: 250, 600 mg] AND
-Rifabutin (Mycobutin)
6-12 yr: 5 mg/kg/day PO qd, max 300 mg/day
>12 yr: 300 mg/day PO qd
[cap: 150 mg] OR
-Ethambutol (Myambutol) 15-25 mg/kg/day PO qd, max 1 gm /day [tab: 100,
400 mg] OR
-Rifampin (Rifadin) 10-20 mg/kg/day PO q12-24h, max 600 mg/day [caps:
150, 300 mg; extemporaneous suspension].
Single drug therapy results in frequent development of MAC antimicrobial
resistance. Patients with HIV should continue treatment at full therapeutic
doses for life.
Septic Arthritis
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Septic arthritis
Condition:
Activity: No weight bearing on infected joint.
Nursing: Warm compresses prn. Consent for arthrocentesis. Age appropriate
pain scale.
7. Diet:
Appendicitis 63
8. IV Fluids:
Empiric Therapy for Infants 1-6 months (strep, staph, gram neg,
gonococcus):
-Nafcillin (Nafcil) or oxacillin (Bactocill, Prostaphlin) 100 mg/kg/day IV/IM q6h
AND
-Gentamicin (Garamycin) or tobramycin (Nebcin) (normal renal function): 7.5
mg/kg/day IV/IM q8h.
Empiric Therapy for Patients Age 6 months-4 yr (H influenzae, streptococci,
staphylococcus):
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h (preferred for H flu
coverage until culture results available) AND/OR
-Nafcillin (Nafcil) or oxacillin (Bactocill) 100-200 mg/kg/day IV/IM q6h.
Empiric Therapy for Children Older than 4 Years (staph, strep):
max 12 gm/day OR
-Vancomycin (Vancocin) (MRSA) 40-60 mg/kg/day IV q6-8h, max 4 gm/day.
-Acetaminophen and codeine 0.5-1 mg codeine/kg/dose PO q4-6h prn pain
[elixir per 5 mL: codeine 12 mg, acetaminophen 120 mg].
-Ibuprofen (Childrens Advil) 5-10 mg/kg/dose PO q6-8 hrs prn fever.
11. Extras and X-rays: X-ray views of joint, CXR. Orthopedics and infectious
disease consults. CT scan.
12. Labs: CBC, blood culture and sensitivity x 2, PPD, ESR, UA. Antibiotic lev
els. Urine antigen screen (H flu).
Synovial fluid:
Tube 1 - Gram stain, culture and sensitivity.
Tube 2 - Glucose, protein, pH.
Tube 3 - Cell count.
Appendicitis
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Appendicitis.
Condition: Guarded.
Activity:
Nursing: Inputs and outputs, daily weights; cooling measures prn temp
>38C. Age appropriate pain scale.
7. Diet:
64 Lower Urinary Tract Infection

-Gentamicin (Garamycin):
30 days-5 yr: 7.5 mg/kg/day IV/IM q8h.
>10 yr: 5.0 mg/kg/day IV/IM q8h AND
-Metronidazole (Flagyl) 30 mg/kg/day q6h, max 4 gm/day
OR (non-perforated)
-Cefotetan (Cefotan) 40-80 mg/kg/day IM/IV q12h, max 6 gm/day OR
-Cefoxitin (Mefoxin) 100 mg/kg/day IM/IV q6-8h, max 12 gm/day

-Ibuprofen 5-10 mg/kg/dose PO q6-8h prn OR
11. Extras and X-rays: Abdominal ultrasound, abdominal x-ray series.
12. Labs: CBC, SMA 7, blood culture and sensitivity, antibiotic levels.
Lower Urinary Tract Infection

1. Admit to:
2. Diagnosis: UTI
3. Condition:
5. Activity:
6. Nursing: Inputs and outputs
7. Diet:
8. IV Fluids:
Lower Urinary Tract Infection:
-Trimethoprim/sulfamethoxazole (Bactrim, Septra) 6-10 mg/kg/day TMP PO
q12h, max 320 mg TMP/day [susp per 5 mL: TMP 40 mg, SMX 200 mg;
tab, SS: 80 mg/400 mg; tab, DS: 160 mg/800 mg] OR
-Cefpodoxime (Vantin) 10 mg/kg/day PO q12h, max 800 mg/day [susp: 50
mg/5 mL, 100 mg/5 mL; tabs: 100, 200 mg] OR
-Cefprozil (Cefzil) 30 mg/kg/day PO q12h, max 1 gm/day [susp: 125 mg/5 mL,
250 mg/5 mL; tabs: 250, 500 mg] OR
Prophylactic Therapy:
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 2 mg TMP/kg/day and 10
mg SMX/kg/day PO qhs [ susp per 5 mL: TMP 40 mg/SMX 200 mg; tab
DS: TMP 160 mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400 mg] OR
-Sulfisoxazole (Gantrisin) 10-20 mg/kg/day PO q12h [syr: 500 mg/5 mL; tab:
500 mg].
Pyelonephritis 65
-Phenazopyridine (Pyridium), children 6-12 yrs: 12 mg/kg/day PO tid (max 200
mg/dose); >12 yrs: 100-200 mg PO tid x 2 days prn dysuria [tabs: 100, 200
mg]. Does not treat infection; acts only as an analgesic.
11. Extras and X-rays: Renal ultrasound. Voiding cystourethrogram 3 weeks
after infection. Radiological work up on all children <1 year of age.
12. Labs: CBC, SMA 7. UA with micro, urine Gram stain, culture and sensitivity.
Repeat urine culture and sensitivity 24-48 hours after therapy; blood culture
and sensitivity.
Pyelonephritis
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Pyelonephritis
Condition:
Activity:
Nursing: Inputs and outputs, daily weights
Diet:
IV Fluids:
-If less than 1 week old, see suspected sepsis, pages 43, 121.
-Gentamicin (Garamycin) or Tobramycin (Nebcin):
-Cefotaxime (Claforan) 100 mg/kg/day IV/IM q8h, max 12 gm/day.
11. Extras and X-rays: Renal ultrasound.
12. Labs: CBC, SMA-7. UA with micro, urine culture and sensitivity. Repeat
urine culture and sensitivity 24-48 hours after initiation of therapy; blood
culture and sensitivity x 2; drug levels.
66 Osteomyelitis
Osteomyelitis
1. Admit to:
2. Diagnosis: Osteomyelitis
3. Condition:
5. Activity:
6. Nursing: Keep involved extremity elevated. Consent for osteotomy.
7. Diet:
8. IV Fluids:
Children #3 yrs (H flu, strep, staph):
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h, max 9 gm/day.
Children >3 yrs (staph, strep, H flu):
-Nafcillin (Nafcil) or oxacillin (Bactophill) 100-150 mg/kg/day IV/IM q6h, max
12 gm/day OR
-Cefazolin (Ancef) 100 mg/kg/day IV/IM q6-8h, max 6 gm/day OR
-Cefuroxime (Zinacef) 100-150 mg/kg/day IV/IM q8h, max 9 gm/day.
Postoperative or Traumatic (staph, gram neg, Pseudomonas):
-Ticarcillin/clavulanate (Timentin) 200-300 mg/kg/day of ticarcillin IV/IM q6-8h,
max 24 gm/day OR
-Vancomycin (Vancocin) 40-60 mg/kg/day IV q6-8h, max 4 gm/day AND
-Ceftazidime (Fortaz) 150 mg/kg/day IV/IM q8h, max 12 gm/day OR
-Nafcillin (Nafcil) or oxacillin (Bactocill) 150 mg/kg/day IV/IM q6h, max 12
gm/day AND
-Tobramycin (Nebcin)
>10 yr: 5.0 mg/kg/day IV q8h.
Chronic Osteomyelitis (staphylococcal):
-Dicloxacillin (Dycill, Dynapen, Pathocil) 75-100 mg/kg/day PO q6h, max 2
gm/day [caps: 125, 250, 500 mg; susp: 62.5 mg/5 mL] OR
-Cephalexin (Keflex) 50-100 mg/kg/day PO q6-12h, max 4 gm/day [caps: 250,
500 mg; drops 100 mg/mL; susp 125 mg/5 mL, 250 mg/5 mL; tabs: 500
mg, 1 gm].
11. Extras and X-rays: Bone scan, multiple X-ray views, CT. Orthopedic and
infectious disease consultations.
12. Labs: CBC, SMA 7, blood culture and sensitivity x 3, ESR, sickle prep, UA,
culture and sensitivity, antibiotic levels, serum bacteriocidal titers.
Otitis Media 67
Otitis Media
Acute Otitis Media (S pneumoniae, non-typable H flu, M catarrhalis, Staph
a, group A strep):
-Amoxicillin (Amoxil) 25-50 mg/kg/day PO q8h, max 3 gm/day
[caps: 250, 500 mg; drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL,
250 mg/5mL, 400 mg/5mL; tabs: 500, 875 mg; tabs, chew: 125, 200, 250,
400 mg] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 6-8 mg/kg/day of TMP PO
bid, max 320 mg TMP/day
[susp per 5 mL: TMP 40 mg/SMX 200 mg; tab DS: TMP 160 mg/SMX 800
mg; tab SS: TMP 80mg/SMX 400 mg] OR
-Erythromycin/sulfisoxazole (Pediazole) 1 mL/kg/day PO qid or 40 mg/kg/day
of erythromycin PO qid, max 50 mL/day
[susp per 5 mL: erythromycin 200 mg/sulfisoxazole 600 mg] OR
-Amoxicillin/clavulanate (Augmentin) 40 mg/kg/day of amoxicillin PO q8h x 710d, max 500 mg/dose
[susp per 5 mL: 125, 250 mg; tabs: 250, 500 mg; tab, chew: 125, 250 mg]
OR
40 mg/kg/day PO q12h, max 875 mg of amoxicillin/dose
[susp: 200 mg/5mL, 400 mg/5mL; tab: 875 mg; tab, chew: 200, 400 mg]
OR
-Clarithromycin (Biaxin) 15-30 mg/kg/day PO bid, max 1 gm/day
-Cefixime (Suprax) 8 mg/kg/day PO bid-qd, max 400 mg/day
[susp: 100 mg/5 mL; tabs: 200, 400 mg] OR
-Cefuroxime axetil (Ceftin) tab: child: 125-250 mg PO bid; adult: 250-500 mg
PO bid; susp: 30 mg/kg/day PO q12h, max 500 mg/day
[susp: 125 mg/5 mL; tabs 125, 250, 500 mg] OR
-Loracarbef (Lorabid) 30 mg/kg/day PO bid, max 400 mg/day
[caps: 200, 400 mg; susp: 100 mg/5 mL, 200 mg/5mL] OR
-Cefpodoxime (Vantin) 10 mg/kg/day PO bid, max 800 mg/day
-Cefprozil (Cefzil) 30 mg/kg/day PO bid, max 1gm/day
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 250 mg, 500 mg] OR
-Ceftriaxone (Rocephin) 50 mg/kg IM x one dose, max 2000 mg
Acute Otitis Media (resistant strains of Strep pneumoniae):
-Amoxicillin (Amoxil) 80-90 mg/kg/day PO q12h, max 3 gm/day
68 Otitis Externa
[caps: 250, 500 mg; drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL,
400mg]
-Amoxicillin/clavulanate (Augmentin BID) 80-90 mg/kg/day PO q12h.
[susp 200 mg/5 mL, 400 mg/5 mL; tab: 875 mg; tab, chew: 200, 400 mg]
Prophylactic Therapy ($3 episodes in 6 months):
Therapy reserved for control of recurrent acute otitis media, defined as three or
more episodes per 6 months or 4 or more episodes per 12 months.
-Sulfisoxazole (Gantrisin) 50 mg/kg/day PO qhs
[tab 500 mg; susp 500 mg/5 mL] OR
-Amoxicillin (Amoxil) 20 mg/kg/day PO qhs
[caps: 250,500 mg; drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL,
400mg] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 4 mg/kg/day of TMP PO
qhs
mg; tab SS: TMP 80mg/SMX 400 mg]
Symptomatic Therapy:
-Ibuprofen (Advil) 5-10 mg/kg/dose PO q6-8 hrs prn fever
[suspension: 100 mg/5 mL, tabs: 200, 300, 400, 600, 800 mg] AND/OR
-Acetaminophen (Tylenol) 10-15 mg/kg/dose PO/PR q4-6h prn fever
[tabs: 325, 500 mg; chewable tabs: 80 mg; caplets: 160 mg, 500 mg;
drops: 80 mg/0.8 mL; elixir: 120 mg/5 mL, 130 mg/5 mL, 160 mg/5 mL, 325
mg/5 mL; caplet, ER: 650 mg; suppositories: 120, 325, 650 mg].
-Benzocaine/antipyrine (Auralgan otic): fill ear canal with 2-4 drops; moisten
cotton pledget and place in external ear; repeat every 1-2 hours prn pain
[soln, otic: Antipyrine 5.4%, benzocaine 1.4% in 10 mL and 15 mL bottles]
Extras and X rays: Aspiration tympanocentesis, tympanogram; audiometry.
Otitis Externa
Otitis Externa (Pseudomonas, gram negatives, proteus):
-Polymyxin B/neomycin/hydrocortisone (Cortisporin otic susp or solution) 2-4
drops in ear canal tid-qid x 5-7 days.
[otic soln or susp per mL: neomycin sulfate 5 mg; polymyxin B sulfate
10,000 units; hydrocortisone 10 mg in 10 mL bottles)].
The suspension is preferred. The solution should not be used if the
eardrum is perforated.
Malignant Otitis Externa in Diabetes (Pseudomonas):
-Ceftazidime (Fortaz) 100-150 mg/kg/day IV/IM q8h, max 12gm/day OR
-Piperacillin (Pipracil) or ticarcillin (Ticar) 200-300 mg/kg/day IV/IM q4-6h, max
Tonsillopharyngitis 69
24gm/day OR
-Tobramycin (Nebcin)
>10 yr: 5.0 mg/kg/day IV q8h.
Tonsillopharyngitis
Streptococcal Pharyngitis:
-Penicillin V (Pen Vee K) 25-50 mg/kg/day PO qid x 10 days, max 3 gm/day
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 125, 250, 500 mg] OR
-Penicillin G benzathine (Bicillin LA) 25,000-50,000 U/kg (max 1.2 MU) IM x
1 dose OR
-Azithromycin (Zithromax) 12 mg/kg/day PO qd x 5 days, max 500 mg/day
[cap: 250 mg; susp: 100 mg/5mL, 200 mg/5mL; tabs: 250, 600 mg] OR
-Clarithromycin (Biaxin)15 mg/kg/day PO bid, max 1 gm/day
[susp 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg] OR
-Erythromycin (penicillin allergic patients) 40 mg/kg/day PO qid x 10 days, max
2 gm/day
Erythromycin ethylsuccinate (EryPed, EES)
Erythromycin base (E-Mycin, Ery-Tab, Eryc)
[cap, DR: 250 mg; tabs: 250, 333, 500 mg]
Refractory Pharyngitis:
40 mg/kg/day of amoxicillin PO q8h x 7-10d, max 500 mg/dose
[susp: 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg; tabs, chew: 125,
250 mg] OR
-Dicloxacillin (Dycill, Dynapen, Pathocil)
50 mg/kg/day PO qid, max 2 gm/day
[caps 125, 250, 500; elixir 62.5 mg/5 mL] OR
-Cephalexin (Keflex)
50 mg/kg/day PO qid-tid, max 4 gm/day
[caps: 250, 500 mg; drops 100 mg/mL; susp 125 mg/5 mL, 250 mg/5 mL;
tabs: 500 mg, 1 gm].
Prophylaxis (5 strep infections in 6 months):
-Penicillin V Potassium (Pen Vee K)
40 mg/kg/day PO bid, max 3 gm/day
[susp 125 mg/5 mL, 250 mg/5 mL; tabs: 125, 250, 500 mg].
Retropharyngeal Abscess (strep, anaerobes, E corrodens):
-Clindamycin (Cleocin) 25-40 mg/kg/day IV/IM q6-8h, max 4.8 gm/day OR
70 Epiglottitis
q6h, max 12 gm/day AND
-Cefuroxime (Zinacef) 75-100 mg/kg/day IV/IM q8h, max 9 gm/day
Labs: Throat culture, rapid antigen test; PA lateral and neck films; CXR.
Otolaryngology consult for incision and drainage.
Epiglottitis
1.
2.
3.
4.
5.
6.
Admit to: Pediatric intensive care unit.

Diagnosis: Epiglottitis
Condition:
Vital Signs: Call MD if:
Activity:
Nursing: Pulse oximeter. Keep head of bed elevated, allow patient to sit;
curved blade laryngoscope, tracheostomy tray and oropharyngeal tube at
bedside. Avoid excessive manipulation or agitation. Respiratory isolation.
7. Diet: NPO
8. IV Fluids:
-Oxygen, humidified, blow-by; keep sat >92%.
Antibiotics:
Most common causative organism is Haemophilus influenzae.
-Ceftriaxone (Rocephin) 50 mg/kg/day IV/IM qd, max 2 gm/day OR
-Cefotaxime (Claforan) 100-150 mg/kg/day IV/IM q6-8h, max 12 gm/day
10. Extras and X-rays: CXR PA and LAT, lateral neck. Otolaryngology
consult.
11. Labs: CBC, CBG/ABG. Blood culture and sensitivity, latex agglutination;
UA, urine antigen screen.
Sinusitis
Treatment of Sinusitis (S. pneumoniae, H flu, M catarrhalis, group A strep,
anaerobes):
-Treat for 14-21 days.
-Amoxicillin (Amoxil) 40 mg/kg/day PO tid, max 3 gm/day [caps: 250,500 mg;
drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL, 250 mg/5mL, 400
mg/5mL; tabs: 500, 875 mg; tabs, chew: 125, 200, 250 , 400mg] OR
Helicobacter Pylori 71
[cap: 250 mg; susp: 100 mg/5mL, 200 mg/5mL; tab: 250, 600 mg] OR
-Trimethoprim/sulfamethoxazole (Bactrim, Septra) 6-8 mg/kg/day of TMP PO
bid, max 320 mg TMP/day
mg; tab SS: TMP 80mg/SMX 400 mg] OR
-Erythromycin/sulfisoxazole (Pediazole) 1 mL/kg/day PO qid or 40-50 mg/kg/day
of erythromycin PO qid, max 2 gm erythromycin/day
[susp per 5 mL: Erythromycin 200 mg, sulfisoxazole 600 mg] OR
-Amoxicillin/clavulanate (Augmentin) 40 mg/kg/day of amoxicillin PO tid, max
500 mg/dose
mg] OR
40 mg/kg/day PO bid, max 875 mg (amoxicillin)/dose
[susp: 200 mg/5 mL, 400 mg/5 mL; tab: 875 mg; tabs, chew: 200, 400 mg]
OR
susp: 30 mg/kg/day PO qid, max 500 mg/day
[susp: 125 mg/5 mL; tabs: 125, 250, 500 mg]
Labs: Sinus x-rays, MRI scan.
Helicobacter Pylori
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Helicobacter pylori.
Condition: Guarded.
Activity:
Nursing:
Diet:
IV Fluids: Isotonic fluids at maintenance rate.
Triple drug regimens are more effective for eradication than are two drug
regimens.
Antimicrobial Agents
-Amoxicillin (Amoxil) 25-50 mg/kg/day PO bid-tid (max 3 gm/day)
[caps: 250,500 mg; drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL, 250
mg/5mL, 400 mg/5mL; tabs: 500, 875 mg; tabs, chew: 125, 200, 250mg ,
400mg]
-Tetracycline (Achromycin) >8 yrs only
25-50 mg/kg/day PO q6h, max 2 gm/day
72 Active Pulmonary Tuberculosis

[caps: 100, 250, 500 mg; susp: 125 mg/5 mL; tabs: 250, 500 mg]
-Metronidazole (Flagyl): 35-50 mg/kg/day PO q8h, max 2250 mg/day [tabs: 250,
500 mg; extemporaneous suspension]
-Clarithromycin (Biaxin)15 mg/kg/day PO bid, max 1 gm/day
[susp 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg]
H-2 Blockers
-Ranitidine (Zantac) 4-6 mg/kg/day PO q12h [liquid: 15 mg/mL; tabs: 75, 150,
300 mg]
Proton Pump Inhibitors
-Lansoprazole (Prevacid)
<10 kg: 7.5 mg PO qd
10-20 kg: 15 mg PO qd
> 20 kg: 30 mg PO qd
Adolescents: 15-30 mg PO qd
[caps: 15, 30 mg; simplified lansoprazole suspension (SLS) can be made by
dissolving the capsules in sodium bicarbonate. The capsule may also be
opened and mixed with applesauce].
-Omeprazole (Prilosec)
0.3-3 mg/kg/day PO qd (max 20 mg/day)
[caps: 10, 20, 40 mg; simplified omeprazole suspension (SOS) is made by
dissolving the capsule in sodium bicarbonate]
Bismuth subsalicylate (Pepto-Bismol)
#10 yrs: 262 mg PO qid
>10 yrs: 524 mg PO qid
[cap: 262 mg; liquid: 262 mg/15 mL, 525 mg/15 mL; tab, chew: 262 mg]
11. Extras and X-rays: Endoscopy, gastric biopsy.
12. Labs: Culture on gastric biopsy tissue.
Active Pulmonary Tuberculosis

1. Admit to:
2. Diagnosis: Active Pulmonary Tuberculosis
3. Condition:
4. Vital signs:
5. Activity:
6. Nursing: Respiratory isolation.
7. Diet:
Pulmonary Infection:
Six Month Regimen: Two months of isoniazid, rifampin and pyrazinamide daily,
Active Pulmonary Tuberculosis 73

followed by 4 months of isoniazid and rifampin daily OR
Two months of isoniazid, rifampin and pyrazinamide daily, followed by 4 months
of isoniazid and rifampin twice weekly.
Nine Month Regimen (for hilar adenopathy only): Nine months of isoniazid and
rifampin daily OR one month of isoniazid and rifampin daily, followed by 8
months of isoniazid and rifampin twice weekly.
Anti-tuberculosis Agents
Drug
Daily Dose
Twice Weekly
Dose
Dosage Forms
Isoniazid
(Laniazid)
10-15 mg/kg/day
PO qd, max 300
mg
20-30 mg/kg PO,

max 900 mg
Tab: 50, 100, 300

mg
Syr: 10 mg/mL
Rifampin
(Rifadin)
10-20 mg/kg/day
PO qd, max 600
mg
10-20 mg/kg,
max 600 mg
Cap: 150, 300 mg

Extemporaneous
suspension
Pyrazinamide
20-40 mg/kg PO
qd, max 2000 mg
50 mg/kg PO,
max 2000 mg
Tab: 500 mg
Extemporaneous
suspension
Ethambutol
(Myambutol)
15-25 mg/kg/day
PO qd, max
2500 mg
50 mg/kg PO,
max 2500 mg
Tab: 100, 400 mg
Streptomycin
20-40 mg/kg IM
qd, max 1 gm
20-40 mg/kg IM,

max 1 gm
Inj: 400 mg/mL, IM

only
-Directly observed therapy should be considered for all patients. All household
contacts should be tested.
Tuberculosis Prophylaxis for Skin Test Conversion:
-Isoniazid-susceptible: Isoniazid (Laniazid) 10 mg/kg/day (max 300 mg) PO qd
x 6-9 months.
-Isoniazid-resistant: Rifampin (Rifadin) 10 mg/kg/day (max 600 mg) PO qd for
9 months.
9. Extras and X-rays: CXR PA, LAT, spinal series.
10. Labs: CBC, SMA7, liver panel, HIV antibody, ABG. First AM sputum for AFB
x 3 (drug sensitivity tests on first isolate). Gastric aspirates for AFB qAM x 3.
UA, urine AFB.
74 Cellulitis
Cellulitis
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Cellulitis
Condition:
Activity:
Nursing: Keep affected extremity elevated; warm compresses tid prn. Monitor
area of infection.
7. Diet:
8. IV Fluids:
Empiric Therapy for Extremity Cellulitis:
-Nafcillin (Nafcil) or oxacillin (Bactocill, Prostaphlin) 100-200 mg/kg/day/IV/IM
q4-6h, max 12gm/day OR
-Cefazolin (Ancef) 75-100 mg/kg/day IV/IM q6-8h, max 6 gm/day OR
-Cefoxitin (Mefoxin) 100-160 mg/kg/day IV/IM q6h, max 12 gm/day OR
-Ticarcillin/clavulanate (Timentin) 200-300 mg/kg/day IV/IM q6-8h, max 24
gm/day OR
-Dicloxacillin (Dycill, Dynapen, Pathocil) 50-100 mg/kg/day PO qid, max 2
gm/day [caps: 125, 250, 500 mg; susp: 62.5 mg/5 mL].
Cheek/Buccal Cellulitis (H flu):
Periorbital Cellulitis (H. flu, pneumococcus):
susp: 30 mg/kg/day PO qid, max 500 mg/day
[susp: 125 mg/5 mL; tabs: 125, 250, 500 mg]

-Acetaminophen and codeine, 0.5-1 mg codeine/kg/dose PO q4-6h prn pain
11. Extras and X-rays: X-ray views of site.
12. Labs: CBC, SMA 7, blood culture and sensitivity. Leading edge aspirate,
Gram stain, culture and sensitivity; UA, urine culture.
Impetigo, Scalded Skin Syndrome, and Staphylococcal Scarlet Fever 75
Impetigo, Scalded Skin Syndrome, and

Staphylococcal Scarlet Fever
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Impetigo, scalded skin syndrome or staphylococcal scarlet fever
Condition:
Activity:
Nursing: Warm compresses tid prn.
Diet:
IV Fluids:
-Dicloxacillin (Dycill, Dynapen, Pathocil) 25-50 mg/kg/day PO qid x 5-7days,
max 2 gm/day [caps 125, 250, 500 mg; elixir 62.5 mg/5 mL] OR
-Cephalexin (Keflex) 25-50 mg/kg/day PO qid, max 4 gm/day [caps: 250, 500
mg; drops 100 mg/mL; susp 125 mg/5 mL, 250 mg/5 mL; tabs: 500 mg, 1
gm] OR
-Loracarbef (Lorabid) 30 mg/kg/day PO bid, max 800 mg/day [caps: 200, 400
mg; susp: 100 mg/5 mL, 200 mg/5mL] OR
-Cefpodoxime (Vantin) 10 mg/kg/day PO bid, max 800 mg/day [susp: 50 mg/5
mL, 100 mg/5 mL; tabs: 100 mg, 200 mg] OR
-Cefprozil (Cefzil) 30 mg/kg/day PO bid, max 1 gm/day [susp 125 mg/5 mL, 250
mg/5 mL; tabs: 250, 500 mg] OR
-Vancomycin (Vancocin) 40 mg/kg/day IV q6-8h, max 4 gm/day
-Mupirocin (Bactroban) ointment or cream, apply topically tid (cream/oint: 2%
15 gm). Extensive involvement requires systemic antibiotics.
-Acetaminophen and codeine, 0.5-1 mg codeine/kg/dose PO q4-6h prn pain
11. Labs: CBC, SMA 7, blood culture and sensitivity. Drainage fluid for Gram
stain, culture and sensitivity; UA.
76 Tetanus
Tetanus
History of One or Two Primary Immunizations or Unknown:
Low risk wound - Tetanus toxoid 0.5 mL IM.
Tetanus prone - Tetanus toxoid 0.5 mL IM, plus tetanus immunoglobulin (TIG)
250 U IM.
Three Primary Immunizations and 10 yrs or more Since Last Booster:
Low risk wound - Tetanus toxoid, 0.5 mL IM.
Tetanus prone - Tetanus toxoid, 0.5 mL IM.
Three Primary Immunizations and 5-10 yrs Since Last Booster:
Low risk wound - None
Tetanus prone - Tetanus toxoid 0.5 mL IM.
Three Primary Immunizations and #5 yrs Since Last Booster:

Low risk wound - None
Tetanus prone - None
Treatment of Clostridium Tetani Infection:
-Tetanus immune globulin (TIG): single dose of 3,000 to 6,000 U IM (consider
immune globulin intravenous if TIG is not available). Part of the TIG dose
may be infiltrated locally around the wound. Keep wound clean and dbrided.
-Penicillin G 100,000 U/kg/day IV q4-6h, max 24 MU/day x 10-14 days OR
-Metronidazole (Flagyl) 30 mg/kg/day PO/IV q6h, max 4 gm/day x 10-14 days
Pelvic Inflammatory Disease

1. Admit to:
2. Diagnosis: Pelvic Inflammatory Disease (PID)
3. Condition:
5. Activity:
6. Nursing:
7. Diet:
8. IV Fluids:
Adolescent Outpatients
Regimen A:
-Ofloxacin (Floxin) 400 mg PO bid x 14 days
[tab: 200, 300, 400 mg] AND
-Metronidazole (Flagyl) 500 mg PO bid x 14 days
[tab: 250, 500 mg; extemporaneous suspension]
Regimen B:
-Ceftriaxone (Rocephin) 250 mg IM x 1 dose and doxycycline (Vibramycin) 100
mg PO bid [caps: 50, 100 mg; syr: 50 mg/5 mL; tabs: 50, 100 mg] for 14
Pelvic Inflammatory Disease 77

days OR
-Cefoxitin (Mefoxin) 2 gm IM x 1 dose concurrent with probenecid (Probalan) 1
gm PO 1 dose [tab: 500 mg] and doxycycline (Vibramycin) 100 mg PO bid
[caps: 50, 100 mg; susp: 25 mg/5mL; syr: 50 mg/5 mL; tabs: 50, 100 mg] x
14 days.
Adolescent Inpatients
Regimen A:
-Cefoxitin (Mefoxin) 2 gm IV q6h OR
-Cefotetan (Cefotan) 2 gm IV q12h AND
-Doxycycline (Vibramycin) 100 mg IV/PO q12h (IV until afebrile for at least 48h,
then complete total of 14 days of doxycycline 100 mg PO bid [caps: 50,100
mg; susp: 25 mg/5mL; syr: 50 mg/5mL; tabs: 50,100 mg]
Regimen B:
-Clindamycin (Cleocin) 900 mg IV q8h plus gentamicin (Garamycin) 2 mg/kg IV
loading dose followed by 1.5 mg/kg IV q8h. Continue for 48h after clinical
improvement, followed by clindamycin (Cleocin) 600 mg PO tid (caps: 75,
150, 300 mg; soln: 75 mg/5 mL) to complete total of 14 days of treatment.
Gonorrhea in Children less than 45 kg:
Uncomplicated Vulvovaginitis, Cervicitis, Urethritis, Proctitis, or Pharyngitis:
-Ceftriaxone (Rocephin) 125 mg IM x 1 dose (uncomplicated disease only)

AND
-Erythromycin 50 mg/kg/day PO q6h, max 2gm/day x 7 days OR
-Azithromycin (Zithromax) 20 mg/kg PO x 1 dose, max 1 gm
Disseminated Gonococcal Infection:
-Ceftriaxone (Rocephin) 50 mg/kg/day (max 2gm/day) IV/IM q24h x 7 days AND
-Azithromycin (Zithromax) 20 mg/kg (max 1gm) PO x 1 dose OR
-Erythromycin 40 mg/kg/day PO q6h (max 2gm/day) x 7 days OR
-Doxycycline 100 mg PO bid.
Gonorrhea in Children $ 45 kg and $8 yrs:
Uncomplicated Vulvovaginitis, Cervicitis, Urethritis, Proctitis, or Pharyngitis:
-Ceftriaxone (Rocephin) 125 mg IM x 1 dose OR cefixime (Suprax) 400 mg PO
x 1 dose or ofloxacin (Floxin) 400 mg PO x 1 dose
AND
-Azithromycin (Zithromax) 1000 mg PO x 1 dose OR
-Doxycycline 100 mg PO bid x 7 days.
Disseminated Gonococcal Infection:
-Ceftriaxone (Rocephin) 1000 mg/day IV/IM q24h x 7 days OR cefotaxime
(Claforan) 1000 mg IV q8h x 7 days AND
-Azithromycin (Zithromax) 1000 mg PO x 1 dose OR
-Doxycycline 100mg PO bid x 7 days.
-Acetaminophen (Tylenol) 10-15 mg/kg/dose PO/PR q4-6h prn.
11. Extras and X-rays: Pelvic ultrasound; social services consult.
78 Pediculosis
12. Labs: CBC, SMA 7 and 12. GC culture and chlamydia test, RPR or VDRL. UA
with micro; urine pregnancy test.
Pediculosis
Pediculosis Capitis (head lice):
-Permethrin (Nix) is the preferred treatment. Available in a 1% cream rinse that
is applied to the scalp and hair for 10 minutes. A single treatment is
adequate, but a second treatment may be applied 7-10 days after the first
treatment [cream rinse: 1% 60 mL].
-Pyrethrin (Rid, A-2000, R&C). Available as a shampoo that is applied to the
scalp and hair for 10 minutes. A repeat application 7-10 days later may
sometimes be necessary [shampoo (0.3% pyrethrins, 3% piperonyl
butoxide): 60, 120, 240 mL].
-For infestation of eyelashes, apply petrolatum ointment tid-qid for 8-10 days
and mechanically remove the lice.
Pediculosis Corporis (body lice):
-Treatment consists of improving hygiene and cleaning clothes. Infested
clothing should be washed and dried at hot temperatures to kill the lice.
Pediculicides are not necessary.
Pediculosis Pubis (pubic lice, crabs): Permethrin (Nix) or pyrethrin-based
products may be used as described above for pediculosis capitis. Retreatment
is recommended 7-10 days later.
Scabies
Treatment:
Bathe with soap and water; scrub and remove scaling or crusted detritus; towel
dry. All clothing and bed linen contaminated within past 2 days should be
washed in hot water for 20 min.
Permethrin (Elimite) - 5% cream: Adults and children: Massage cream into skin
from head to soles of feet. Remove by washing after 8 to 14 hours. Treat infants
on scalp, temple and forehead. One application is curative. [cream: 5% 60 gm]
Lindane (Kwell, Gamma benzene) - available as 1% cream or lotion: Use 1%
lindane for adults and older children; not recommended in pregnancy, infants,
or on excoriated skin. 1-2 treatments are effective. Massage a thin layer from
neck to toes (including soles). In adults, 20-30 gm of cream or lotion is sufficient
for 1 application. Bathe after 8 hours. May be repeated in one week if mites
remain or if new lesions appear. Contraindicated in children <2 years of age.
[lotion: 1% 60, 473 mL; shampoo:1%: 60, 473 mL].
Dermatophytoses 79
Dermatophytoses
Diagnostic procedures:
(1) KOH prep of scales and skin scrapings for hyphae.
(2) Fungal cultures are used for uncertain cases.
Treat for at least 4 weeks.
Tinea corporis (ringworm), cruris (jock itch), pedis (athletes foot):
-Ketoconazole (Nizoral) cream qd [2%: 15, 30, 60 gm].
-Clotrimazole (Lotrimin) cream bid [1%: 15, 30, 45 gm].
-Miconazole (Micatin) cream bid [2%: 15, 30 gm].
-Econazole (Spectazole) cream bid [1%: 15, 30, 85 gm].
-Oxiconazole (Oxistat) cream or lotion qd-bid [1% cream: 15, 30, 60 gm; 1%
lotion: 30 mL].
-Sulconazole (Exelderm) cream or lotion qd-bid [1% cream: 15, 30, 60 gm; 1%
lotion: 30 mL].
-Naftifine (Naftin) cream or gel applied bid [1%: 15, 30 gm].
-Terbinafine (Lamisil) cream or applied bid [1% cream: 15, 30 gm; 1% gel: 5,
15, 30 gm].
Tinea capitis:
-Griseofulvin Microsize (Grisactin, Grifulvin V) 15-20 mg/kg/day PO qd, max
1000 mg/day [caps: 125, 250 mg; susp: 125 mg/5 mL; tabs: 250, 500 mg]
-Griseofulvin Ultramicrosize (Fulvicin P/G, Grisactin Ultra, Gris-PEG) 5-10
mg/kg/day PO qd, max 750 mg/day [tabs: 125, 165, 250, 330 mg].
-Give griseofulvin with whole-milk or fatty foods to increase absorption. May
require 4-6 weeks of therapy and should be continued for two weeks beyond
clinical resolution.
Tinea Unguium (Fungal Nail Infection):
-Griseofulvin (see dosage above) is effective, but may require up to 4 months
of therapy.
Tinea Versicolor:
-Cover body surface from face to knees with selenium sulfide 2.5% lotion or
selenium sulfide 1% shampoo daily for 30 minutes for 1 week, then monthly
x 3 to help prevent recurrences.
Bite Wounds
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Bite Wound.
Condition: Guarded.
Activity:
Nursing: Cooling measures prn temp >38 C, age appropriate pain scale.
80 Bite Wounds
7. Diet:
8. IV Fluids: D5 NS at maintenance rate.
-Initiate antimicrobial therapy for: moderate/severe bite wounds, especially if
edema or crush injury is present; puncture wounds, especially if bone,
tendon sheath, or joint penetration may have occurred; facial bites; hand and
foot bites; genital area bites; wounds in immunocompromised or asplenic
patients.
Dog Bites and Cat Bites:
Oral: amoxicillin/clavulanate
Oral, penicillin allergic: extended-spectrum cephalosporins or trimethoprim
sulfamethoxazole PLUS clindamycin
IV: ampicillin-sulbactam
IV, penicillin allergic: extended spectrum cephalosporins or trimethoprim
Reptile Bites:
Oral: amoxicillin-clavulanate
Oral, penicillin allergic: extended-spectrum cephalosporins or trimethoprim
IV: ampicillin-sulbactam PLUS gentamicin
IV, penicillin allergic: clindamycin PLUS gentamicin
Human Bites:
Oral: amoxicillin-clavulanate
Oral, penicillin allergic: trimethoprim-sulfamethoxazole PLUS clindamycin
IV: ampicillin-sulbactam
IV, penicillin allergic: extended-spectrum cephalosporins or trimethoprim
Antibiotic Dosages:
40 mg/kg/day of amoxicillin PO tid, max 500 mg/dose
mg] OR
40 mg/kg/day PO bid, max 875 mg (amoxicillin)/dose
[susp: 200 mg/5 mL, 400 mg/5 mL; tab: 875 mg; tabs, chew: 200, 400 mg]
-Cefpodoxime (Vantin)
10 mg/kg/day PO bid, max 800 mg/day
[susp: 50 mg/5 mL, 100 mg/5 mL; tabs: 100 mg, 200 mg] OR
-Cefprozil (Cefzil)
30 mg/kg/day PO bid, max 1 gm/day
[susp 125 mg/5 mL, 250 mg/5 mL; tabs: 250, 500 mg] OR
-Cefixime (Suprax)
8 mg/kg/day PO bid-qd, max 400 mg/day
[susp: 100 mg/5 mL; tabs: 200, 400 mg]
Lyme Disease 81
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra)
6-8 mg/kg/day of TMP PO/IV bid, max 320 mg TMP/day
[inj per mL: TMP 16 mg/SMX 80 mg; susp per 5 mL: TMP 40 mg/SMX 200
mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400 mg]
-Clindamycin (Cleocin) 10-30 mg/kg/day PO q6-8h, max 1800 mg/day or 25-40
mg/kg/day IV/IM q6-8h, max 4.8 gm/day [cap: 75, 150, 300 mg; soln: 75
mg/5mL]
-Ampicillin-sulbactam (Unasyn) 100-200 mg/kg/day ampicillin IV/IM a6h, max
12 gm ampicillin/day
[1.5 gm (ampicillin 1 gm and sulbactam 0.5 gm; 3 gm (ampicillin 2 gm and
sulbactam 1 gm)]
-Ceftriaxone (Rocephin) 50 mg/kg/day IV/IM qd, max 2 gm/day
-Gentamicin (Garamycin) (normal renal function):
>10 yr: 5.0 mg/kg/day IV/IM q8h.
Additional Considerations:
-Sponge away visible dirt. Irrigate with a copious volume of sterile saline by
high-pressure syringe irrigation. Debride any devitalized tissue.
-Tetanus immunization if not up-to-date.
-Assess risk of rabies from animal bites and risk of hepatitis and HIV from
human bites.
-Ibuprofen (Motrin) 5-10 mg/kg/dose PO q6-8h prn OR
-Acetaminophen (Tylenol) 15 mg/kg PO/PR q4h prn temp >38C or pain.
11. Extras and X-rays: X-ray views of site of injury.
12. Labs: CBC, SMA 7, wound culture.
Lyme Disease
1. Admit to:
2. Diagnosis: Lyme disease.
3. Condition:
5. Activity:
6. Nursing:
7. Diet:
Early Localized Disease:
Age $8 yrs: doxycycline 100 mg PO bid x 14-21 days [caps: 50, 100 mg; susp:
82 Lyme Disease
25 mg/5mL; syrup: 50 mg/5mL; tabs 50, 100 mg]
All ages: amoxicillin 25-50 mg/kg/day PO bid (max 3 gm/day) x 14-21 days
[caps: 250,500 mg; drops: 50 mg/mL; susp; 125 mg/5mL, 200 mg/5mL, 250
mg/5mL, 400 mg/5mL; tabs: 500, 875 mg; tabs, chew: 125, 200, 250 ,
400mg]
Early Disseminated and Late Disease:
Multiple Erythema Migrans: Take same oral regimen as for early disease but
for 21 days.
Isolated Facial Palsy: Take same oral regimen as for early disease but for 2128 days.
Arthritis: Take same oral regimen as for early disease but for 28 days.
Persistent or Recurrent Arthritis:
-Ceftriaxone (Rocephin) 75-100 mg/kg/day IM/IV 12-24h (max 2 gm/dose)
for 14-21 days OR
-Penicillin G 300,000 U/kg/day IV q4h (max 20 million units/day) x 14-21
days.
Carditis or Meningitis or Encephalitis:
-Ceftriaxone (Rocephin) 75-100 mg/kg/day IM/IV q12-24h (max 2 gm/dose) for
14-21 days OR
-Penicillin G 300,000 U/kg/day IV q4h (max 20 million units/day) x 14-21 days.
Lyme disease vaccine is available for children $15 years of age.
-Ibuprofen (Advil) 5-10 mg/kg/dose PO q6-8h prn temp >38 C OR
-Acetaminophen (Tylenol) 15 mg/kg PO/PR q4h prn temp >38 C.
11. Extras and X-rays: CXR, MRI.
12. Labs: IgM-specific antibody titer usually peaks between weeks 3 and 6 after
the onset of infection. Enzyme immunoassay (EIA) is the most commonly used
test for detection of antibodies. The Western immunoblot test is the most useful
for corroborating a positive or equivocal EIA test.
Gastroenteritis 83
Gastroenterology
Gastroenteritis
1. Admit to:
2. Diagnosis: Acute Gastroenteritis
3. Condition:
5. Activity:
6. Nursing: Inputs and outputs, daily weights, urine specific gravity.
7. Diet: Rehydralyte, Pedialyte or soy formula (Isomil DF), bland diet.
8. IV Fluids: See Dehydration, page 111.
Severe Gastroenteritis with Fever, Gross Blood and Neutrophils in Stool
(E coli, Shigella, Salmonella):
-Ceftriaxone (Rocephin) 50-75 mg/kg/day IV/IM q 12-24h, max 4 gm/day OR
-Cefixime (Suprax) 8 mg/kg/day PO bid-qd, max 400 mg/day [susp: 100 mg/5
mL; tabs: 200, 400 mg] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 10 mg of TMP
component/kg/day PO bid x 5-7d, max 320 mg TMP/day [susp per 5 mL:
TMP 40 mg/SMX 200 mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS: TMP
80mg/SMX 400 mg].
Salmonella (treat infants and patients with septicemia):
-Ceftriaxone (Rocephin) 50-75 mg/kg/day IV/IM q12-24h, max 4 gm/day OR
mL; tabs: 200, 400 mg] OR
-Ampicillin 100-200 mg/kg/day IV q6h, max 12 gm/day or 50-100 mg/kg/day PO
qid x 5-7d, max 4 gm/day [caps: 250, 500 mg; drops: 100 mg/mL; susp: 125
mg/5 mL, 250 mg/5 mL, 500 mg/5 mL] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 10 mg TMP/kg/day PO bid
x 5-7d, max 320 mg TMP/day [susp per 5 mL: TMP 40 mg/SMX 200 mg; tab
DS: TMP 160 mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400 mg] OR
-If >18 yrs: Ciprofloxacin (Cipro) 250-750 mg PO q12h or 200-400 mg IV q12h
[inj: 200, 400 mg; susp: 100 mg/mL; tabs: 100, 250, 500, 750 mg]
Antibiotic Associated Diarrhea and Pseudomembranous Colitis (Clostridium
difficile):
-Treat for 7-10 days. Do not give antidiarrheal drugs.
-Metronidazole (Flagyl) 30 mg/kg/day PO/IV (PO preferred) q8h x 7 days, max
4 gm/day. [inj: 500 mg; tabs: 250, 500 mg; extemporaneous suspension] OR
-Vancomycin (Vancocin) 40 mg/kg/day PO qid x 7 days, max 2 gm/day [caps:
125, 250 mg; oral soln: 250 mg/5 mL, 500 mg/6 mL]. Vancomycin therapy
84 Gastroenteritis
is reserved for patients who are allergic to metronidazole or who have not
responded to metronidazole therapy.
Rotavirus supportive treatment, see Dehydration page 111.
10. Extras and X-rays: Upright abdomen
11. Labs: SMA7, CBC; stool Wright stain for leukocytes, Rotazyme. Stool culture
and sensitivity for enteric pathogens; C difficile toxin and culture, ova and parasites; occult blood. Urine specific gravity, UA, blood culture and sensitivity.
Specific Therapy for Gastroenteritis

Shigella Sonnei:
-Treat x 5 days. Oral therapy is acceptable except for seriously ill patients. For
resistant strains, ciprofloxacin should be considered but is not recommended
for use for persons younger than 18 years of age except in exceptional
circumstances.
-Ampicillin (preferred over amoxicillin) 50-100 mg/kg/day PO q6h, max 3
gm/day [caps: 250, 500 mg; drops: 100 mg/mL; susp: 125 mg/5 mL, 250
mg/5 mL; 500 mg/5 mL] OR
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 10 mg TMP/kg/day PO/IV
q12h x 5 days [inj per mL: TMP 16mg/SMX 80mg; susp per 5 mL: TMP 40
mg/SMX 200 mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS: TMP
80mg/SMX 400 mg] OR
-Ampicillin 50-80 mg/kg/day PO q6h, max 4 gm/day; or 100 mg/kg/day IV/IM
q6h for 5-7 days, max 12 gm/day [caps: 250, 500 mg; susp: 125 mg/5 mL,
250 mg/5 mL] OR
-Ceftriaxone (Rocephin) 50-75 mg/kg/day IV/IM q 12-24h, max 4 gm/day OR
mL; tabs: 200, 400 mg].
Yersinia (sepsis):
-Most isolates are resistant to first-generation cephalosporins and penicillins.
-Trimethoprim/sulfamethoxazole (Bactrim, Septra) 10 mg/kg/day TMP PO q12h
x 5-7days [susp per 5 mL: TMP 40 mg/SMX 200 mg; tab DS: TMP 160
mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400 mg]
Campylobacter jejuni:
-Erythromycin 40 mg/kg/day PO q6h x 5-7 days, max 2 gm/day
Erythromycin ethylsuccinate (EryPed, EES)
Erythromycin base (E-Mycin, Ery-Tab, Eryc)
[cap, DR: 250 mg; tabs: 250, 333, 500 mg] OR
10 mg/kg PO x 1 on day 1 (max 500 mg) followed by 5 mg/kg/day PO qd on
days 2-5 (max 250 mg)
Gastroenteritis 85
Enteropathogenic E coli (Travelers Diarrhea):
-Trimethoprim/Sulfamethoxazole (Bactrim, Septra) 10 mg/kg/day TMP PO/IV
bid [inj per mL: TMP 16 mg/SMX 80 mg; susp per 5 mL: TMP 40 mg/SMX
200 mg; tab DS: TMP 160 mg/SMX 800 mg; tab SS: TMP 80mg/SMX 400
mg].
-Patients older than 8 years old: Doxycycline (Vibramycin) 2-4 mg/kg/day PO
q12-24h, max 200 mg/day [caps: 50, 100 mg; susp: 25 mg/5mL; syrup: 50
mg/5mL; tabs 50, 100 mg].
Enteroinvasive E coli:
-Antibiotic selection should be based on susceptibility testing of the isolate. If
systemic infection is suspected, parenteral antimicrobial therapy should be
given.
Giardia Lamblia:
-Metronidazole is the drug of choice. A 5-7 day course of therapy has a cure
rate of 80-95%. Furazolidone is 72-100% effective when given for 7-10 days.
Albendazole is also an acceptable alternative when given for 5 days.
-Metronidazole (Flagyl) 15 mg/kg/day PO q8h x 5-7 days (max 4 gm/day) [tabs:
250, 500 mg; extemporaneous suspension] OR
-Furazolidone (Furoxone) 5-8.8 mg/kg/day PO qid for 7-10 days, max 400
mg/day [susp: 50 mg/15 mL; tab: 100 mg] OR
-Albendazole (Albenza): if > 2 yrs, 400 mg PO qd x 5 days [tab: 200mg;
extemporaneous suspension]
Entamoeba Histolytica:
Asymptomatic cyst carriers:
-Iodoquinol (Yodoxin) 30-40 mg/kg/day PO q8h (max 1.95 gm/day) x 20 days
[tabs: 210, 650 mg; powder for reconstitution] OR
-Paromomycin (Humatin) 25-35 mg/kg/day PO q8h x 7 days [cap: 250 mg]
OR
-Diloxanide: 20 mg/kg/day PO q8h x 10 days, max 1500 mg/day. (Available
only through CDC).
Mild-to-moderate intestinal symptoms with no dysentery:
-Metronidazole (Flagyl): 35-50 mg/kg/day PO q8h x 10 days, max 2250
mg/day [tabs: 250, 500 mg; extemporaneous suspension] followed by:
OR
only through CDC).
Dysentery or extraintestinal disease (including liver abscess):
-Metronidazole (Flagyl): 35-50 mg/kg/day PO q8h x 10 days, max 2250
mg/day [tabs: 250, 500 mg; extemporaneous suspension] followed by:
86 Hepatitis A
OR
only through CDC).
Hepatitis A
1. Admit to:
2. Diagnosis: Hepatitis A
3. Condition:
5. Activity: Up ad lib
6. Nursing: Contact precautions.
7. Diet:
8. IV Fluids: D5NS IV at maintenance rate.
-Acetaminophen (Tylenol) 15 mg/kg PO/PR q4h prn temp >38 C or pain.
-Hepatitis A immune globulin, 0.02 mL/kg IM (usually requires multiple
injections at different sites), when given within 2 weeks after exposure to
HAV, is 85% effective in preventing symptomatic infection.
-Hepatitis A vaccine (Havrix) if $2 yrs: 0.5 mL IM, repeat in 6-12 months.
11. Extras and X-rays: Abdominal x-ray series.
12. Labs: IgM anti-HAV antibody, HAV IgG, liver function tests, INR, PTT, stool
culture for enteric pathogens.
Hepatitis B
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Hepatitis B.
Condition: Guarded.
Activity:
Nursing: Standard precautions.
Ulcerative Colitis 87
7. Diet: Low fat diet.
-Diphenhydramine (Benadryl) 1 mg/kg/dose IV/IM/IO/PO q6h prn pruritus or
nausea, max 50 mg/dose OR
-Acetaminophen (Tylenol)15 mg/kg PO/PR q4h prn temp >38 C or pain.
Post exposure prophylaxis for previously unimmunized persons:
-Hepatitis B immune globulin 0.06 mL/kg (minimum 0.5 mL) IM x1 AND
-Hepatitis B vaccine 0.5 mL IM (complete three dose series with second dose
in one month and third dose in six months)
10. Extras and X-rays:
11. Labs: IgM anti-HAV, IgM anti-HBc, HBsAg, anti-HCV; alpha-1-antitrypsin,
ANA, ferritin, ceruloplasmin, urine copper, liver function tests, INR, PTT.
Ulcerative Colitis
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Ulcerative colitis.
Condition:
Activity:
Nursing: Daily weights, inputs and outputs.
Diet: NPO except for ice chips, no milk products.
IV Fluids:
-Mesalamine (Asacol): 50 mg/kg/day PO q8-12h, max 800 mg PO TID [tab, EC:
400 mg] OR
-Mesalamine (Pentasa) 50 mg/kg/day PO q6-12h, max 1000 mg PO qid [cap,
CR: 250 mg] OR
-Mesalamine (Rowasa) >12 yrs: 60 mL (4 gm) retention enema at bedtime
retained overnight for approximately 8 hrs [4 gm/60 mL] OR > 12 yrs:
mesalamine (Rowasa) 1 suppository PR bid [supp: 500 mg] OR
-Olsalazine sodium (Dipentum) >12 yrs: 500 mg PO with food bid [cap: 250 mg]
OR
-Sulfasalazine (Azulfidine), children >2 yrs:
Mild exacerbation: 40-50 mg/kg/day PO q6h
Moderate to severe exacerbation: 50-75 mg/kg/day PO q4-6h, max 6
88 Parenteral Nutrition
gm/day.
Maintenance therapy: 30-50 mg/kg/day PO q4-8h, max 2 gm/day.
[susp: 50 mg/mL; tab, EC: 500 mg] OR
-Hydrocortisone retention enema 100 mg PR qhs OR
-Hydrocortisone acetate 90 mg aerosol foam PR qd-bid or 25 mg supp PR bid.
-Prednisone 1-2 mg/kg/day PO qAM or bid (max 40-60 mg/day).
Other Medications:
-Vitamin B12 100 mcg IM qd x 5 days, then 100-200 mcg IM q month.
-Multivitamin PO qAM or 1 ampule IV qAM.
-Folic acid 1 mg PO qd.
10. Extras and X-rays: Upright abdomen, GI consult.
11. Labs: CBC, platelets, SMA 7, Mg, ionized calcium; liver panel, blood culture
and sensitivity x 2. Stool culture and sensitivity for enteric pathogens, ova and
parasites, C. difficile toxin and culture, Wright's stain.
Parenteral Nutrition
1.
2.
3.
4.
5.
Admit to:
Diagnosis:
Condition:
Nursing: Daily weights, inputs and outputs; measure head circumference and
height. Finger stick glucose bid.
6. Diet:
Total Parenteral Nutrition:
-Calculate daily protein solution fluid requirement less fluid from lipid and other
sources. Calculate total amino acid requirement.
-Protein: Neonates and infants start with 0.5 gm/kg/day and increase to 2-3
gm/kg/day. For children and young adults, start with 1 gm/kg/day, and in
crease by 1.0 gm/kg/day (max 2-3 gm/kg/day). Calculate percent amino acid
to be infused: amino acid requirement in grams divided by the volume of fluid
from the dextrose/protein solution in mL x 100.
-Advance daily dextrose concentration as tolerated, while following blood
glucose levels. Usual maximum concentration is D35W.
Total Parenteral Nutrition Requirements
Calories
Infants-25 kg
25-45 kg
>45 kg
90-120 kcal/kg/day
60-105 kcal/kg/day
40-75
kcal/kg/day
Parenteral Nutrition 89
Infants-25 kg
25-45 kg
>45 kg
Fluid
120-180 mL/kg/day
120-150 mL/kg/day
50-75 mL/kg/day
Dextrose
4-6 mg/kg/min
7-8 mg/kg/min
7-8 mg/kg/min
Protein
2-3 gm/kg/day
1.5-2.5 gm/kg/day
0.8-2.0
gm/kg/day
Sodium
2-6 mEq/kg/day
2-6 mEq/kg/day
60-150 mEq/day
Potassium
2-5 mEq/kg/day
2-5 mEq/kg/day
70-150 mEq/day
Chloride
2-3 mEq/kg/day
2-3 mEq/kg/day
2-3 mEq/kg/day
Calcium
1-2 mEq/kg/day
1 mEq/kg/day
0.2-0.3
mEq/kg/day
Phosphate
0.5-1 mM/kg/day
0.5 mM/kg/day
7-10 mM/1000
cal
Magnesium
1-2 mEq/kg/day
1 mEq/kg/day
0.35-0.45
mEq/kg/day
Multi-Trace
Element
Formula
1 mL/day
1 mL/day
1 mL/day
Multivitamin (Peds MVI or MVC 9+3)

<2.5 kg
2 mL/kg Peds MVI
2.5 kg -11 yr
5 mL/day Peds MVI
$11 yrs
MVC 9+3 10 mL/day
Dextrose Infusion:
-Dextrose mg/kg/min = [% dextrose x rate (mL/hr) x 0.167] kg
-Normal Starting Rate: 6-8 mg/kg/min
Lipid Solution:
-Minimum of 5% of total calories should be from fat emulsion. Max of 40% of
calories as fat (10% soln = 1 gm/10 mL = 1.1 kcal/mL; 20% soln = 2 gm/10
mL = 2.0 kcal/mL). 20% Intralipid is preferred in most patients.
-For neonates, begin fat emulsion at 0.5 gm/kg/day and advance to 0.5-1
gm/kg/day.
-For infants, children and young adults, begin at 1 gm/kg/day, advance as
tolerated by 0.5-1 gm/kg/day; max 3 gm/kg/day or 40% of calories/day.
90 Gastroesophageal Reflux
-Neonates - infuse over 20-24h; children and infants - infuse over 16-24h, max
0.15 gm/kg/hr.
-Check serum triglyceride 6h after infusion (maintain <200 mg/dL)
Peripheral Parenteral Supplementation:
-Calculate daily fluid requirement less fluid from lipid and other sources. Then
calculate protein requirements: Begin with 1 gm/kg/day. Advance daily
protein by 0.5-0.6 gm/kg/day to maximum of 3 gm/kg/day.
-Protein requirement in grams fluid requirement in mL x 100 = % amino
acids.
-Begin with maximum tolerated dextrose concentration. (Dextrose
concentration >12.5% requires a central line.)
-Calculate max fat emulsion intake (3 gm/kg/day), and calculate volume of
20% fat required (20 gm/100 mL = 20 %):
[weight (kg) x gm/kg/day] 20 x 100 = mL of 20% fat emulsion.
Start with 0.5-1.0 gm/kg/day lipid, and increase by 0.5-1.0 gm/kg/day until
3 gm/kg/day. Deliver over 18-24 hours.
-Draw blood 4-6h after end of infusion for triglyceride level.
8. Extras and X-rays: CXR, plain film for line placement, dietitian consult.
9. Labs:
Daily labs: Glucose, Na, K, Cl, HCO3, BUN, creatinine, osmolarity, CBC,
cholesterol, triglyceride, urine glucose and specific gravity.
Twice weekly Labs: Calcium, phosphate, Mg, SMA-12
Weekly Labs: Protein, albumin, prealbumin, Mg, direct and indirect bilirubin,
AST, GGT, alkaline phosphatase, iron, TIBC, transferrin, retinol-binding
protein, PT/PTT, zinc, copper, B12, folate, 24h urine nitrogen and cre
atinine.
Gastroesophageal Reflux
A. Treatment:
-Thicken feedings; give small volume feedings; keep head of bed elevated 30
degrees.
-Metoclopramide (Reglan) 0.1-0.2 mg/kg/dose PO qid 20-30 minutes prior to
feedings, max 1 mg/kg/day [concentrated soln: 10 mg/mL; syrup: 1 mg/mL;
tab: 10 mg]
-Cimetidine (Tagamet) 20-40 mg/kg/day IV/PO q6h (20-30 min before feeding)
[inj: 150 mg/mL; oral soln: 60 mg/mL; tabs: 200, 300, 400, 800 mg]
-Ranitidine (Zantac) 2-4 mg/kg/day IV q8h or 4-6 mg/kg/day PO q12h [inj: 25
mg/mL; liquid: 15 mg/mL; tabs: 75, 150, 300 mg]
-Erythromycin (used as a prokinetic agent not as an antibiotic) 2-3 mg/kg/dose
PO q6-8h. [ethylsuccinate susp: 200 mg/5mL, 400 mg/5mL] Concomitant
cisapride is contraindicated due to potentially fatal drug interaction.
Constipation 91
-Cisapride (Propulsid) 0.15-0.3 mg/kg/dose PO tid-qid [susp: 1 mg/mL; tab,
scored: 10 mg]. Available via limited-access protocol only (Janssen, 1-800Janssen) due to risk of serious cardiac arrhythmias.
B. Extras and X-rays: Upper GI series, pH probe, gastroesophageal nuclear
scintigraphy (milk scan), endoscopy.
Constipation
I. Management of Constipation in Infants
A. Glycerin suppositories are effective up to 6 months of age: 1 suppository
rectally prn. Barley malt extract, 1-2 teaspoons, can be added to a feeding
two to three times daily. Four to six ounces prune juice are often effective.
After 6 months of age, lactulose 1 to 2 mL/kg/day is useful.
B. Infants that do not respond may be treated with emulsified mineral oil
(Haleys MO) 2 mL/kg/dose PO bid, increasing as needed to 6-8 oz per day.
II. Management of Constipation in Children >2 years of Age
A. The distal impaction should be removed with hypertonic phosphate enemas
(Fleet enema). Usually three enemas are administered during a 36 to 48
hour period.
B. Lactulose may also be used at 5 to 10 mL PO bid, increasing as required up
to 45 mL PO bid.
C. Emulsified mineral oil (Haleys MO) may be begun at 2 mL/kg/dose PO bid
and increased as needed up to 6 to 8 oz per day. Concerns about mineral
oil interfering with absorption of fat-soluble vitamins have not been
substantiated.
D. Milk of magnesia: Preschoolers are begun at 2 tsp PO bid, with adjustments
made to reach a goal of one to three substantial stools a day over 1 to 2
weeks. Older children: 1-3 tablets (311mg magnesium hydroxide/chewable
tablet) PO bid prn.
E. A bulk-type stool softener (e.g., Metamucil) should be initiated. Increase
intake of high-residue foods (e.g. fruits, vegetables), bran, and whole grain
products. Water intake should be increased.
III. Stool Softeners and Laxatives:
A. Docusate sodium (Colace):
<3y
20-40 mg/day PO q6-24h
3-6y
20-60 mg/day PO q6-24h
6-12y
40-150 mg/day PO q6-24h
$12y
50-400 mg/day PO q6-24h
[caps: 50,100, 250 mg; oral soln: 10 mg/mL, 50 mg/mL]
B. Magnesium hydroxide (Milk of Magnesia) 0.5 mL/kg/dose or 2-5 yr: 5-15 mL;
6-12y: 15-30 mL; >12y: 30-60 mL PO prn.
C. Hyperosmotic soln (CoLyte or GoLytely) 15-20 mL/kg/hr PO/NG.
92 Constipation
D. Polyethylene glycol (MiraLax)
3-6 yr: 1 tsp powder dissolved in 3 ounces fluid PO qd-tid
6-12 yr: tablespoon powder dissolved in 4 ounces fluid PO qd-tid
$12 yr: one tablespoon powder dissolved in 8 ounces fluid PO qd-tid
E. Senna (Senokot, Senna-Gen) 10-20 mg/kg PO/PR qhs prn (max 872
mg/day) [granules: 362 mg/teaspoon; supp: 652 mg; syrup: 218 mg/5mL;
tabs: 187, 217, 600 mg]
F. Sennosides (Agoral, Senokot, Senna-Gen), 2-6 yrs: 3-8.6 mg/dose PO qd
bid; 6-12 yrs: 7.15-15 mg/dose PO qd-bid; > 12 yrs: 12-25 mg/dose PO qd
bid [granules per 5 mL: 8.3, 15, 20 mg; liquid: 33 mg/mL; syrup: 8.8 mg/5
mL; tabs: 6, 8.6, 15, 17, 25 mg]
IV. Diagnostic Evaluation: Anorectal manometry, anteroposterior and lateral
abdominal radiographs, lower GI study of unprepared colon.
Poisonings 93
Toxicology
Poisonings
Gastric Decontamination:
Ipecac Syrup:
<6 mos: not recommended
6-12 mos: 5-10 mL PO followed by 10-20 mL/kg of water
1-12 yrs: 15 mL PO followed by 10-20 mL/kg of water
>12 yrs: 30 mL PO followed by 240 mL of water
May repeat dose one time if vomiting does not occur within 20-30 minutes.
Syrup of ipecac is contraindicated in corrosive or hydrocarbon ingestions or in
patients without or soon to lose gag reflex.
Activated Charcoal: 1 gm/kg/dose (max 50 gm) PO/NG; the first dose should be
given using product containing sorbitol as a cathartic. Repeat of initial dose
q4h if indicated.
Gastric Lavage: Left side down, with head slightly lower than body; place largebore orogastric tube and check position by injecting air and auscultating.
Normal saline lavage: 15 mL/kg boluses until clear (max 400 mL), then give
activated charcoal or other antidote. Save initial aspirate for toxicological exam.
Gastric lavage is contraindicated if corrosives, hydrocarbons, or sharp objects
were ingested.
Cathartics:
-Magnesium citrate 6% sln:
<6 yrs: 2-4 mL/kg/dose PO/NG
6-12 yrs: 100-150 mL PO/NG
>12 yrs: 150-300 mL PO/NG
Antidotes to Common Poisonings

Narcotic or Propoxyphene Overdose:
-Naloxone (Narcan) 0.1 mg/kg/dose (max 4 mg) IV/IO/ET/IM, may repeat
q2min.
Methanol or Ethylene Glycol Overdose:
-Ethanol 8-10 mL/kg (10% inj soln) IV in D5W over 30min, then 0.8-1.4
mL/kg/hr. Maintain ethanol level at 100-130 mg/dL.
Carbon Monoxide Inhalation:
-Oxygen 100% or hyperbaric oxygen.
Cyanide Ingestion:
-Amyl nitrite, break ampule and inhale ampule contents for 30 seconds q1min
94 Poisonings
until sodium nitrite is administered. Use new amp q3min AND
-Sodium nitrite 0.33 mL/kg of 3% inj soln (max 10 mL) IV over 5 minutes.
Repeat dose 30 min later if inadequate clinical response.
Followed By:
-Sodium thiosulfate 1.65 mL/kg of 25% soln (max 50 mL) IV.
Phenothiazine Reaction (Extrapyramidal Reaction):
-Diphenhydramine (Benadryl) 1 mg/kg IV/IM q6h x 4 doses (max 50 mg/dose)
followed by 5 mg/kg/day PO q6h for 2-3 days.
Digoxin Overdose:
-Digibind (Digoxin immune Fab). Dose (# vials) = digoxin level in ng/mL x body
wt (kg)/100 OR
Dose (# of vials) = mg of digoxin ingested divided by 0.6
Benzodiazepine Overdose:
-Flumazenil (Romazicon) 0.01 mg/kg IV (max 0.5 mg). Repeat dose if
symptoms return.
Alcohol Overdose: Cardiorespiratory support
-Labs: Blood glucose; CBC, ABG, rapid toxicology screen.
-Treatment: Dextrose 0.5-1 gm/kg (2-4 mL/kg D25W or 5-10 mL/kg D10W),
max 25 gm.
-Naloxone (Narcan) 0.1 mg/kg (max 2 mg) IV, repeat q2min prn to max dose 810 mg if drug overdose suspected. For extreme agitation, give diazepam 0.10.5 mg/kg IV (max 5 mg if < 5 yrs, 10 mg if $5 yrs).
Organophosphate Toxicity
-Atropine: 0.01-0.02 mg/kg/dose (minimum dose 0.1mg, maximum dose 0.5 mg
in children and 1 mg in adolescents) IM/IV/SC. May repeat prn.
-Pralidoxime (2-PAM): 20-50 mg/kg/dose IM/IV. Repeat in 1-2 hrs if muscle
weakness has not been relieved, then at 10-12 hr intervals if cholinergic signs
recur.
Anticholinergic Toxicity
-Physostigmine (Antilirium): 0.01-0.03 mg/kg/dose IV; may repeat after 15-20
minutes to a maximum total dose of 2 mg.
Heparin Overdose
-Protamine sulfate dosage is determined by the most recent dosage of heparin
and the time elapsed since the overdose.
Dosage of Protamine Sulfate

Time Elapsed
IV Dose of Protamine (mg) to Neutralize 100

units of Heparin
Immediate
1-1.5
30-60 minutes
0.5-0.75
Acetaminophen Overdose 95
Time Elapsed
IV Dose of Protamine (mg) to Neutralize 100

units of Heparin
> 2 hrs
0.25-0.375
Warfarin Overdose
-Phytonadione (Vitamin K1)
-If no bleeding and rapid reversal needed and patient will require further oral
anticoagulation therapy, give 0.5-2 mg IV/SC
-If no bleeding and rapid reversal needed and patient will not require further oral
anticoagulation therapy, give 2-5 mg IV/SC
-If significant bleeding but not life-threatening, give 0.5-2 mg IV/SC
-If significant bleeding and life-threatening, give 5 mg IV
[inj: 2 mg/mL, 10 mg/mL]
Acetaminophen Overdose
1.
2.
3.
4.
6.
Admit to:
Diagnosis: Acetaminophen overdose
Condition:
Vital signs: Call MD if
Nursing: ECG monitoring, inputs and outputs, pulse oximeter, aspiration
precautions.
7. Diet:
8. IV Fluids:
-Gastric lavage with 10 mL/kg (if >5 yrs, use 150-200 mL) of normal saline by
nasogastric tube if < 60 minutes after ingestion.
-Activated charcoal (if recent ingestion) 1 gm/kg PO/ NG q2-4h, remove via
suction prior to acetylcysteine.
-N-Acetylcysteine (Mucomyst, NAC) loading dose 140 mg/kg PO/ NG, then 70
mg/kg PO/NG q4h x 17 doses (20% sln diluted 1:4 in carbonated beverage);
follow acetaminophen levels. Continue for full treatment course even if serum
levels fall below nomogram.
-Phytonadione (Vitamin K) 1-5 mg PO/IV/IM/SQ (if INR >1.5).
-Fresh frozen plasma should be administered if INR >3.
10. Extras and X-rays: Portable CXR. Nephrology consult for charcoal hemoper
fusion.
11. Labs: CBC, SMA 7, liver panel, amylase, INR/PTT; SGOT, SGPT, bilirubin,
acetaminophen level now and q4h until nondetectable. Plot serum
96 Lead Toxicity
acetaminophen level on Rumack-Matthew nomogram to assess severity of
ingestion unless sustained release Tylenol was ingested. Toxicity is likely with
ingestion $150 mg/kg (or 7.5 gm in adolescents/adults).
Lead Toxicity
1. Admit to:
2. Diagnosis: Lead toxicity
3. Condition:
4. Vital signs: Call MD if
6. Nursing: ECG monitoring, inputs and outputs, pulse oximeter
7. Diet:
8. IV Fluids:
Symptoms of lead encephalopathy and/or blood level >70 mcg/DL:
-Treat for five days with edetate calcium disodium and dimercaprol:
-Edetate calcium disodium 250 mg/m2/dose IM q4h or 50 mg/kg/day continuous
IV infusion or 1-1.5 gm/m2 IV as either an 8hr or 24 hr infusion.
-Dimercaprol (BAL): 4 mg/kg/dose IM q4h
Symptomatic lead poisoning without encephalopathy or asymptomatic with
blood level >70 mcg/dL:
-Treat for 35 days with edetate calcium disodium and dimercaprol until blood
lead level < 50 mcg/dL.
-Edetate calcium disodium 167 mg/m2 IM q4h or 1 gm/m2 as a 8-24 hr
continuous IV infusion.
-Dimercaprol (BAL): 4 mg/kg IM x 1 then 3 mg/kg/dose IM q4h
Asymptomatic children with blood lead level 45-69 mcg/dL:
-Edetate calcium disodium 25 mg/kg/day as a 8-24 hr IV infusion or IV q12h OR
-Succimer (Chemet): 10 mg/kg/dose (or 350 mg/m2/dose) PO q8h x 5 days
followed by 10 mg/kg/dose (or 350 mg/m2/dose) PO q12h x 14 days [cap: 100
mg]
11. Labs: CBC, SMA 7, blood lead level, serum iron level.
Theophylline Overdose 97
Theophylline Overdose
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Theophylline overdose
Condition:
Activity:
Nursing: ECG monitoring until serum level is less than 20 mcg/mL; inputs and
outputs, aspiration and seizure precautions.
7. Diet:
8. IV Fluids: Give IV fluids at rate to treat dehydration.
-No specific antidote is available.
-Activated charcoal 1 gm/kg PO/NG (max 50 gm) q2-4h, followed by cathartic,
regardless of time of ingestion. Multiple dose charcoal has been shown to be
effective in enhancing elimination.
-Gastric lavage if greater than 20 mg/kg was ingested or if unknown amount
ingested or if symptomatic.
-Charcoal hemoperfusion (if serum level >60 mcg/mL or signs of neurotoxicity,
seizure, coma).
10. Extras and X-rays: Portable CXR, ECG.
11. Labs: CBC, SMA 7, theophylline level; INR/PTT, liver panel. Monitor K, Mg,
phosphorus, calcium, acid/base balance.
Iron Overdose
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Iron overdose
Condition:
Activity:
Nursing: Inputs and outputs
Diet:
IV Fluids: Maintenance IV fluids
Toxicity likely if >60 mg/kg elemental iron ingested.
Possibly toxic if 20-60 mg/kg elemental iron ingested.
Induce emesis with ipecac if recent ingestion (<1 hour ago). Charcoal is not
effective. Gastric lavage if greater than 20 mg/kg of elemental iron ingested
or if unknown amount ingested.
If hypotensive, give IV fluids (10-20 mL/kg normal saline) and place the patient
in Trendelenburg's position.
98 Iron Overdose
Maintain urine output of >2 mL/kg/h.
If peak serum iron is greater than 350 mcg/dL or if patient is symptomatic, begin
chelation therapy.
-Deferoxamine (Desferal) 15 mg/kg/hr continuous IV infusion. Continue until
serum iron is within normal range.
Exchange transfusion is recommended in severely symptomatic patients with
serum iron >1,000 mcg/dL.
10. Extras and X-rays: KUB to determine if tablets are present in intestine.
11. Labs: Type and cross, CBC, electrolytes, serum iron, TIBC, INR/PTT, blood
glucose, liver function tests, calcium.
Seizure and Status Epilepticus 99
Neurology and Endocrinology

Seizure and Status Epilepticus
1. Admit to: Pediatric intensive care unit.
2. Diagnosis: Seizure
3. Condition:
4. Vital signs: Neurochecks q2-6h; call MD if:
5. Activity:
6. Nursing: Seizure and aspiration precautions, ECG and EEG monitoring.
7. Diet: NPO
8. IV Fluids:
Febrile Seizures: Control fever with antipyretics and cooling measures.
Anticonvulsive therapy is usually not required.
Status Epilepticus:
1. Maintain airway, 100% O2 by mask; obtain brief history, fingerstick glucose.
2. Start IV NS. If hypoglycemic, give 1-2 mL/kg D25W IV/IO (0.25-0.5 gm/kg).
3. Lorazepam (Ativan) 0.1 mg/kg (max 4 mg) IV/IM. Repeat q15-20 min x 3
prn.
4. Phenytoin (Dilantin) 15-18 mg/kg in normal saline at <1 mg/kg/min (max
50 mg/min) IV/IO. Monitor BP and ECG (QT interval).
5. If seizures continue, intubate and give phenobarbital loading dose of 15-20
mg/kg IV or 5 mg/kg IV every 15 minutes until seizures are controlled or 30
mg/kg is reached.
6. If seizures are refractory, consider midazolam (Versed) infusion (0.1
mg/kg/hr) or general anesthesia with EEG monitoring.
7. Rectal Valium gel formulation
< 2 yrs: not recommended
2-5 yrs: 0.5 mg/kg
6-11 yrs: 0.3 mg/kg
$12 yrs: 0.2 mg/kg
Round dose to 2.5, 5, 10, 15, and 20 mg/dose. Dose may be repeated in 4-12
hrs if needed. Do not use more than five times per month or more than once
every five days.
[rectal gel (Diastat): pediatric rectal tip - 5 mg/mL (2.5, 5, 10 mg size); adult
rectal tip - 5 mg/mL (10, 15, 20 mg size)]
Generalized Seizures Maintenance Therapy:
-Carbamazepine (Tegretol):
<6 yr: initially 10-20 mg/kg/day PO bid, then may increase in 5-7 day intervals
by 5 mg/kg/day; usual max dose 35 mg/kg/day PO q6-8h
100 Seizure and Status Epilepticus

6-12 yr: initially 100 mg PO bid (10 mg/kg/day PO bid), then may increase by
100 mg/day at weekly intervals; usual maintenance dose 400-800 mg/day PO
bid-qid.
>12 yr: initially 200 mg PO bid, then may increase by 200 mg/day at weekly
intervals; usual maintenance dose 800-1200 mg/day PO bid-tid
Dosing interval depends on product selected. Susp: q6-8h; tab: q8- 12h; tab,
chew: q8-12h; tab, ER: q12h
[susp: 100 mg/5 mL; tab: 200 mg; tab, chewable: 100 mg; tab, ER: 100, 200,
400 mg] OR
-Divalproex sodium (Depakote, Valproic acid) PO: Initially 10-15 mg/kg/day bid
tid, then increase by 5-10 mg/kg/day weekly as needed; usual maintenance
dose 30-60 mg/kg/day bid-tid. Up to 100 mg/kg/day tid-qid may be required
if other enzyme-inducing anticonvulsants are used concomitantly. IV: total
daily dose is equivalent to total daily oral dose but divide q6h and switch to
oral therapy as soon as possible. PR: dilute syrup 1:1 with water for use as
a retention enema, loading dose 17-20 mg/kg x 1 or maintenance 10-15
mg/kg/dose q8h
[cap: 250 mg; cap, sprinkle: 125 mg; inj: 100 mg/mL; syrup: 250 mg/5 mL;
tab, DR: 125, 250, 500 mg] OR
-Phenobarbital (Luminal): Loading dose 10-20 mg/kg IV/IM/PO, then
maintenance dose 3-5 mg/kg/day PO qd-bid
[cap: 16 mg; elixir: 15 mg/5mL, 4 mg/mL; inj: 30 mg/mL, 60 mg/mL, 65
mg/mL, 130 mg/mL; tabs: 8, 15, 16, 30, 32, 60, 65,100 mg] OR
-Phenytoin (Dilantin): Loading dose 15-18 mg/kg IV/PO, then maintenance dose
5-7 mg/kg/day PO/IV q8-24h (only sustained release capsules may be dosed
q24h)
[caps: 30, 100 mg; elixir: 125 mg/5 mL; inj: 50 mg/mL; tab, chewable: 50 mg]
-Fosphenytoin (Cerebyx): > 5 yrs: loading dose 10-20 mg PE IV/IM,
maintenance dose 4-6 mg/kg/day PE IV/IM q12-24h. Fosphenytoin 1.5 mg is
equivalent to phenytoin 1 mg which is equivalent to fosphenytoin 1 mg PE
(phenytoin equivalent unit). Fosphenytoin is a water-soluble pro-drug of
phenytoin and must be ordered as mg of phenytoin equivalent (PE).
[inj: 150 mg (equivalent to phenytoin sodium 100 mg) in 2 mL vial; 750 mg
(equivalent to phenytoin sodium 500 mg) in 10 mL vial]
Partial Seizures and Secondary Generalized Seizures:
-Carbamazepine (Tegretol), see above OR
-Phenytoin (Dilantin), see above
-Phenobarbital (Luminal), see above OR
-Valproic acid (Depacon, Depakote, Depakene), see above.
-Lamotrigine (Lamictal):
Adding to regimen containing valproic acid: 2-12 yrs: 0.15 mg/kg/day PO
qd-bid weeks 1-2, then increase to 0.3 mg/kg/day PO qd-bid weeks 3-4,
then increase q1-2 weeks by 0.3 mg/kg/day to maintenance dose 1-5
mg/kg/day (max 200 mg/day)
Seizure and Status Epilepticus 101

>12 yrs: 25 mg PO qOD weeks 1-2, then increase to 25 mg PO qd weeks
3-4, then increase q1-2 weeks by 25-50 mg/day to maintenance dose 100400 mg/day PO qd-bid
Adding to regimen without valproic acid: 2-12 yrs: 0.6 mg/kg/day PO bid
weeks 1-2, then increase to 1.2 mg/kg/day PO bid weeks 3-4, then increase
q1-2 weeks by 1.2 mg/kg/day to maintenance dose 5-15 mg/kg/day PO bid
(max 400 mg/day)
>12 yrs: 50 mg PO qd weeks 1-2, then increase to 50 mg PO bid weeks 34, then increase q1-2 weeks by 100 mg/day to maintenance dose 300-500
mg/day PO bid.
[tabs: 25, 100, 150, 200 mg]
-Primidone (Mysoline) PO: < 8 yrs: 50-125 mg/day qhs, increase by 50-125
mg/day q3-7d; usual dose 10-25 mg/kg/day tid-qid
$8 yrs: 125-250 mg qhs; increase by 125-250 mg/day q3-7d, usual dose 750-
1500 mg/day tid-qid (max 2 gm/day).
[susp: 250 mg/5mL; tabs: 50, 250 mg]
10. Extras and X-rays: MRI with and without gadolinium, EEG with hy
perventilation, CXR, ECG. Neurology consultation.
11. Labs: ABG/CBG, CBC, SMA 7, calcium, phosphate, magnesium, liver panel,
VDRL, anticonvulsant levels, blood and urine culture. UA, drug and toxin
screen.
Therapeutic Serum Levels

Carbamazepine
4-12 mcg/mL
Clonazepam
20-80 ng/mL
Ethosuximide
40-100 mcg/mL
Phenobarbital
15-40 mcg/mL
Phenytoin
10-20 mcg/mL
Primidone
5-12 mcg/mL
Valproic acid
50-100 mcg/mL
102 Adjunctive Anticonvulsants
Adjunctive Anticonvulsants
Felbamate (Felbatol)
2-14 yrs: 15 mg/kg/day PO tid-qid, increase weekly by 15 mg/kg/day if needed
to maximum of 45 mg/kg/day or 3600 mg/day (whichever is smaller)
$14 yrs: 1200 mg/day PO tid-qid, increase weekly by 1200 mg/day if needed to
maximum of 3600 mg/day
[susp: 600 mg/5 mL; tabs: 400, 600 mg]
Warning: due to risk of aplastic anemia and hepatic failure reported with this
drug, written informed consent must be obtained from patient/parent prior to
initiating therapy. Patients must have CBC, liver enzymes, and bilirubin
monitored before starting drug therapy and q1-2 weeks during therapy.
Discontinue the drug immediately if bone marrow suppression or elevated
liver function tests occur.
Gabapentin (Neurontin)
2-12 yrs: 5-35 mg/kg/day PO q8h
> 12 yrs: initially 300 mg PO tid, titrate dose upward if needed; usual dose 9001800 mg/day, maximum 3600 mg/day
[caps: 100, 300, 400 mg; soln: 250 mg/5 mL; tabs: 600, 800 mg]
Adjunctive treatment of partial and secondarily generalized seizures.
Levetiracetam (Keppra)
$ 16 yrs: 500 mg PO bid, may increase by 1000 mg/day q2 weeks to maximum
of 3000 mg/day [tabs: 250, 500, 750 mg]
Tiagabine (Gabitril)
< 12 yrs: dosing guidelines not established
12-18 yrs: 4 mg PO qd x 1 week, then 4 mg bid x 1 week, then increase weekly
by 4-8 mg/day and titrate to response; maximum dose 32 mg/day bid-qid. [tabs:
2, 4, 12, 16, 20 mg]. Lower doses may be effective in patients not receiving
enzyme-inducing drugs.
Topiramate (Topamax)
2-16 yrs with partial onset seizures: 1-3 mg/kg/day PO qhs x 1 week (max 25
mg/day), may increase q1-2 weeks by 1-3 mg/kg/day bid to usual maintenance
dose 5-9 mg/kg/day bid
2-16 yrs with primary generalized tonic clonic seizures: use slower initial titration
rate to max of 6 mg/kg/day PO by the end of eight weeks
> 16 yrs with partial onset seizures: 50 mg/day qhs x 1 week, then 100 mg/day
bid x 1 week, then increase by 50 mg/day q week; usual maintenance dose 200
mg bid, max 1600 mg/day
> 16 yrs with generalized tonic clonic seizures: use slower initial titration rate to
usual maintenance dose 200 mg bid, max 1600 mg/day
[caps, sprinkles: 15, 25, 50 mg; tabs: 25, 100, 200 mg]
Vigabatrin (Sabril) PO
3-9 yrs: 500 mg bid
Spasticity 103
> 9 yrs: 1000 mg bid, may increase if needed to max 4000 mg/day
[tab: 500 mg]. Most effective in complex partial seizures, with or without
generalization. Should be used as add-on therapy in patients with drug-resistant
seizures, not as monotherapy. Do not abruptly discontinue therapy; gradually
taper off to avoid rebound increase in seizure frequency and possible psychotic-
like episodes.
Spasticity
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Cerebral palsy, spasticity
Condition:
Vital signs:
Activity: Physical Therapy
Nursing: Inputs and outputs, daily weights;
Diet:
IV Fluids: Isotonic fluids at maintenance rate if NPO
-Baclofen (Lioresal)
2-7 yrs: 10-15 mg/day PO q8h, titrate dose upwards by 5-15 mg/day q3 days
to a maximum of 40 mg/day
> 7 yrs: 10-15 mg/day PO q8h, titrate dose upwards by 5-15 mg/day q3 days
to a maximum of 60 mg/day
[tabs: 10, 20 mg; extemporaneous suspension]
-Diazepam (Valium), 0.12-0.8 mg/kg/day PO q6-8h or 0.04-0.3 mg/kg/dose
IV/IM q4h prn
[inj: 5 mg/mL; soln: 1 mg/mL, 5 mg/mL; tabs: 2, 5, 10 mg]
-Dantrolene (Dantrium), 0.5 mg/kg/dose PO bid, may increase q4-7 days by 0.5
mg/kg/day to maximum of 3 mg/kg/dose PO bid-qid up to 400 mg/day
[caps: 25, 50, 100 mg; extemporaneous suspension]
10. Extras and X-rays: Occupational therapy consult; physical therapy consult;
rehab consult.
New Onset Diabetes

1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: New Onset Diabetes Mellitus
Condition:
Activity:
Nursing: Record labs on a flow sheet. Fingerstick glucose at 0700, 1200, 1700,
104 Diabetic Ketoacidosis

2100, 0200; diabetic and dietetic teaching.
7. Diet: Diabetic diet with 1000 kcal + 100 kcal/year of age. 3 meals and 3 snacks
(between each meal and qhs.)
8. IV Fluids: Hep-lock with flush q shift.
-Goal is preprandial glucose of 100-200 mg/dL
Total Daily Insulin Dosage

<5 Years (U/kg)
5-11 Years (U/kg)
12-18 Years (U/kg)
0.6-0.8
0.75-0.9
0.8-1.5
-Divide 2/3 before breakfast and 1/3 before dinner. Give 2/3 of total insulin
requirement as NPH and give 1/3 as lispro or regular insulin.
10. Extras and X-rays: CXR. Endocrine and dietary consult.
11. Labs: CBC, ketones; SMA 7 and 12, antithyroglobulin, antithyroid microsomal,
anti-insulin, anti-islet cell antibodies. UA, urine culture and sensitivity; urine
pregnancy test; urine ketones.
Diabetic Ketoacidosis
1. Admit to: Pediatric intensive care unit.
2. Diagnosis: Diabetic ketoacidosis
3. Condition: Critical
5. Activity:
6. Nursing: ECG monitoring; capillary glucose checks q1-2h until glucose level
is <200 mg/dL, daily weights, inputs and outputs. O2 at 2-4 L/min by NC.
Record labs on flow sheet.
7. Diet: NPO
8. IV Fluids: 0.9% saline 10-20 mL/kg over 1h, then repeat until hemodynamically
stable. Then give 0.45% saline, and replace of calculated deficit plus
insensible loss over 8h, replace remaining of deficit plus insensible losses
over 16-24h. Keep urine output >1.0 mL/kg/hour.
Diabetic Ketoacidosis 105

Add KCL when potassium is <6.0 mEq/dL
Serum K+
Infusate KCL
<3
40-60 mEq/L
3-4
30
4-5
20
5-6
10
>6
0
Rate: 0.25-1 mEq KCL/kg/hr, maximum 1 mEq/kg/h or 20 mEq/h.
-Insulin Regular (Humulin) 0.05-0.1 U/kg/hr (50 U in 500 mL NS) continuous IV
infusion. Adjust to decrease glucose by 50-100 mg/dL/hr.
-If glucose decreases at less than 50 mg/dL/hr, increase insulin to 0.14-0.2
U/kg/hr. If glucose decreases faster than 100 mg/dL/hr, continue insulin at
0.05-0.1 U/kg/h and add D5W to IV fluids.
-When glucose approaches 250-300 mg/dL, add D5W to IV. Change to
subcutaneous insulin (lispro or regular) when bicarbonate is >15, and patient
is tolerating PO food; do not discontinue insulin drip until one hour after
subcutaneous dose of insulin.
10. Extras and X-rays: Portable CXR, ECG. Endocrine and dietary consultation.
11. Labs: Dextrostixs q1-2h until glucose <200, then q3-6h. Glucose, potassium,
phosphate, bicarbonate q3-4h; serum acetone, CBC. UA, urine ketones,
culture and sensitivity.
106 Diabetic Ketoacidosis
Sickle Cell Crisis 107
Hematologic and Inflammatory Dis

orders
Sickle Cell Crisis
1.
2.
3.
4.
5.
6.
7.
8.
9.
Admit to:
Diagnosis: Sickle Cell Anemia, Sickle Cell Crisis
Condition:
Vital signs: Call MD if
Activity:
Nursing: Age appropriate pain scale.
Diet:
IV Fluids: D5 NS at 1.5-2.0 x maintenance.
-Oxygen 2-4 L/min by NC.
-Morphine sulfate 0.1 mg/kg/dose (max 10-15 mg) IV/IM/SC q2-4h prn or follow
bolus with infusion of 0.05-0.1 mg/kg/hr prn or 0.3-0.5 mg/kg PO q4h prn OR
-Acetaminophen/codeine 0.5-1 mg/kg/dose (max 60 mg/dose) of codeine PO
q4-6h prn [elixir: 12 mg codeine/5 mL; tabs: 15, 30, 60 mg codeine
component] OR
-Acetaminophen and hydrocodone [elixir per 5 mL: hydrocodone 2.5 mg,
acetaminophen] 167 mg; tabs:
Hydrocodone 2.5 mg, acetaminophen 500 mg;
Hydrocodone 5 mg, acetaminophen 500 mg;
Hydrocodone 7.5 mg, acetaminophen 500 mg,
Hydrocodone 7.5 mg, acetaminophen 650 mg,
Hydrocodone 10 mg, acetaminophen 500 mg,
Hydrocodone 10 mg, acetaminophen 650 mg
Children: 0.6 mg hydrocodone/kg/day PO q6-8h prn
<2 yr: do not exceed 1.25 mg/dose
2-12 yr: do not exceed 5 mg/dose
>12 yr: do not exceed 10 mg/dose
Patient Controlled Analgesia
-Morphine
Basal rate 0.01-0.02 mg/kg/hr
Intermittent bolus dose 0.01-0.03 mg/kg
Bolus frequency (lockout interval) every 6-15 minutes
-Hydromorphone (Dilaudid)
Basal rate 0.0015-0.003 mg/kg/hr
Intermittent bolus dose 0.0015-0.0045 mg/kg
108 Kawasaki's Syndrome

Bolus frequency (lockout interval) every 6-15 min
Adjunctive Therapy:
-Hydroxyzine (Vistaril) 0.5-1 mg/kg/dose PO q6h (max 50 mg/dose)
-Ibuprofen (Motrin) 10 mg/kg/dose PO q6h (max 800 mg/dose) OR
-Ketorolac (Toradol) 0.4 mg/kg/dose IV/IM q6h (max 30 mg/dose); maximum 3
days, then switch to oral ibuprofen
Maintenance Therapy:
-Hydroxyurea (Hydrea): 15 mg/kg/day PO qd, may increase by 5 mg/kg/day q12
weeks to a maximum dose of 35 mg/kg/day. Monitor for myelotoxicity. [caps:
200, 300, 400, 500 mg]
-Folic acid 1 mg PO qd (if >1 yr).
-Transfusion PRBC 5 mL/kg over 2h, then 10 mL/kg over 2h, then check hemo
globin. If hemoglobin is less than 6-8 gm/dL, give additional 10 mL/kg.
-Deferoxamine (Desferal) 15 mg/kg/hr x 48 hours (max 12 gm/day)
concomitantly with transfusion or 1-2 gm/day SQ over 8-24 hrs
-Vitamin C 100 mg PO qd while receiving deferoxamine
-Vitamin E PO qd while receiving deferoxamine
<1 yr: 100 IU/day
1-6 yr: 200 IU/day
>6 yr: 400 IU/day
-Penicillin VK (Pen Vee K) (prophylaxis for pneumococcal infections): <3 yrs:
125 mg PO bid; $3 yrs: 250 mg PO bid [elixir: 125 mg/5 mL, 250 mg/5 mL;
tabs: 125, 250, 500 mg]. If compliance with oral antibiotics is poor, use
penicillin G benzathine 50,000 U/kg (max 1.2 million units) IM every 3 weeks.
Erythromycin is used if penicillin allergic.
11. Labs: CBC, blood culture and sensitivity, reticulocyte count, type and cross,
SMA 7, parvovirus titers, UA, urine culture and sensitivity.
Kawasaki's Syndrome
1.
2.
3.
4.
5.
6.
7.
8.
Admit to:
Diagnosis:
Condition:
Activity: Bedrest
Nursing: temperature at least q4h
Diet:
-Immunoglobulin (IVIG) 2 gm/kg/dose IV x 1 dose. Administer dose at 0.02
mL/kg/min over 30 min; if no adverse reaction, increase to 0.04 mL/kg/min
over 30 min; if no adverse reaction, increase to 0.08 mL/kg/min for remainder
Kawasaki's Syndrome 109

of infusion. Defer measles vaccination for 11 months after receiving high
dose IVIG. [inj: 50 mg/mL, 100 mg/mL]
-Aspirin 100 mg/kg/day PO or PR q6h until fever resolves, then 8-10 mg/kg/day
PO/PR qd [supp: 60, 120, 125, 130, 195, 200, 300, 325, 600, 650 mg; tabs:
325, 500, 650 mg; tab, chew: 81 mg].
-Ambubag, epinephrine (0.1 mL/kg of 1:10,000), and diphenhydramine 1 mg/kg
(max 50 mg) should be available for IV use if an anaphylactic reaction to
immunoglobulin occurs.
9. Extras and X-rays: ECG, echocardiogram, chest X-ray. Rheumatology consult.
10. Labs: CBC with differential and platelet count. ESR, CBC, liver function tests,
rheumatoid factor, salicylate levels, blood culture and sensitivity x 2, SMA 7.
110 Kawasaki's Syndrome
Dehydration 111
Fluids and Electrolytes

Dehydration
1. Admit to:
2. Diagnosis: Dehydration
3. Condition:
5. Activity:
6. Nursing: Inputs and outputs, daily weights. Urine specific gravity q void.
7. Diet:
8. IV Fluids:
Maintenance Fluids:
<10 kg
100 mL/kg/24h
10-20 kg
1000 mL plus 50 mL/kg/24h for each kg >10 kg
>20 kg
1500 mL plus 20 mL/kg/24h for each kg >20 kg.
Electrolyte Requirements:
Sodium: 3-5 mEq/kg/day
Potassium: 2-3 mEq/kg/day
Chloride: 3 mEq/kg/day
Glucose: 5-10 gm/100 mL water required (D5W - D10W)
Estimation of Dehydration
Degree of Dehydration
Mild
Moderate
Severe
Weight Loss--Infants
5%
10%
15%
Weight Loss--Children
3%-4%
6%-8%
10%
Pulse
Normal
Slightly
increased
Very increased
Blood Pressure
Normal
Normal to
orthostatic, >10
mm Hg change
Orthostatic to
shock
Behavior
Normal
Irritable
Hyperirritable to
lethargic
Thirst
Slight
Moderate
Intense
Mucous Membranes
Normal
Dry
Parched
Tears
Present
Decreased
Absent, sunken
eyes
112 Dehydration
Degree of Dehydration
Mild
Moderate
Severe
Anterior Fontanelle
Normal
Normal to
sunken
Sunken
External Jugular Vein
Visible when
supine
Not visible
except with
supraclavicular
pressure
Not visible even

with supraclavic
ular pressure
Skin
Capillary refill
<2 sec
Delayed cap
illary refill, 2-4
sec (decreased
turgor)
Very delayed cap

illary refill (>4
sec), tenting; cool
skin, acrocyan
otic, or mottled
Urine Specific Gravity

(SG)
>1.020
>1.020; oliguria
Oliguria or anuria
Approximate Fluid
Deficit
<50 mL/kg
50-100 mL/kg
$100 mL/kg
Electrolyte Deficit Calculation:

Na+ deficit = (desired Na - measured Na in mEq/L) x 0.6 x weight in kg
K+ deficit = (desired K - measured K in mEq/L) x 0.25 x weight in kg
Cl! deficit= (desired Cl - measured Cl in mEq/L) x 0.45 x weight in kg
Free H2O deficit in hypernatremic dehydration = 4 mL/kg for every mEq that
serum Na >145 mEq/L.
Phase 1, Acute Fluid Resuscitation (Symptomatic Dehydration):
-Give NS 20-30 mL/kg IV at maximum rate; repeat fluid boluses of NS 20-30
mL/kg until adequate circulation.
Phase 2, Deficit and Maintenance Therapy (Asymptomatic dehydration):
Hypotonic Dehydration (Na+ <125 mEq/L):
-Calculate total maintenance and deficit fluids and sodium deficit for 24h (minus
fluids and electrolytes given in phase 1). If isotonic or hyponatremic
dehydration, replace 50% over 8h and 50% over next 16h.
-Estimate and replace ongoing losses q6-8h.
-Add potassium to IV solution after first void.
-Usually D5 NS or D5 1/4 NS saline with 10-40 mEq KCL/liter 60 mL/kg over
2 hours. Then infuse at 6-8 mL/kg/h for 12h.

-See hyponatremia, page 115.
Isotonic Dehydration (Na+ 130-150 mEq/L):
-Calculate total maintenance and replacement fluids for 24h (minus fluids and
electrolytes given in phase 1) and give half over first 8h, then remaining half
over next 16 hours.
-Add potassium to IV solution after first void.
-Estimate and replace ongoing losses.
Hyperkalemia 113
-Usually D5 NS or D5 1/4 NS with 10-40 mEq KCL/L.
Hypertonic Dehydration (Na+ >150 mEq/L):
-Calculate and correct free water deficit and correct slowly. Lower sodium by 10
mEq/L/day; do not reduce sodium by more than 15 mEq/L/24h or by >0.5
mEq/L/hr.
-If volume depleted, give NS 20-40 mL/kg IV until adequate circulation, then
give -1/4 NS in 5% dextrose to replace half of free water deficit over first
24h. Follow serial serum sodium levels and correct deficit over 48-72h.
-Free water deficit: 4 mL/kg x (serum Na+ -145)
-Also see "hypernatremia" page 115.
-Add potassium to IV solution after first void as KCL.
-Usually D5 1/4 NS or D5W with 10-40 mEq/L KCL. Estimate and replace
ongoing losses and maintenance.

Replacement of ongoing losses (usual fluids):
-Nasogastric suction: D5 NS with 20 mEq KCL/L or NS with KCL 20
mEq/L.
-Diarrhea: D5 1/4 NS with 40 mEq KCl/L
Oral Rehydration Therapy (mild-moderate dehydration <10%):
-Oral rehydration electrolyte solution (Rehydralyte, Pedialyte, Ricelyte, Revital
Ice) deficit replacement of 60-80 mL/kg PO or via NG tube over 2h. Provide
additional fluid requirement over remaining 18-20 hours; add anticipated fluid
losses from stools of 10 mL/kg for each diarrheal stool.
Oral Electrolyte Solutions

Product
Na (mEq/L)
K (mEq/L)
Cl (mEq/L)
Rehydralyte
75
20
65
Ricelyte
50
25
45
Pedialyte
45
20
35
Hyperkalemia
1.
2.
3.
4.
5.
6.
7.
8.
Admit to: Pediatric ICU

Diagnosis: Hyperkalemia
Condition:
Activity:
Nursing: Continuous ECG monitoring, inputs and outputs, daily weights.
Diet:
IV Fluids:
114 Hypokalemia
Hyperkalemia (K+ >7 or EKG Changes)
-Calcium gluconate 50-100 mg/kg (max 1 gm) IV over 5-10 minutes or calcium
chloride 10-20 mg/kg (max 1 gm) IV over 10 minutes.
-Regular insulin 0.1 U/kg plus glucose 0.5 gm/kg IV bolus (as 10% dextrose).
-Sodium bicarbonate 1-2 mEq/kg IV over 3-5 min (give after calcium in separate
IV), repeat in 10-15 min if necessary.
-Furosemide (Lasix) 1 mg/kg/dose (max 40 mg IV) IV q6-12h prn, may increase
to 2 mg/kg/dose IV [inj: 10 mg/mL]
-Kayexalate resin 0.5-1 gm/kg PO/PR. 1 gm resin binds 1 mEq of potassium.
9. Extras and X-rays: ECG, dietetics, nephrology consults.
10. Labs: SMA7, Mg, calcium, CBC, platelets. UA; urine potassium.
Hypokalemia
1. Admit to: Pediatric ICU
2. Diagnosis: Hypokalemia
3. Condition:
5. Activity:
6. Nursing: ECG monitoring, inputs and outputs, daily weights.
7. Diet:
8. IV Fluids:
If serum K >2.5 mEq/L and ECG changes are absent:
Add 20-40 mEq KCL/L to maintenance IV fluids. May give 1-4 mEq/kg/day to
maintain normal serum potassium. May supplement with oral potassium.
K <2.5 mEq/L and ECG abnormalities:
Give KCL 1-2 mEq/kg IV at 0.5 mEq/kg/hr; max rate 1 mEq/kg/hr or 20
mEq/kg/hr in life-threatening situations (whichever is smaller). Recheck se
rum potassium, and repeat IV boluses prn; ECG monitoring required.
Oral Potassium Therapy:
-Potassium chloride (KCl) elixir 1-3 mEq/kg/day PO q8-24h [10% soln = 1.33
mEq/mL].
9. Extras and X-rays: ECG, dietetics, nephrology consults.
10. Labs: SMA7, Mg, calcium, CBC. UA, urine potassium.
Hypernatremia 115
Hypernatremia
1.
2.
3.
4.
5.
6.
7.
8.
Admit to:
Diagnosis: Hypernatremia
Condition:
Activity:
Nursing: Inputs and outputs, daily weights.
Diet:
IV Fluids:
If volume depleted or hypotensive, give NS 20-40 mL/kg IV until adequate
circulation, then give D5 NS IV to replace half of body water deficit over
first 24h. Correct serum sodium slowly at 0.5-1 mEq/L/hr. Correct remaining
deficit over next 48-72h.
Body water deficit (liter) = 0.6 x (weight kg) x (serum Na -140)
Hypernatremia with ECF Volume Excess:
-Furosemide (Lasix) 1 mg/kg IV.
-D5 1/4 NS to correct body water deficit.
9. Extras and X-rays: ECG.
10. Labs: SMA 7, osmolality, triglycerides. UA, urine specific gravity; 24h urine
Na, K, creatinine.
Hyponatremia
1. Admit to:
2. Diagnosis: Hyponatremia
3. Condition:
5. Activity:
6. Nursing: Inputs and outputs, daily weights, neurochecks.
7. Diet:
8. IV Fluids:
Hyponatremia with Edema (Hypervolemia)(low osmolality <280, urine sodium
<10 mM/L: nephrosis, CHF, cirrhosis; urine sodium >20: acute/chronic renal
failure):
-Water restrict to half maintenance.

-Furosemide (Lasix) 1 mg/kg/dose IV over 1-2 min or 2-3 mg/kg/day PO q824h.
116 Hypophosphatemia
Hyponatremia with Normal Volume Status (low osmolality <280, urine sodium
<10 mM/L: water intoxication; urine sodium >20 mM/L: SIADH, hypothyroidism,
renal failure, Addison's disease, stress, drugs):
-0.9% saline with 20-40 mEq KCL/L infused to correct hyponatremia at rate of
<0.5 mEq/L/hr) OR use 3% NS in severe hyponatremia [3% NS = 513
mEq/liter].
Hyponatremia with Hypovolemia (low osmolality <280; urine sodium <10 mM/L:
vomiting, diarrhea, 3rd space/respiratory/skin loss; urine sodium >20 mM/L:
diuretics, renal injury, renal tubular acidosis, adrenal insufficiency, partial
obstruction, salt wasting):
-If volume depleted, give NS 20-40 mL/kg IV until adequate circulation.
-Gradually correct sodium deficit in increments of 10 mEq/L. Determine volume
deficit clinically, and determine sodium deficit as below.
-Calculate 24 hour fluid and sodium requirement and give half over first 8 hours,
then give remainder over 16 hours. 0.9% saline = 154 mEq/L
-Usually D5NS 60 mL/kg IV over 2h (this will increase extracellular sodium by
10 mEq/L), then infuse at 6-8 mL/kg/hr x 12h.
Severe Symptomatic Hyponatremia:
-If volume depleted, give NS 20-40 mL/kg until adequate circulation.
-Determine volume of 3% hypertonic saline (513 mEq/L) to be infused as
follows:
Na(mEq) deficit = 0.6 x (wt kg) x (desired Na - actual Na)
Volume of soln (L) = Sodium to be infused (mEq) mEq/L in solution
-Correct half of sodium deficit slowly over 24h.
-For acute correction, the serum sodium goal is 125 mEq/L; max rate for acute
replacement is 1 mEq/kg/hr. Serum Na should be adjusted in increments of
5 mEq/L to reach 125 mEq/L. The first dose is given over 4 hrs. For further
correction for serum sodium to above 125 mEq/L, calculate mEq dose of
sodium and administer over 24-48h.
9. Extras and X-rays: CXR, ECG.
10. Labs: SMA 7, osmolality, triglyceride. UA, urine specific gravity. Urine
osmolality, Na, K; 24h urine Na, K, creatinine.
Hypophosphatemia
Indications for Intermittent IV Administration:
1. Serum phosphate <1.0 mg/dL or
2. Serum phosphate <2.0 mg/dL and patient symptomatic or
3. Serum phosphate <2.5 mg/dL and patient on ventilator
Hypophosphatemia 117
Treatment of Hypophosphatemia
Dosage of IV Phosphate
Serum Phosphate
Low dose
0.08 mM/kg IV over 6 hrs
>1 mg/dL
Intermediate dose

0.5-1 mg/dL
High Dose
<0.5 mg/dL
IV Phosphate Cations:
Sodium phosphate: Contains sodium 4 mEq/mL, phosphate 3 mM/mL
Potassium phosphate: Contains potassium 4.4 mEq/mL, phosphate 3 mM/mL
Max rate 0.06 mM/kg/hr
Oral Phosphate Replacement
1-3 mM/kg/day PO bid-qid
Potassium Phosphate:
Powder (Neutra-Phos-K): phosphorus 250 mg [8 mM] and potassium 556 mg
[14.25 mEq] per packet; Tab (K-Phos Original): phosphorus 114 mg [3.7 mM],
potassium 144 mg [3.7 mEq]
Sodium Phosphate: Phosphosoda Soln per 100 mL: sodium phosphate 18 gm and
sodium biphosphate 48 gm [contains phosphate 4 mM/mL]
Sodium and Potassium Phosphate: Powd Packet: phosphorus 250 mg [8 mM],
potassium 278 mg [7.125 mEq], sodium 164 mg [7.125 mEq];
Tabs:
K-Phos MF: phosphorus 125.6 mg [4 mM], potassium 44.5 mg [1.1 mEq],
sodium 67 mg [2.9 mEq]
K-Phos Neutral: phosphorus 250 mg [8 mM], potassium 45 mg [1.1 mEq],
sodium 298 mg [13 mEq]
K-Phos No 2: phosphorus 250 mg [8 mM], potassium 88 mg [2.3 mEq], sodium
134 mg [5.8 mEq]
Uro-KP-Neutral: phosphorus 250 mg [8 mM], potassium 49.4 mg [1.27 mEq],
sodium 250.5 mg [10.9 mEq]
118 Hypomagnesemia
Hypomagnesemia
Indications for Intermittent IV Administration:
1. Serum magnesium <1.2 mg/dL
2. Serum magnesium <1.6 mg/dL and patient symptomatic
3. Calcium resistant tetany
Magnesium Sulfate, Acute Treatment:
-25-50 mg/kg/dose (0.2-0.4 mEq/kg/dose) IV every 4-6 hrs x 3-4 doses as

needed (max 2000 mg = 16 mEq/dose); max rate 1 mEq/kg/hr (125
mg/kg/hr).
Magnesium sulfate IV maintenance dose: 1-2 mEq/kg/day (125-250 mg/kg/day)
in maintenance IV solution.
Magnesium PO Maintenance Dose: 10-20 mg/kg/dose elemental magnesium
PO qid.
Magnesium Chloride (Slow-Mag): mg salt (mEq elemental magnesium; mg
elemental magnesium)
Tab, SR: 535 mg (5.2 mEq; 63 mg).
Magnesium Gluconate (Magonate): mg salt (mEq elemental magnesium; mg
elemental magnesium)
Liq: 1000 mg/5mL (4.8 mEq/5mL; 54 mg).
Tab: 500 mg (2.4 mEq; 27 mg).
Magnesium Oxide: mg salt (mEq elemental magnesium; mg elemental
magnesium).
Tabs: 400 mg (20 mEq; 242 mg), 420 mg (21 mEq; 254 mg), 500 mg (25 mEq;
302 mg).
Caps: 140 mg (7 mEq; 84 mg).
Magnesium Sulfate: mg salt (mEq elemental magnesium; mg elemental
magnesium)
Soln: 500 mg/mL (4.1 mEq/mL; 49.3 mg/mL).
Neonatal Resuscitation 119
Newborn Care
Neonatal Resuscitation
APGAR Score
Sign
Heart rate per

minute
Absent
Slow (<100)
>100
Respirations
Absent
Slow, irregular
Good, crying
Muscle tone
Limp
Some flexion
Active motion
Reflex
irritability
No response
Grimace
Cough or
sneeze
Color
Blue or pale
Pink body with

blue
extremities
Completely
pink
Assess APGAR score at 1 minute and 5 minutes, then continue

assessment at 5 minute intervals until APGAR is greater than 7.
General Measures:
1. Review history, check equipment, oxygen, masks, laryngoscope, ET tubes,
medications.
Vigorous, Crying Infant: Provide routine delivery room care for infants with heart
rate >100 beats per minute, spontaneous respirations, and good color and tone:
warmth, clearing the airway, and drying.
Meconium in Amniotic Fluid:
1. Deliver the head and suction meconium from the hypopharynx on delivery of
the head. If the newly born infant has absent or depressed respirations, heart
rate <100 bpm, or poor muscle tone, perform direct tracheal suctioning to
remove meconium from the airway.
2. If no improvement occurs or if the clinical condition deteriorates, bag and mask
ventilate with intermittent positive pressure using 100% Fi02; stimulate
vigorously by drying. Initial breath pressure: 30-40 cm H2O for term infants, 2030 cm H2O for preterm infants. Ventilate at 15-20 cm H20 at 30-40 breaths per
minute. Monitor bilateral breath sounds and expansion.
120 Neonatal Resuscitation

3. If spontaneous respirations develop and heart rate is normal, gradually reduce
ventilation rate until using only continuous positive airway pressure (CPAP).
Wean to blow-by oxygen, but continue blow-by oxygen if the baby remains
dusky.
4. Consider intubation if the heart rate remains <100 beats per minute and is not
rising, or if respirations are poor and weak.
Resuscitation:
1. Provide assisted ventilation with attention to oxygen delivery, inspiratory time,
and effectiveness as judged by chest rise if stimulation does not achieve
prompt onset of spontaneous respirations or the heart rate is <100 bpm.
2. Provide chest compressions if the heart rate is absent or remains <60 bpm
despite adequate assisted ventilation for 30 seconds. Coordinate chest
compressions with ventilations at a ratio of 3:1 and a rate of 120 events per
minute to achieve approximately 90 compressions and 30 breaths per minute.
3. Chest compressions should be done by two thumb-encircling hands in newly
born infants and older infants. The depth of chest compression should be one
third of the anterior-posterior diameter of the chest. Chest compressions
should be sufficiently deep to generate a palpable pulse.
4. If condition worsens or if there is no change after 30 seconds, or if mask
ventilation is difficult: use laryngoscope to suction oropharynx and trachea and
intubate. Apply positive pressure ventilation. Check bilateral breath sounds
and chest expansion. Check and adjust ET tube position if necessary.
Continue cardiac compressions if heart rate remains depressed. Check CXR
for tube placement.
Hypotension or Bradycardia or Asystole: Epinephrine 0.1-0.3 mL/kg [0.010.03 mg/kg (0.1 mg/mL = 1:10,000)] IV or ET q3-5min. Dilute ET dose to 2-3
mL in NS. If infant fails to respond, consider increasing dose to 0.1 mg/kg (0.1
mL/kg of 1 mg/mL = 1:1000).
Hypovolemia: Insert umbilical vein catheter and give O negative blood, plasma,
5% albumin, Ringers lactate, or normal saline 10 mL/kg IV over 5-10 minutes.
Repeat as necessary to correct hypovolemia.
Severe Birth Asphyxia, Mixed Respiratory/Metabolic Acidosis (not
responding to ventilatory support; pH <7.2): Give sodium Bicarbonate 1
mEq/kg, dilute 1:1 in sterile water IV q5-10min as indicated.
Narcotic-Related Depression:
1. Naloxone (Narcan) 0.1 mg/kg = 0.25 mL/kg (0.4 mg/mL concentration) or 0.1
mL/kg (1 mg/mL concentration) ET/IV/IM/SC, may repeat q2-3 min. May cause
drug withdrawal and seizures in the infant if the mother is a drug abuser.
2. Repeat administration may be necessary since the duration of action of
naloxone may be shorter than the duration of action of the narcotic.
Suspected Neonatal Sepsis 121
Endotracheal Tube Sizes

Weight (gm)
Gestational
Age (weeks)
Tube Size
(mm)
Depth of
Insertion from
Upper Lip
(cm)
< 1000
<28
2.5
6.5-7
1000-2000
28-34
3.0
7-8
2000-3000
34-38
3.5
8-9
> 3000
>38
3.5-4.0
>9
Suspected Neonatal Sepsis

1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Suspected sepsis
Condition:
Activity:
Nursing: Inputs and outputs, daily weights, cooling measures prn temp
>38C, consent for lumbar puncture.
7. Diet:
8. IV Fluids: IV fluids at 1-1.5 times maintenance.
Newborn Infants <1 month old (group B strep, E coli, or group D strep, gram
negatives, Listeria monocytogenes):
-Ampicillin and gentamicin OR ampicillin and cefotaxime as below.

-Add vancomycin as below if >7 days old and a central line is present.
Neonatal Dosage of Ampicillin:
<1200 gm 0-4 weeks: 100 mg/kg/day IV/IMq12h
1200-2000 gm:
#7d: 100 mg/kg/day IV/IM q12h
>7d: 150 mg/kg/day IV/IM q8h
>2000 gm:
#7d: 150 mg/kg/day IV/IM q8h
>7d: 200 mg/kg/day IV/IM q6h
122 Suspected Neonatal Sepsis

Cefotaxime (Claforan):
<1200 grams: 0-4 wks: 100 mg/kg/day IV/IM q12h
>
$ 1200 grams: 0-7 days: 100 mg/kg/day IV/IM q12h
>7 days: 150 mg/kg/day IV/IM q8h
Gentamicin (Garamycin)/Tobramycin (Nebcin):
<1200 gm 0-4 weeks: 2.5 mg/kg/dose IV/IMq24h
1200-2000 gm:
#7d: 2.5 mg/kg/dose IV/IM q12-24h
>7d: 2.5 mg/kg/dose IV/IM q12-24h
>2000 gm:
#7d: 2.5 mg/kg/dose IV/IM q12-24h
>7d: 2.5 mg/kg/dose IV/IM q12h
Neonatal Vancomycin (Vancocin) Dosage:
<1200 gm 0-4 weeks: 15 mg/kg/dose IV q24h
1200-2000 gm:
#7d: 10 mg/kg/dose IV q12-18h
>7d: 10 mg/kg/dose IV q8-12h
>2000 gm:
#7d: 10 mg/kg/dose IV q12h
>7d: 10 mg/kg/dose IV q8-12h
Nafcillin (Nafcil):
<1200 gm:
0-4 weeks 50 mg/kg/day IV/IM q12h
1200-2000 gm:
#7 days: 50 mg/kg/day IV/IM q12h
>2000 gm:
Mezlocillin (Mezlin):
<1200 gm:
0-4 weeks 150 mg/kg/day IV/IM q12h
1200-2000 gm:
>2000 gm:
Amikacin:
<1200 gm 0-4 weeks: 10 mg/kg/dose IV/IM q24h
1200-2000 gm:
#7d: 10 mg/kg/dose IV/IM q12-24h
>7d: 10 mg/kg/dose IV/IM q12-24h
Respiratory Distress Syndrome 123

>2000 gm:
#7d: 10 mg/kg/dose IV/IM q12-24h
>7d: 10 mg/kg/dose IV/IM q12h
10. Extras and X-rays: CXR
11. Laboratory Studies: CBC, SMA 7, blood culture and sensitivity; UA,
culture and sensitivity, antibiotic levels.
CSF Tube 1 - Gram stain, bacterial culture and sensitivity, antigen screen (1-2
mL).
CSF Tube 2 - Glucose protein (1-2 mL).
Respiratory Distress Syndrome

1. Provide mechanical ventilation as indicated.
2. Exogenous surfactant:
Prophylactic Therapy: Infants at risk for developing RDS with a birth weight
<1250gm.
Rescue Therapy: Treatment of infants with RDS based on respiratory distress
not attributable to any other causes and chest radiographic findings
consistent with RDS.
-Beractant (Survanta): 4 mL/kg of birth weight via endotracheal tube then q6h
up to 4 doses total [100 mg (4 mL), 200 mg (8 mL)]
-Colfosceril (Exosurf): 5 mL/kg of birth weight via endotracheal tube then q12h
for 2-3 doses total [108 mg (10 mL)]
-Poractant alfa (Curosurf): first dose 2.5 mL/kg (200 mg/kg/dose) of
birthweight via endotracheal tube, may repeat with 1.25 mL/kg/dose (100
mg/kg/dose) at 12-hour intervals for up to two additional doses [120 mg (1.5
mL), 240 mg (3 mL)]
-Calfactant (Infasurf): 3 mL/kg via endotracheal tube, may repeat q12h up to
a total of 3 doses [6 mL]
Necrotizing Enterocolitis
Treatment:
1. Decompress bowel with a large-bore (10 or 12 French), double lumen
nasogastric or orogastric tube and apply intermittent suction.
2. Replace fluid losses with IV fluids; monitor urine output, tissue perfusion and
blood pressure; consider central line monitoring.
3. Give blood and blood products for anemia, thrombocytopenia, or
coagulopathy. Monitor abdominal X-rays for free air from perforation.
124 Apnea
4. Antibiotics: Ampicillin and gentamicin or tobramycin or cefotaxime. Add
vancomycin if a central line is present
5. Diagnostic Evaluation: Serial abdominal X-rays with lateral decubitus, CBC
with differential and platelets; DIC panel, blood cultures x 2; Wright's stain of
stool; stool cultures.
6. Monitor the patient frequently for perforation, electrolyte disturbances, and
radiologic evidence of pneumatosis intestinalis and portal vein gas. Obtain
surgical evaluation if perforation is suspected.
Apnea
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Apnea
Condition:
Activity:
Nursing: Heart rate monitor, impedance apnea monitor, pulse oximeter. Keep
bag and mask resuscitation equipment at bed side. Rocker bed or oscillating
water bed.
7. Diet: Infant formula ad lib
8. IV Fluids:
Apnea of Prematurity/Central Apnea:
-Aminophylline: loading dose 5 mg/kg IV, then maintenance 5 mg/kg/day IV

q12h [inj: 25 mg/mL] OR
-Theophylline: loading dose 5 mg/kg PO, then 5 mg/kg/day PO q12h. [elixir:
80 mg/15mL].
-Caffeine citrate: Loading dose 10-20 mg/kg IV/PO, then 5 mg/kg/day PO/IV
q12-24h [inj: 20 mg/mL, oral soln: 20 mg/mL, extemporaneously prepared
oral suspension: 10 mg/mL].
10. Extras and X-rays: Pneumogram, cranial ultrasound. Upper GI (rule out reflux), EEG.
11. Labs: CBC, SMA 7, glucose, calcium, theophylline level (therapeutic range
6-14 mcg/mL) , caffeine level (therapeutic range 10-20 mcg/mL).
Bronchopulmonary Dysplasia
1.
2.
4.
5.
Admit to:
Diagnosis: Bronchopulmonary Dysplasia.
Activity:
Hyperbilirubinemia 125
6. Nursing: Inputs and outputs, daily weights
7. Diet:
Diuretics:
-Furosemide (Lasix) 1 mg/kg/dose PO/IV/IM q6-24h prn [inj: 10 mg/mL; oral
soln: 10 mg/mL, 40 mg/5mL]
-Chlorothiazide (Diuril) 2-8 mg/kg/day IV q12-24h or 20-40 mg/kg/day PO
q12h [inj: 500 mg; susp: 250 mg/5mL]
-Spironolactone (Aldactone) 2-3 mg/kg/day PO q12-24h [tabs: 25, 50, 100
mg; extemporaneous suspension]
Steroids:
-Dexamethasone (Decadron) 0.5-1 mg/kg/day IV/IM q6-12h
-Prednisone 1-2 mg/kg/day PO q12-24h [soln: 1 mg/mL, 5 mg/mL]
11. Extras and X-rays: CXR
12. Labs: CBC, SMA 7.
Hyperbilirubinemia
1.
2.
3.
4.
5.
6.
Admit to:
Diagnosis: Hyperbilirubinemia.
Condition: Guarded.
Activity:
Nursing: Inputs and outputs, daily weights, monitor skin color, monitor for
lethargy and hypotonia
7. Diet:
8. IV Fluids: Isotonic fluids at maintenance rate (100-150 mL/kg/day).
Encourage enteral feedings if possible.
-Phenobarbital 5 mg/kg/day PO/IV q12-24h [elixir: 15 mg/5mL, 20 mg/5mL;
inj: 30 mg/mL, 60 mg/mL, 65 mg/mL, 130 mg/mL]
-Phototherapy
-Exchange transfusion for severely elevated bilirubin
11. Extras and X-rays:
12. Labs: Total bilirubin, indirect bilirubin, albumin, SMA 7. Blood group typing
of mother and infant, a direct Coombs' test. Complete blood cell count,
reticulocyte count, blood smear. In infants of Asian or Greek descent, glucose
6-phosphate dehydrogenase (G6PD) should be measured.
126 Congenital Syphilis
Congenital Syphilis
Treatment:
-Penicillin G aqueous: 50,000 U/kg/dose IV/IM; 0-7 days of age: q12h; >7
days: q8h. Treat for 10-14 days. If one or more days is missed, restart
entire course OR
-Procaine penicillin G 50,000 U/kg/day IM qd for 10-14 day. Procaine penicillin
does not achieve adequate CSF concentrations and may NOT be
administered intravenously.
-Obtain follow-up serology at 3, 6, 12 months until nontreponemal test is nonreactive. Infectious skin precautions should be taken.
Congenital Herpes Simplex Infection

-Acyclovir (Zovirax) 60 mg/kg/day IV q8h. Infuse each dose over 1 hr x 14
days (if disease is limited to skin, eye, and mouth) or 21 days (if disease is
disseminated or involves the CNS). Infants with ocular involvement should
also receive topical ophthalmic trifluridine.
-Trifluridine ophthalmic solution (Viroptic) 1 drop in each affected eye q2h
while awake [ophth soln 1%: 7.5 mL bottle].
Patent Ductus Arteriosus

Treatment:
1. Restrict fluids if the infant is symptomatic.
2. Provide respiratory support and maintain hematocrit at 40%.
3. Furosemide (Lasix) 1-2 mg/kg/dose q6-8h PO.
4. Indomethacin (Indocin):
Three dose course:

Age at First
Dose
Dose 1
(mg/kg/dose)
Dose 2
(mg/kg/dose)
Dose 3
(mg/kg/dose)
<48h
0.2
0.1
0.1
2-7d
0.2
0.2
0.2
Hepatitis Prophylaxis 127
Age at First
Dose
Dose 1
(mg/kg/dose)
Dose 2
(mg/kg/dose)
Dose 3
(mg/kg/dose)
>7d
0.2
0.25
0.25
Give q12-24h IV over 20-30 min. Check serum creatinine and urine output
prior to each dose.
Five-dose course: 0.1 mg/kg/dose IV q24h x 5 days. Check serum creatinine
and urine output prior to each dose.
5. Diagnostic Considerations: ABG, chest X-ray, ECG, CBC, electrolytes.
Echocardiogram (to determine if PDA has closed).
6. Consider surgical intervention if two courses of indomethacin fail to close the
PDA or if indomethacin therapy is contraindicated (hemodynamically unstable,
renal impairment).
Hepatitis Prophylaxis
Infant born to HBs-Ag Positive Mother or Unknown Status Mother:
-Hepatitis B immune globulin (HBIG) 0.5 mL IM x 1 within 12 hours of birth
-Hepatitis B vaccine 0.5 mL IM (at separate site) within 12 hours of birth,
second dose at age 1-2 months, third dose at age 6 months.
Neonatal HIV Prophylaxis

1. Pregnant women with HIV should be given oral zidovudine (200 mg PO q8h
or 300 mg PO q12h) beginning at 14 weeks gestation and continuing
throughout the pregnancy.
2. Intravenous zidovudine should be given to the mother during labor until
delivery (2 mg/kg during the first hour and then 1 mg/kg/hr until delivery).
3. Oral administration of zidovudine to the newborn should be instituted
immediately after birth and continued for at least six weeks (start at
8mg/kg/day PO q6h for the first two weeks, and then follow the dosing
regimens on page 59. The mother should not breast feed the infant.
Commonly Used Formulas

Normal urine output = 50 mL/kg/day
Oliguria <1 mL/kg/hr
Normal feedings = 5 ounces/kg/day
Formula = 20 kcal/ounce, 24 kcal/ounce, 27 kcal/ounce
Ounce = 30 mL
Caloric Needs = 100 kcal/kg/day
Calories/kg = mL of formula x 30 mL/ounce x kcal/ounce divided by weight.
Weight in kg = pounds divided by 2.2
Blood volume (mL) = 80 mL/kg x weight (kg)
Blood Products:
10 mL/kg of PRBC will raise hematocrit 5%
0.1 unit/kg platelets will raise platelet count by 25,000/mm3.
1 U/kg of factor VIII will raise level by 2%.
Cardiac output = HR x stroke volume
CO L/min =
125 mL O2/min/m2
8.5 {(1.36)(Hgb)(SaO2) (1.36)(Hgb)(SvO2)}
x 100
Anion Gap = Na - (Cl + HCO3)

Creatinine clearance =
U Creatinine (mg/100 mL) x U vol (mL)

P Creatinine (mg/100 mL) x time (1440 min for 24h)
Body water deficit (L) = 0.6(weight kg)([Na serum]-140)

140
Osmolality = 2[Na + K] + BUN + glucose = NL 270-290 mOsm/kg
2.8
18
Fractional excreted Na = U Na/ Serum Na x 100 = NL<1%
U Creatinine/ Serum Creatinine
Corrected = measured Na + serum glucose (mg/dL) = NL 140 mEq/L
serum Na+
36
Basal energy expenditure (BEE):
Males = 66 + (13.7 x actual weight in kg) + (5 x height in cm) - (6.8 x age)
Females = 655 + (9.6 x actual weight in kg) + (1.7 x height in cm) - (4.7 x age)
Nitrogen Balance = Gm protein intake/6.25 - urine urea nitrogen - (3-4 gm/day

insensible loss)
Normal Heart Rates

Age
Range
Normal Rate
(beats/min)
Newborn to 30 mth
85-200
140
30 mth to 2 yrs
100-190
130
2 yrs to 10 yrs
60-190
80
>10 yrs
50-100
75
Index
2-PAM 94
3TC 59
5-FC 61
A-2000 78
Abelcet 61
Accolate 37
Acetaminophen 17, 22, 44,
51
Acetaminophen overdose 95
Acetaminophen/Codeine 22,
107
Acetaminophen/Hydrocodone
22, 107
Acetylcysteine 95
Achromycin 53, 71
Acidosis 120
Actifed 18, 38
Actifed with Codeine 18
Activated Charcoal 93, 95, 97
Acyclovir 46, 57, 61, 126
Adalat 34
Adenosine 29
Advil 17, 23, 44, 68
Aerobid 37
Agoral 92
AIDS 58, 59
Albendazole 85
Albenza 85
Albumin 120
Albuterol 35, 37, 40, 55
Alcohol Overdose 94
Aldactone 125
Aleve 24
Allegra 38
Allergic conjunctivitis 38
Allergic rhinitis 38
Alupent 35, 37
Amantadine 54, 56
AmBisome 61
Amikacin 122
Aminophylline 36
Amoxicillin 67, 70, 71
Amoxicillin/clavulanate 50,
67, 69, 71, 80
Amoxil 70, 71
Amphotericin B 61, 62
Amphotericin B lipid complex
61
Amphotericin B liposomal 61
Ampicillin 43, 44, 49, 50, 121
Ampicillin-sulbactam 81
Amyl Nitrate 93
Analgesia 22
Analgesics 17
Anaphylaxis 40
Ancef 48, 66, 74
Ancobon 61
Anticholinergic toxicity 94
Antiemetics 24
Antihistamines 18
Antilirium 94
Antipyretics 17
Antiretroviral therapy 59
Antitussives 17, 18
APGAR Score 119
Apnea 124
Appendicitis 63
Arthrocentesis 63
Asacol 87
Asphyxia 120
Aspirin 109
Astelin 38
Astemizole 38
Asthma 35
Asystole 29, 31, 120
Athletes foot 79
Ativan 23, 99
Atovaquone 59
Atrial fibrillation 32
Atropine 29, 94
Augmentin 50, 67, 69, 71,
80
Auralgan 68
Avlosulfon 59
Azactam 51
Azelastine 38, 39
Azithromycin 48, 50, 54, 62,
67, 70, 77
Azmacort 37
AZT 59
Aztreonam 51
Azulfidine 87
Baclofen 103
Bactocill 46, 51, 52, 74
Bactrim 53, 58, 64, 67, 70
Bactroban 75
BAL 96
Barley malt extract 91
Beclomethasone 37, 38
nasal 39
Beclovent 37
Beconase 38, 39
Benadryl 23, 24, 87, 94

Benylin DM 18
Benzathine penicillin 69
Benzocaine/antipyrine 68
Benzodiazepine overdose
94
Beractant 123
Biaxin 48, 50-52, 67, 69, 71
Bicarbonate 114, 120
Bicillin 69
Bismuth subsalicylate 72
Bite Wound 80
Blood products 128
Body lice 78
Body water deficit 115, 128
Bradycardia 28, 120
Brethaire 35
Brethine 35
Brevital 23
Bricanyl 35
Brompheniramine 17
Bronchiolitis 55
Bronchopulmonary
dysplasia 124
Budesonide 37, 39
Bumetanide 31
Bumex 31
Caffeine 124
Calan 29
Calcium gluconate 114
Calfactant 123
Caloric needs 128
Campylobacter jejuni 84
Candidiasis 61
Capoten 32
Captopril 32
Carbamazepine 99, 100
Carbinoxamine 20
Carbon monoxide 93
Cardiac output 128
Cardiopulmonary failure 28
Cardioversion 30
Cat Bite 80
Cathartics 93
Cefadroxil 48
Cefazolin 48, 66, 74
Cefixime 50, 67, 81, 83, 84
Cefotan 64, 77
Cefotaxime 43-45, 49, 52,
65, 122
Cefotetan 64, 77
Cefoxitin 64, 74, 77

Cefpodoxime 50, 64, 67, 75,
81
Cefprozil 50, 64, 67, 75, 81
Ceftazidime 43, 51, 52, 66,
68
Ceftin 50, 67, 71, 74
Ceftriaxone 43-46, 67, 70,
76, 77
Cefuroxime 49, 50, 52, 53,
70, 74
Cefuroxime axetil 50, 67, 71,
74
Cefzil 50, 64, 67, 75, 81
Cellulitis 74
Cephalexin 48, 66, 69, 75
Cerebrospinal fluid 44
Cerebyx 100
Cervicitis 77
Charcoal 93, 95
Cheek cellulitis 74
Chemet 96
Chief Compliant 7
Children's Motrin 17, 23
Chlamydia pneumoniae 54
Chlamydia psittaci 54
Chlamydia trachomatous 54
Chlor-Trimeton 17, 38
Chloral hydrate 23
Chloramphenicol 45
Chloride requirements 111
Chloromycetin 45
Chlorothiazide 125
Chlorpheniramine 17, 38
Chlorpromazine 23, 24
Cimetidine 90
Cipro 46
Ciprofloxacin 46
Cisapride 90
Claforan 43, 44, 49, 52, 65,
122
Clarithromycin 48, 50-52, 67,
69, 71
Claritin 38
Cleocin 69, 77
Clindamycin 48, 69, 77, 81
Clostridium difficile 83
Clostridium tetani 76
Clotrimazole 79
Coccidiomycosis 62
Codeine 18-20
Colace 91
Colfosceril 123
CoLyte 91
Combivir 60
Compazine 24
Congenital Herpes Simplex
126
Congenital syphilis 126
Congestive Heart Failure 31
Conjunctivitis 38
Constipation 91
Cortisporin 68
Crabs 78
Creatinine clearance 128
Crixivan 60
Crolom 40
Cromolyn 37, 39
Ophthalmic 40
Croup 56
Cryptococcus 61
Curosurf 123
Cyanide 93
Cystic fibrosis 51
Cytomegalovirus 62
Cytovene 62
d4T 60
Dantrium 103
Dantrolene 103
Dapsone 59
Daraprim 62
ddC 60
ddI 60
Decadron 57, 125
Decongestants 17, 18
Deep tendon reflexes 8
Deferoxamine 98, 108
Defibrillation 30
Dehydration 111, 112
Demerol 23, 86, 87
Depakote 100
Dermatophytoses 79
Desferal 98, 108
Developmental milestones
11
Dexamethasone 45, 57, 125
Dextromethorphan 18
Dextrose 94
Dextrose infusion 89
Diabetes 103
Diabetic ketoacidosis 104
Diarrhea 83
Diazepam 23, 94, 103
Dicloxacillin 66, 69, 74
Didanosine 60
Diflucan 61
Digibind 94
Digoxin 31, 33
Digoxin immune fab 94
Digoxin overdose 94
Dilantin 99, 100
Dilaudid 22, 107
Diloxanide 85
Dimenhydrinate 24
Dimercaprol 96
Dimetane 17, 19
Dipentum 87
Diphenhydramine 23, 24,
40, 94
Discharge Note 9
Diuril 125
Divalproex 100
Dobutamine 28, 32
Dobutrex 32
Docusate 91
Dog Bite 80
Dopamine 28, 32
Doxycycline 77, 82
Dramamine 24
Dronabinol 25
Droperidol 25
Duricef 48
Dycill 66, 69, 74
Dynapen 66, 69, 74
Dysentery 85
E-mycin 51, 53
Econazole 79
Edetate calcium disodium
96
EES 50, 53, 54
ELAMax 22
Electrolyte deficit 112
Electrolyte requirements 111
Electrolytes 8
Elimite 78
EMLA cream 22
Enalaprilat 34
Encephalitis 45, 46
Endocarditis 47
Endocarditis prophylaxis 48
Entamoeba Histolytica 85
Enteroinvasive E coli 85
Enteropathogenic E coli 85
Epiglottitis 70
Epinephrine 28, 29, 40, 120
Epivir 59
Ery-Tab 51, 53
Eryc 51, 53
EryPed 50, 53, 54
Erythema migrans 82
Erythrocin 53
Erythromycin 51, 54, 69, 77,
84
Erythromycin base 52-54, 69
Erythromycin estolate 50, 69
Erythromycin ethylsuccinate
50, 52-54, 69
Erythromycin lactobionate
51-54, 56
Erythromycin/sulfisoxazole
67, 71
Ethambutol 62, 73
Ethanol 93
Ethylene glycol overdose 93
Eutectic mixture of local
anesthetics 22
Exelderm 79
Exosurf 123
Extrapyramidal reaction 94
Factor VIII 128
Feedings 128
Felbamate 102
Felbatol 102
Fentanyl 22, 23
Fexofenadine 38
Flagyl 71, 76, 83, 85
Fleet enema 91
Flonase 39
Flovent 37
Floxin 76
Fluconazole 61
Flucytosine 61
Fluid Resuscitation 112
Fluids 111
Flumadine 54, 56
Flumazenil 94
Flunisolide 37, 39
Fluticasone 37, 39
Folic acid 88, 108
Foradil 35
Formoterol 35
Formula 128
Fortaz 43, 51, 52, 66, 68
Fortovase 60
Fosphenytoin 100
Fresh frozen plasma 95
Fulvicin 79
Fungizone 61
Furazolidone 85
Furosemide 31, 114, 115,
125
Furoxone 85
Gabapentin 102
Gabitril 102
Gamma benzene 78
Ganciclovir 62
Gantrisin 64, 68
Garamycin 43, 47, 49, 50,
65, 122
Gastric Decontamination 93
Gastric lavage 93, 95
Gastroenteritis 83
Gastroesophageal reflux
disease 90
Generalized Seizures 99
Gentamicin 43, 46, 47, 49,
50, 65, 122
Giardia 85
Glucose 114
Glucose requirements 111
Golytely 91
Gonococcal infection 77
Gonorrhea 77
Granisetron 25
Grifulvin V 79
Gris-PEG 79
Grisactin 79
Griseofulvin 79
Group A Streptococcus 46
Group B Streptococcus 46
Group D Streptococcus 46
Guaifenesin 18, 20
Haemophilus immunization
14, 46
Haemophilus influenza 46,
52
Haemophilus influenzae
exposure prophylaxis
46
Haleys MO 91
HBIG 127
Head lice 78
Heart failure 31
Helicobacter pylori 71
Heparin overdose 94
Hepatitis A 86
Hepatitis B 86
Hepatitis B immune globulin
87, 127
Hepatitis B vaccine 87, 127
Hepatitis prophylaxis 127
Herpes encephalitis 46
Herpes simplex 61, 126
Herpes Varicella Zoster 62
HibTITER 14
Hismanal 38
Histoplasmosis 62
History 7
History of Present Illness 7
HIV Prophylaxis 127
Hivid 60
Human Bite 80
Humatin 85, 86
Humulin 105
Hydrea 108
Hydrocortisone 88
enema 88
Hydromorphone 22, 107
Hydroxyurea 108
Hydroxyzine 23, 41, 108
Hyperbilirubinemia 125
Hyperkalemia 113
Hypernatremia 115
Hyperosmotic soln 91
Hypertensive Crisis 34
Hypertensive emergencies
34
Hypertonic dehydration 113
Hypertonic phosphate
enemas 91
Hypertonic saline 116
Hypokalemia 114
Hypomagnesemia 118
Hyponatremia 115
Hypophosphatemia 116
Hypotension 120
Hypotonic dehydration 112
Hypovolemia 120
Ibuprofen 17, 23, 44, 63, 68,
108
IDV 60
Ilosone 50, 52-54
Imipenem/Cilastatin 51
Immunization 12
Immunoglobulin 108
Impetigo 75
Inapsine 25
Indinavir 60
Indocin 126
Indomethacin 126
Infasurf 123
Infective endocarditis 47
Influenza A 55
Influenza Immunization 16
Insulin 105
Intal 37
Intropin 32
Invirase 60
Iodoquinol 85
Ipecac 93
Iron overdose 97
Isoniazid 73
Isotonic dehydration 112
Itraconazole 61
IVIG 108
Jock itch 79
Kawasaki's syndrome 108
Kayexalate 114
KCl 32
Keflex 48, 66, 69, 75
Keppra 102
Ketamine 22
Ketoacidosis 104
Ketoconazole 61, 79
Ketorolac 24, 108
Kwell 78
Kytril 25
Labetalol
HTN crisis 34
Lactulose 91
Lamictal 100
Lamisil 79
Lamivudine 59, 60
Lamotrigine 100
Laniazid 73
Lansoprazole 72
Laryngotracheitis 56
Lasix 31, 114, 115, 125
Lead Toxicity 96
Levalbuterol 35
Levetiracetam 102
LFT's 8
Lidocaine 22, 30
Lindane 78
Lioresal 103
Lipid Solution 89
Listeria monocytogenes 46
Lorabid 50, 67, 75
Loracarbef 50, 67, 75
Loratadine 38
Lorazepam 23, 99
seizures 99
Lotrimin 79
Lumbar puncture 44, 45
Luminal 100
Lyme disease 82
Magnesium Chloride 118
Magnesium Citrate 93
Magnesium Gluconate 118
Magnesium Hydroxide 91
Magnesium Oxide 118
Magnesium sulfate 118
Magonate 118
Maintenance fluids 111
Malignant otitis media 68
Marinol 25
Medipren 17, 23
Mefoxin 64, 74, 77
Meningitis 44, 45
Meningococcal exposure
prophylaxis 46
Meperidine 23, 86, 87
Mepron 59
Meropenem 45, 51
Merrem 45, 51
Mesalamine 87
Metamucil 91
Metaprel 35, 37
Metaproterenol 35, 37
Methanol overdose 93
Methicillin-resistant
Staphylococcus aureus
47
Methicillin-sensitive
Staphylococcus aureus
47
Methohexital 23
Methylprednisolone 36
enema 88
Metoclopramide 25, 90
Metronidazole 71, 76, 83
Mezlin 122
Mezlocillin 122
Micatin 79
Miconazole 79
Micro-K 114
Midazolam 23, 33
Milk of Magnesia 91
Mineral oil 91
Mometasone 39
Montelukast 37
Moraxella 53
Morphine 23, 107
Motrin 17, 23, 108
Mucomyst 95
Mupirocin 75
Murmurs 8
Myambutol 62, 73
Mycobacterium avium
complex 62
Mycobutin 62
Mycoplasma pneumoniae
52
Mysoline 101
N-Acetylcysteine 95
Nafcil 46, 47, 51, 74, 122
Nafcillin 46, 47, 51, 74, 122
Naftifine 79
Naftin 79
Nail fungus 79
Naloxone 93, 94, 120
Naprelan 24
Naprosyn 24
Naproxen 24
Naproxen sodium 24
Narcan 93, 94, 120
Narcotic depression 120
Narcotic overdose 93
Nasacort 39
Nasalcrom 39
Nasalide 39
Nasonex 39
Nebcin 43, 46, 47, 51, 122
NebuPent 59
Necrotizing enterocolitis 123
Nedocromil 37
Neisseria meningitides 45
Neo-Synephrine 18
Neonatal resuscitation 119
Neonatal Sepsis 121
Neurontin 102
Newborn care 119
Nifedipine 34
Nipride 34
Nitroglycerine 32
Nitroprusside 34
Nix 78
Nizoral 61, 79
Norvir 60
Novafed 18, 40
Nuprin 17, 23
Nystatin 61
Ofloxacin 76
Oliguria 128
Olsalazine 87
Omeprazole 72
Ondansetron 25
Opticrom 40
Optivar 39
Oral rehydration 113
Organophosphates 94
Oseltamivir 54, 55
Osmolality, estimate of 128
Osteomyelitis 66
Otitis externa 68
Otitis media 67
Ounce 128
Oxacillin 46, 51, 52, 74
Oxiconazole 79
Oxistat 79
Pain 22
Palivizumab 55
Parenteral Nutrition 88
Paromomycin 85, 86
Partial seizure 100
Past Medical History 7
Patent ductus arteriosus 126
Pathocil 66, 69, 74
Patient controlled analgesia
107
PCP prophylaxis 59
PediaCare 19
PediaCare Cold Allergy 19
PediaCare Cough-Cold 19
PediaCare Night Rest 19
Pedialyte 113
Pediatric Advanced Life
Support 27
Pediazole 67, 71
Pediculosis 78
PedvaxHIB 14
Pelvic Inflammatory Disease
76
Pen Vee K 69, 108
Penicillin G 45, 47, 69, 126
Penicillin V 69, 108
Pentam 58
Pentamidine 58, 59
Pentasa 87
Pentothal 23
Pepto-Bismol 72
Periorbital cellulitis 74
Peripheral parenteral
nutrition 90
Permethrin 78
Pertussis 56
Pharyngitis 69, 77
Phenazopyridine 65
Phenergan 19, 23, 24
Phenergan with Codeine 19
Phenergan with
Dextromethorphan 20
Phenobarbital 99, 100, 125
Phenothiazine reaction 94
Phenylephrine 18
Phenytoin 99, 100
Phosphate 117
Physical Examination 7, 8
Physostigmine 94
Phytonadione 95
Piperacillin 43, 51, 52, 68

Piperacillin/tazobactam 43,
51
Pipracil 43, 51, 52, 68
Platelet count 128
Pleural effusion 41
Pleurocentesis 41
Pneumocystis Carinii
Pneumonia 58
Pneumonia 49, 52
Poisoning 93
Polyethylene glycol 91
Polymyxin B 68
Poractant alfa 123
Potassium 32, 114
elixir 114
Potassium chloride 114
Potassium phosphate 117
Potassium requirements
111
Pralidoxime 94
Prednisolone 36, 57
Prednisone 36, 57, 59, 125
Prescription Writing 10
Prevacid 72
Prilocaine 22
Prilosec 72
Primaxin 51
Primidone 101
Probenecid 77
Procainamide 33, 34
Procaine penicillin G 126
Procardia 34
Procedure Note 10
Prochlorperazine 24
Proctitis 77
Progress Notes 9
Promethazine 19, 20, 23, 24
Propoxyphene overdose 93
Propranolol 33
Propulsid 90
Prostaphlin 46, 51, 52, 74
Protamine sulfate 94
Proventil 35, 37, 55
Pseudoephedrine 18, 40
Pseudomembranous Colitis
83
Pseudomonas 52
Pubic lice 78
Pulmicort 37
Pulseless electrical activity
30
Pyelonephritis 65
Pyrazinamide 73
Pyrethrin 78
Pyridium 65
Pyrimethamine 62
Quinidine 33
R&C 78
Racemic epinephrine 35
Ranitidine 72, 90
Reglan 25, 90
Rehydralyte 113
Reptile Bite 80
RespiGam 55
Respiratory distress
syndrome 123
Respiratory failure 27
Respiratory syncytial virus
55
Retropharyngeal Abscess
69
Retrovir 59
Review of Systems 7
Revital Ice 113
Rhinitis 38
Rhinocort 39
Ribavirin 55
Ricelyte 113
Rid 78
Rifabutin 62
Rifadin 62, 73
Rifampin 45, 46, 62, 73
Rimantadine 54, 56
Ringworm 79
Ritonavir 60
Robitussin 18
Robitussin AC 20
Robitussin DM 20
Robitussin-DAC 20
Rocephin 43-46, 67, 70, 76,
77
Romazicon 94
Rondec 20
Rondec DM 21
Rotavirus 84
Rowasa 87
RSV-IVIG 55
RTV 60
Ryna 21
Rynatan 21
Sabril 102
Salmeterol 35
Salmonella 83
Saquinavir 60
Scabies 78
Scalded skin syndrome 75
Sedation 22
Seizure 99
Selenium sulfide 79
Senna 92
Senna-Gen 92
Sennosides 92
Senokot 92
Septic arthritis 62
Septra 53, 58, 64, 67, 70
Serevent 35
Shigella 83, 84
Shigella Sonnei 84
Shock 28
SIADH 115
Sickle Cell Crisis 107
Singulair 37
Sinusitis 70
Slo-Phyllin 36
Slobid 36
Slow-Mag 118
Sodium bicarbonate 114
Sodium deficit 116
Sodium Nitrite 94
Sodium phosphate 117
Sodium requirements 111
Sodium thiosulfate 94
Solu-Medrol 36
Spasticity 103
Spectazole 79
Spironolactone 125
Sporanox 61
SQV 60
Staphylococcal scarlet fever
75
Staphylococcus 46
Staphylococcus aureus 47
Staphylococcus epidermidis
47
Status epilepticus 99
Stavudine 60
Streptococcal pharyngitis 69
Streptococcus pneumoniae
45
Streptomycin 73
Succimer 96
Sudafed 18, 40
Sulconazole 79
Sulfadiazine 62
Sulfasalazine 87
Sulfisoxazole 64, 68, 71
Supraventricular tachycardia
29
Suprax 50, 67, 83, 84
Surfactant 123
Survanta 123
Suspected neonatal sepsis
121
Suspected sepsis 43, 121
Suspected Sepsis, Neonatal
121
Symmetrel 54, 56
Symptomatic Care 17
Synagis 55
Syphilis 126
Tagamet 90
Tamiflu 54, 55
Tegretol 99, 100
Terbinafine 79
Terbutaline 35
Tetanus 76
Tetanus Ig 76
Tetanus immune globulin 76
Tetanus toxoid 76
Tetracycline 53, 71
Theo-Dur 36
Theophylline 36
Theophylline overdose 97
Thiopental 23
Thiosulfate 94
Thoracentesis 41
Thorazine 23, 24
Tiagabine 102
Ticar 43, 52, 68
Ticarcillin 43, 52, 68
Ticarcillin/clavulanate 43,
51, 66, 74
TIG 76
Tigan 25, 86, 87
Tilade 37
Timentin 43, 51, 66, 74
Tinea 79
Tinea capitis 79
Tinea corporis 79
Tinea cruris 79
Tinea pedis 79
Tinea Unguium 79
Tinea Versicolor 79
TMP/SMX 68, 83
Tobramycin 43, 46, 47, 51,
122
Tonsillopharyngitis 69
Topamax 102
Topiramate 102
Toradol 24, 108
Total parenteral nutrition 88
Toxicology 93
Toxoplasmosis 62
TPN 88
Trandate 34
Transfusion 108
Travelers diarrhea 85
Triamcinolone 37, 39
Trifluridine 126
Trimethobenzamide 25, 86,
87
Trimethoprim/SMX 53, 58,
64, 67, 70, 83
Triprolidine 18, 38
Tuberculosis 72
Tylenol 17, 22, 51
Tylenol Cold 21
UA 8
Ulcerative colitis 87
Unasyn 81
Urethritis 77
Urinary tract infection 64
Urine analysis 8
Urine output 128
Uro-KP-Neutral 117
Valium 23, 99, 103
Valproic acid 100
Vancenase 38, 39
Vanceril 37
Vancocin 44-47, 51, 52, 122
Vancomycin 44-47, 51, 52,
122
Vantin 50, 64, 67, 75, 81
Varicella 62
Varicella Immunization 15
Varicella Zoster 57
Varicella zoster immune
globulin 57
Vasotec IV 34
Ventolin 35, 40, 55
Ventricular tachycardia 30
Ventriculoperitoneal shunt
infection 58
Verapamil 29
Versed 23, 33
Vibramycin 77, 85
Vicks Pediatric Formula 44D
21
Vicks Childrens NyQuil 21
Vicks Formula 44 18
Videx 60
Vigabatrin 102
Virazole 55
Viroptic 126
Vistaril 23, 41, 108
Vitamin B12 88
Vitamin C 108
Vitamin K 95
VZIG 57
Warfarin overdose 95
Xopenex 35
Yersinia 84
Yodoxin 85
Zafirlukast 37
Zalcitabine 60
Zantac 72, 90
Zerit 60
Zidovudine 59, 60, 127
Zileuton 37
Zinacef 49, 50, 52, 53, 63, 66
Zithromax 48, 50, 54, 67, 77
Zofran 25
Zoster 62
Zosyn 43, 51
Zovirax 46, 57, 61, 62, 126
Zyflo 37
Zyrtec 38

Pediatrics

Uploaded by

Copyright:

Available Formats

Pediatrics

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pediatrics

Uploaded by

Copyright:

Available Formats

Contents

Pediatric History and Physical Examination . . . . . . . . . . . . . . . . . . . . . . . . 7

Pediatric Symptomatic Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Varicella Zoster Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Gastroesophageal Reflux Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

Neurology and Endocrinology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Seizure and Status Epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Adjunctive Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102

New Onset Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103

Diabetic Ketoacidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104

Hematologic and Inflammatory Disorders . . . . . . . . . . . . . . . . . . . . . . . 107

Sickle Cell Crisis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107

Kawasaki's Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108

Fluids and Electrolytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Newborn Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119

Neonatal Resuscitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119

Suspected Neonatal Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121

Respiratory Distress Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Commonly Used Formulas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128

Pediatric History and Physical Examination 7

problems. Name and relationship to child of informant (patient, mother).

Chief Compliant: Reason given by patient/informant for seeking medical care

and the duration of the symptom(s).

including when it began, character of the symptom(s); aggravating or alleviating

factors; pertinent positives and negatives. Past diagnostic testing.

Past Medical History (PMH): Past diseases, surgeries, hospitalizations; medical

problems; history of asthma.

Birth History: Gestational age at birth, preterm, obstetrical problems.

Developmental History: Motor skills, language development, self-care skills.

Medications: Include prescription and OTC drugs, vitamins, herbal products,

natural remedies, nutritional supplements.

Feedings: Diet, volume of formula per day.

Drug Allergies: Penicillin, codeine?

Family History: Medical problems in family, including the patient's disorder.

Asthma, cancer, tuberculosis, allergies.

Social History: Family situation, alcohol, smoking, drugs. Level of education.

Review of Systems (ROS):

General: Weight loss, fever, chills, fatigue, night sweats.

Skin: Rashes, skin discolorations.

Head: Headaches, dizziness, seizures.

Eyes: Visual changes.

Ears: Tinnitus, vertigo, hearing loss.

Nose: Nose bleeds, discharge.

Mouth and Throat: Dental disease, hoarseness, throat pain.

Respiratory: Cough, shortness of breath, sputum (color and consistency).

Cardiovascular: Dyspnea on exertion, edema, valvular disease.

Gastrointestinal: Abdominal pain, vomiting, diarrhea, constipation.

Genitourinary: Dysuria, frequency, hematuria.

Gynecological: Last menstrual period (frequency, duration), age of menarche;

dysmenorrhea, contraception, vaginal bleeding, breast masses.

Endocrine: Polyuria, polydipsia.

8 Pediatric History and Physical Examination

Skin and Lymphatics: Easy bruising, lymphadenopathy.

Neuropsychiatric: Weakness, seizures.

Pain: quality (sharp/stabbing, aching, pressure), location, duration

Physical Measurements: weight, height, head circumference (plot on growth

Vital Signs: Temperature, heart rate, respiratory rate, blood pressure.

Lymph Nodes: Cervical, axillary, inguinal nodes: size, tenderness.

Head: Bruising, masses, fontanels.

extra ocular movements intact (EOMI). Funduscopy (papilledema, hemorrhages,